Investigation of asparagine-linked glycosylation in archaeal and bacterial systems by Larkin, Angelyn (Angelyn Kathryne)
Investigation of Asparagine-Linked Glycosylation in Archaeal
and Bacterial Systems
by MASSACHUSETTS INSTITUTEOF TECHNOLOGY
Angelyn Larkin FEB 11 2011
B.A. Chemistry and Political Science LIBRARIES
Wellesley College, 2003
ARCHIVES
Submitted to the Department of Chemistry
in Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
at the
Massachusetts Institute of Technology
December 2010
0 2010 Massachusetts Institute of Technology
All rights reserved
Signature of Auth_________________________
Department of Chemistry
December 10, 2010
Certified by:
Barbara Imperiali
Class of 1922 Professor of Chemistry and Professor of Biology
Thesis Supervisor
Accepted by:
Robert W. Field
Haslam and Dewey Professor of Chemistry
Chairman, Departmental Committee on Graduate Students
This doctoral thesis has been examined by a committee of the Department of Chemistry as
follows:
Professor Sarah E. O'Connor:
Chair
Associate Professor of Chemistry
Professor Barbara Imperiali:
Thesis Supervisor
Class of 1922 Professor of Chemistry and Professor of Biology
Professor Catherine L. Drennan:
Professor of Chemistry and Biology
Investigator and Professor, Howard Hughes Medical Institute
Investigation of Asparagine-Linked Glycosylation in Archaeal and Bacterial Systems
by
Angelyn Larkin
Submitted to the Department of Chemistry
on December 10, 2010 in Partial Fulfillment of the
Requirements for the Degree of Doctor of Philosophy
ABSTRACT
Asparagine-linked protein glycosylation entails the stepwise assembly of an
oligosaccharide onto a polyisoprenyl diphosphate carrier, followed by the en bloc transfer of
the glycan onto acceptor proteins by oligosaccharyl transferase (OTase). It is now clear that this
N-linked protein modification catalyzed by OTases is conserved in all three kingdoms of life.
In contrast to eukaryotic OTases, which are multimeric complexes made up of several
membrane-spanning proteins, bacterial and archaeal OTases instead appear to be composed of
just a single membrane-bound subunit, offering a more tractable system for detailed
biochemical characterization. Although significant progress has been made with the bacterial
OTase PglB from Campylobacterjejuni, problems with low protein expression yields and poor
stability have complicated in depth study. In order to identify a more suitable OTase candidate,
a selection of archaeal OTases was screened for heterologous expression levels in Escherichia
coli, and it was determined that the homolog from the methanogen Methanococcus voltae
possessed the best protein expression profile, indicating a 100-fold improvement over PglB.
In an effort to generate a substrate to probe the function of the M voltae OTase, we
required a robust synthesis of the highly modified UDP-GlcNAc(3NAc)A and thus turned to
the Wbp pathway from the opportunistic pathogen Pseudomonas aeruginosa. Early genetic
studies suggested that P. aeruginosa produces UDP-GlcNAc(3NAc)A as a precursor to
ManNAc(3NAc)A, a carbohydrate found in the O-antigen of the lipopolysaccharide of the
organism. Using a combination of protein biochemistry and NMR spectroscopy, three enzymes
(WbpB, WbpE, and WbpD) were confirmed to be responsible for the biosynthesis of UDP-
GlcNAc(3NAc)A. It is shown that WbpB and WbpE are a dehydrogenase/aminotransferase
pair that converts UDP-GlcNAcA to UDP-GIcNAc(3NH 2)A in a coupled reaction via a unique
NAD* recycling pathway. In addition, the X-ray crystal structure of WbpE was solved in
complex with its PLP cofactor and UDP-GlcNAc(3NH 2)A product as the external aldimine.
With UDP-GlcNAc(3NAc)A in hand, preliminary steps towards completion of the desired
dolichyl-linked substrate for the study of the M. voltae OTase are described.
Finally, biochemical studies were undertaken in an attempt to inhibit the C. jejuni
OTase, PglB. To this end, a panel of isosteric peptides was synthesized to identify possible
PglB inhibitors. In addition, treatment of PglB with residue-specific alkylating agents coupled
with site-directed mutagenesis revealed a key histidine residue that may play an important role
in enzyme catalysis. Taken together, these studies offer insight into long-standing questions
about the mechanism of oligosaccharide transfer.
Thesis Supervisor: Barbara Imperiali
Title: Class of 1922 Professor of Chemistry and Professor of Biology
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Chapter 1 Introduction
Introduction
Glycosylation is the most abundant protein modification found in nature, occurring
across all kingdoms of life.1 The great variety of carbohydrates coupled with the vast number of
possible carbohydrate linkages serve to diversify the proteome in a manner beyond what is
directly encoded in the genome. The appendage of a glycan to a protein can profoundly impact
its function, playing important roles in a number of biological processes such as protein stability
and rigidity, intracellular localization, cellular signaling and adhesion, and the immune
response.
There are three major types of protein glycosylation that have been observed in nature
(Figure 1-1): N-linked, 0-linked, and GPI-anchored. N-linked glycosylation, the focus of'this
chapter, involves the en bloc transfer of an oligosaccharide onto the side chain amide nitrogen
of asparagine residues within acceptor proteins. In the case of 0-linked glycosylation,
monosaccharides are typically ligated one at a time onto the side chain hydroxyl oxygen atom of
either serine or threonine residues; however, in recent years, glycosylation of other residues
such as tyrosine, hydroxylysine, and hydroxyproline has also been identified.' In the third type,
a complex glycosylphosphoinositol moiety (GPI anchor) is transferred to the C-terminus of a
target protein, serving to tether it to the cell membrane. Other classes of protein glycosylation
have also been described in addition to these three main types, including phosphoglycosylation,
in which sugar 1-phosphates are added to the hydroxyl oxygen atom of serine,4 ,5 and C-
mannosylation, where mannose residues are transferred to the C2' indole carbon of tryptophan
residues,6 although the biochemical details of these modifications are still unclear and require
further investigation.
N-linked glycan
0-linked glycans
GPI anchor
Figure 1-1: Three major classes of protein glycosylation.
While N-linked glycosylation was once believed to be limited only to eukaryotes, it is
now firmly established that this complex modification occurs in both bacteria and archaea as
well.'', In the last ten years, the field of N-linked glycosylation has made enormous strides in
elucidation of the enzymes involved in glycan assembly and processing, discovery of new and
unusual carbohydrates, and the biological impact that these glycan modifications impart on the
function of target proteins. In this chapter, the process of N-linked glycosylation will be
.... . ...................... .
discussed across the three kingdoms of life. Special focus will be placed on the different means
by which the glycans are assembled, the variety in the glycan structures, and how this structural
diversity imparts function to specific glycoproteins. In addition, a brief overview of the role that
N-linked glycosylation plays in viruses will be presented as well.
N-linked Glycosylation in Eukaryotes
Glycan Assembly
In eukaryotes, N-linked glycosylation occurs at the membrane of the endoplasmic
reticulum (ER), and involves the transfer of a tetradecasaccharide (Glc 3Man9GlcNAc 2) from a
dolichyldiphosphate carrier onto the amide side chain nitrogen of an acceptor protein. Although
a majority of the genetic and biochemical characterization of this pathway has been achieved in
Saccharomyces cerevisiae, the process is remarkably conserved in all eukaryotes, from yeast to
man.9 Assembly of the glycan is carried out by a series of membrane-bound
glycosyltransferases in the Alg family (asparagine-linked glycosylation), which catalyze the
transfer of each monosaccharide onto a dolichyldiphosphate carrier. Dolichol, a long chain a-
saturated polyisoprene that varies in size between 14 and 21 units depending on the cell type
and species, is phosphorylated by the kinase Sec59 prior to glycan assembly.10 "1 In addition to
its role as a membrane anchor, dolichylphosphate may serve other functions in the glycosylation
process as well, such promoting membrane fluidity, facilitating translocation across the ER
membrane, and recruitment of key enzymes to the site of glycosylation.12 14
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Figure 1-2: Pathway of N-linked glycosylation at the ER membrane in S. cerevisiae. In the first
half of the process, the glycan is assembled from nucleotide sugar donors before being flipped
to the ER lumen. The glycosyl donors in the lumen are Dol-P-Man and Dol-P-Glc, the
biosynthesis of which is shown on the right.
The first phase of glycan assembly takes place on the cytoplasmic side of the ER
membrane, where a high concentration of the nucleotide sugars donors (UDP-GlcNAc or GDP-
Man) act as substrates for the early glycosyltransferases. The pathway begins with the addition
of GlcNAc-l-P to the Dol-P carrier by Alg7," followed by the transfer of the second GlcNAc
residue by the Algl3/14 complex. 16'1 7 Recent work has established that the C-terminal domains
of both Alg 13 and Alg14 interact to form a functional glycosyltransferase capable of catalyzing
GlcNAc transfer.1 '"9 The first mannosylation is performed by Algl and serves as the primary
branching point in the glycan structure.20'2 1 Alg2 and Alg 11 then sequentially install the next
.......... 
four mannose residues, in which Alg2 carries out c- 1,6 and c- 1,3 mannosylations, followed by
22-25two iterative a- 1,2 mannose additions by Alg 11 to yield the heptasaccharide.2-2 Genetic and
biochemical studies have recently indicated that these early enzymes form discrete protein
complexes in the ER membrane that may be important for maintaining flux through the
pathway.26,27 After completion of the heptasaccharide, the Dol-PP-GlcNAc 2Man5 intermediate is
flipped from the cytoplasmic to the lumenal face of the ER by a process that remains unclear.
While early genetic studies implicated Rftl as the required flippase,2 8 recent biochemical
evidence has suggested that this protein is in fact not required for translocation of the
oligosaccharide intermediate, although the identity of the enzyme responsible has not yet been
determined.29 32 Further work in this area is necessary to characterize this elusive step.
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Figure 1-3: Structure of the eukaryotic N-linked glycan, Glc3Man9GlcNAc2. The nature of the
linkage between each carbohydrate is specified.
Glycan assembly continues on the lumenal side of the ER membrane, where the
remaining four mannosylations are catalyzed by the actions of Alg3, Alg9, Alg12, and Alg9;33
Alg9 has been shown to transfer both a-1,2-linked mannose residues that cap two of the three
branches of the glycan.34 The three terminal glucose residues are then installed onto the nascent
oligosaccharide by Alg6, Alg8, and Alg10, respectively, to afford the final tetradecasaccharide
Glc3Man9 GlcNAc 2 (Figure 1-3).33 Unlike in the first phase of the pathway, the sugar donors on
the lumenal side are the dolichylphosphate-linked monosaccharides Dol-P-Man and Dol-P-
Glc.3 5 These Dol-P-monosaccharides are synthesized by the enzymes Dpml and Alg5 on the
cytoplasmic face of the ER membrane, and then flipped into the lumen by an unknown
mechanism. 36-38 The underlying reasons behind why the cell switches to membrane-bound
dolichyl-linked glycosyl donors in the ER lumen compared with the soluble nucleotide sugars in
the cytoplasm are unclear, but presumably the scarcity of nucleotide sugar transporters in the ER
membrane is a critical factor.
Although the structure of the core Glc 3Man9 GlcNAc2 tetradecasaccharide is widely
conserved across eukaryotes, several species of protists have been found to assemble only
truncated forms of the glycan. 39,40 Recent studies have found that these truncations are due to a
loss of certain sets of glycosyltransferases over the course of evolution. 41 For example, the
causative agent of Chagas disease, Trypanosoma cruzi, produces only Dol-PP-GlcNAc 2Man9
and is missing the glucosyltransferases Alg6, Alg8, and Alg10. In contrast, Tetrahymena
pyriformis has lost all mannosylation function in the ER lumen, producing only Dol-PP-
GlcNAc 2Man5 Glc 3. In an extreme case, Plasm odium falieparum, the cause of malaria infection
in humans, is missing all the Alg glycosyltransferases except Alg7, thus generating only Dol-
PP-GlcNAc and providing an explanation for the difficulty in identifying N-linked glycoproteins
in this species.41 42
Glycan Transfer
After assembly of the oligosaccharide is complete, it is transferred to the side chain
amide of acceptor proteins by the multimeric oligosaccharyl transferase (OT) complex. In S.
cerevisiae, OT is composed of at least eight membrane-bound subunits (Ost3/6, Ost4, Stt3,
Ost2, Wbpl, Swpl, Ost5, and Ostl) and genetic studies have determined that at least five of
these (Ostl, Ost2, Stt3, Swpl, and Wbpl) are essential for survival (Figure 1-4).4%44 Recent
evidence indicates that multiple isoforms of the OT complex containing various combinations of
subunits can exist within the same cell and may serve to modulate activity. For example, OT
isoforms containing Ostl and Swpl are required for glycosylation of certain membrane
proteins,4 5 while the presence of either Stt3A or Stt3B impacts the kinetics and timing of
glycosylation, promoting either co- or posttranslational catalysis.46
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Figure 1-4: Subunits of the S. cerevisiae oligosaccharyl transferase complex. (A) Predicted
topology of the individual subunits, where the arrows indicate the N-termini of the individual
proteins; (B) Three-dimensional cryo-EM map of the OT complex, as reported by Li et al.47
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Despite challenges associated with isolation and expression of the complex, several key
studies have contributed toward understanding the specific roles of each subunit. The putative
binding site of the dolichyl-linked oligosaccharide was assigned to Wbpl, as incubation of OT
with Dol-PP-GlcNAc 2 was able to prevent alkyation of specific cysteine located within the
Wbp 1 subunit.48 The Ost3/Ost6 proteins have been recently shown to exhibit protein-dependent
oxidoreductase activity in vitro, suggesting a direct role for OT in protein folding.49 In addition,
a number of factors have emerged to suggest that Stt3 is the catalytic subunit of the OT
complex. Stt3 is the most highly conserved subunit of the OT, as homologs of this protein are
found in all eukaryotes and throughout the archaeal and bacterial kingdoms, and the Stt3
homolog in the bacterial pathogen Campylobacterjejuni, PglB, is sufficient to catalyze glycan
transfer. 50 In addition, the eukaryotes Leishmania major and Trypanosoma brucei were found to
contain only the Stt3 subunit of OT but are still capable of N-linked glycosylation.51-53 Although
structural studies of the entire OT complex are currently lacking, progress has been made to
understand the proximity of each subunit to the others. To this end, the cryo-EM structure of the
OT complex at 12 A was recently reported (Figure 1-4B).47
The conformational requirements of the acceptor protein have been widely analyzed and
do not appear to be very stringent.44 However, not all asparagines found within the N-X-T
sequon are glycosylated; in fact, it was recently estimated that roughly 35% of N-linked sequons
that pass through OT are not modified.44 4 Early work showed that OT does not glycosylate
proteins that contain a proline in the X position of the N-X-S/T sequence,55 and exhibits a
modest preference for N-X-T sites compared with N-X-S. 56 In addition, sites within 12-14
residues of the N-terminus are not glycosylated, suggesting that the active site is 30-40 A from
the ER lumenal membrane.57 The secondary structure of the glycosylation site has also been
found to be a determinant for catalysis, as the N-X-S/T sequon must be able to adopt an Asx-
turn, which has been proposed to promote activation of the side chain amide nitrogen in the
catalytic mechanism.58'59
Functional Roles of N-Linked Glycans
After glycosylation, the newly formed glycoproteins are processed by a series of
glycosidases and glycosyltransferases in both the ER and Golgi to alter the core
tetradecasaccharide, resulting the vast diversity of N-linked glycan structures observed in
eukaryotes. These modifications include glycan trimming, as well as the addition of
carbohydrates such as sialic acid, fucose, and N-acetylgalactosamine to form complex and
branched structures.1 The mature glycans are important for a number of biological functions,
including promoting protein stability and rigidity, intracellular targeting, cell signaling, and the
immune response. Mutations in almost every step of the glycan biosynthesis pathway lead to a
group of debilitating and often fatal diseases that are collectively termed the congenital
disorders of glycosylation (CDG), underscoring the importance of this protein modification to
human health.60
Perhaps the most well-studied role for N-linked glycans in eukaryotes involves quality
control for protein folding in the ER.6 1,62 In the cotranslational pathway of N-linked
glycosylation, newly synthesized proteins leaving the ribosome are translocated through the ER
membrane by way of the Sec61 translocation channel and then presented to the OT complex.
After glycan transfer, the nascent glycoproteins enter an elaborate quality control cycle that
serves to ensure proper folding and utilizes all three branches of the core glycan (Figure 1-5).
The first step in this cycle involves the removal of two of the terminal glucose residues from the
glycan core by glucosidases I and II.63 The nascent glycoprotein then encounters two ER
chaperones that recognize the monoglucosylated glycan, the membrane-bound calnexin and
soluble calreticulin. These chaperones sequester the newly formed protein to prevent
aggregation and misfolding, and also provide access to ERp57, an oxidoreductase that aids in
disulfide bond formation. Once the protein is properly folded, glucosidase II removes the
remaining glucose, which stimulates release of the protein from calnexin and calreticulin and
progression through the remainder of the glycan-processing pathway in the ER and Golgi.
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Figure 1-5: The calnexin/calreticulin pathway of quality control for protein folding. (1) Nascent
proteins travel through the translocon and are glycosylated by OT; (2) The two terminal glucose
residues are removed by glucosidase I and II; (3) The folding protein interacts with the
chaperones calnexin and calreticulin and the ERp57 oxidoreductase. If misfolded, they are
recognized by UGGT and cycled through the pathway again; (4) Defective proteins are
demannosylated and ultimately sent for degradation through the ERAD pathway, while properly
folded proteins exit the cycle.
However, if the protein is misfolded, it binds to the folding sensor UDP-
glucose:glycoprotein glucosyltransferase (UGGT).63 ,64 UGGT contains a hydrophobic N-
...........  ..    .. . . ... .. ..........   .... .
.... .. ....
terminal domain that recognizes non-native protein structures, and a C-terminal
glucosyltransferase domain that reglucosylates misfolded proteins, causing them to rebind
calnexin and calreticulin. The iterative removal and addition of glucose by glucosidase II and
UGGT persists until either the protein is folded or it is recognized by the c-1,2-mannosidases
64present in the ER, which remove terminal mannose residues from the glycan core. Progressive
mannose removal lowers the glycan affinity for calnexin/calreticulun and ultimately serves as a
folding timer to interrupt the folding cycle and target the defective glycoprotein for degradation
through the ER-associated degradation pathway (ERAD).65
In addition to their role in the quality control of protein folding, N-linked glycans
perform a variety of other functions within eukaryotes. They serve as identity and localization
tags to direct proteins to the proper cellular destination, and regulate mobility of proteins on or
within the cell membrane through interactions with lattice-forming lectins, such as galectins.66
N-linked glycans also impart structural rigidity to their targets and may provide protection from
proteolysis, such as in the case of the heavily glycosylated lysosomal membrane proteins Lamp-
1 and Lamp-2.61'11 In addition, the surface N-linked glycans of cancer cells have been found to
be highly branched compared with those of healthy tissues; exploitation of this difference may
present a platform for the development of clinical biomarkers of disease.69'70
N-linked Glycosylation in Bacteria
Despite the enormous complexity and structural diversity of glycans that comprise the
lipopolysaccharide (LPS) and capsular polysaccharide (CPS) of bacterial cell walls, it was
believed for the past half century that bacteria were unable to glycosylate proteins.71 73
However, in the last decade, this dogma has been disproven with discovery of both N-linked and
0-linked bacterial glycoproteins. In 1999, the first evidence of a general system of N-linked
glycosylation was uncovered in the human mucosal pathogen C. jejuni.'4 The genes in this pgl
locus (protein glycosylation) are homologous to specific genes in both the CPS or LPS
pathways, yet mutations in this cluster resulted in a loss of immogenicity without affecting LPS
or CPS biosynthesis, providing an initial link between N-linked glycosylation and host
pathogenicity.74'75 Structural characterization of the glycoproteins PEB3 and CgpA determined
that the glycan was the heptasaccharide GlcGalNAc5Bac, which forms a p-linkage to asparagine
(Figure 1-6).76'77 To date, over 65 glycoproteins of various biological functions have been
characterized in C. jejuni, although new approaches to glycan analysis coupled with access to
newly sequenced bacterial genomes suggest that number is sure to increase.7
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Figure 1-6: Structure of the N-linked GlcGalNAc5Bac heptasaccharide identified in C. jejuni.
Glycan Assembly
The N-linked glycosylation pathway in C. jejuni, shown in Figure 1-7, bears
resemblance to the first half of the dolichol pathway in S. cerevisiae (Figure 1-2). The glycan is
assembled on the cytoplasmic face of the membrane, and involves stepwise elaboration onto an
polyisoprenyl-diphosphate carrier by a series of glycosyltransferases that rely on nucleotide
sugar donors. However, although the overall architecture of the pathway is similar, several
differences distinguish N-linked glycosylation in eukaryotes and bacteria. For one, the isoprenyl
carrier in bacteria is undecaprenol, a long chain unsaturated polyisoprene composed of 11 units
that is the most abundant isoprene in bacterial membranes. 8 In addition, the first sugar in the C.
jejuni N-linked glycan is NN'-diacetamidobacillosamine (Bac), rather than the GlcNAc residue
found in eukaryotic glycans. In general, prokaryotes contain a variety of unique, highly-
modified sugars not commonly observed in eukaryotes.79' 80 Originally discovered in Bacillus
subtilis, Bac is found in a number of bacterial glycans including the LPS of Vibrio cholerae, the
CPS of Acinetobacter lwofli, and the pilin of Neisseria meningitidis.81-84
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Figure 1-7: N-linked glycosylation pathway in C. jejuni.
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Figure 1-8: Biosynthesis of UDP-Bac from UDP-GlcNAc by the C. jejuni enzymes PglF, PgIE
and PglD.
The N-linked glycosylation pathway in C. jejuni is initiated by the biosynthesis of the
UDP-Bac by the enzymes PglF, PglE and PglD (Figure 1-8). Starting from UDP-GlcNAc, the
dehydratase PglF generates the UDP-4-keto intermediate via an NAD*-promoted hydride
transfer and facilitated elimination, followed by formation of the UDP-4-amino sugar by the
PLP-dependent aminotransferase PglE. 85 PglD then catalyzes the acetylation of UDP-4-amino
using AcCoA to afford UDP-Bac.86 The phosphoglycosyltransferase PglC initiates carbohydrate
transfer to the undecaprenylphosphate carrier by installing Bac- 1 -P, succeeded by the addition
of the first and second a- 1,3 and a- 1,4-linked GalNAc residues by PglA and PglJ,
respectively. 87-89 Analysis of the polyisoprene specificity of these enzymes revealed that the a-
unsaturation and the cis-double bond geometry of undecaprenol was more important than small
changes in the polyisoprene length, highlighting the significance of the specific polyisoprene
structure to the enzymes in the glycosylation pathway.90 The trisaccharide is then elaborated
through the action of the polymerase PglH, which installs the next three a-1,4-linked GalNAc
residues.91 Detailed kinetic examination revealed that PglH uses a single active site to carry out
three galactosyltransfer reactions, and exhibits an increasingly stronger affinity for its product as
the glycan size lengthens, which serves to halt catalysis after the third transfer. The assembly of
the heptasaccharide is completed with the addition of a branching P-1,3 linked glucose residue
by the membrane protein PglI. The entire pgl locus along with two C. jejuni perisplasmic
proteins, AcrA and PEB3, have been inserted into Escherichia coli and the system was shown
capable of glycosylation, indicating that all of the necessary components of the pathway were
present.92 Interestingly, these enzymes can all be combined with the obligate cofactors and
cosubstrates to generate the full length Und-PP-BacGalNAc5 Glc in vitro, which represents the
first complete synthesis of a polyisoprenyl-linked oligosaccharide.'' 9
In addition to C. jejuni, evidence of N-linked glycosylation pathways in other species of
bacteria is slowly beginning to emerge. Wolinella succinogenes was shown to contain a pg/ gene
cluster, although the glycan structure as well as the identity of possible target proteins is still
unclear. 93 Structural analysis of the HmcA protein from the sulfate-reducing bacterium
Desulfovibrio gigas revealed the presence of a trisaccharide linked to asparagine, but the exact
composition of this glycan remains unknown. Several species of Helicobacter, including H.
canadensis and H. pullorum, also possess pgl gene clusters. Recent biochemical studies have
shown that H. pullorum contains two isoforms of the pg/B OTase gene; however, only one of
these genes is responsible for transfer of a linear N-linked glycan comprising five hexosamine
sugars, while the role of the second isoform is still under investigation. 95 Bioinformatic analyses
of newly sequenced bacterial genomes suggests the presence of pgl genes in over 49 bacterial
species, although biochemical characterization of these pathways is scant.7
Interestingly, 0-linked pilin glycosylation in both Neisseria meningitides and Neisseria
gonorrhoeae is believed to strongly resemble N-linked glycosylation in C. jejuni (Figure 1-
9).96'97 In the N. gonorrhoeae pgl (pilin glycosylation) pathway, genetic studies suggest that the
enzymes PglB, PglA and PglE are responsible for assembly of a trisaccharide onto an
undecaprenyldiphosphate-linked carrier, which is then flipped into the periplasm and transferred
to the hydroxyl side chain serine atom by the oligosaccharyl transferase PglO. This pathway
differs from most 0-linked glycosylation pathways in eukaryotes and bacteria in that the glycan
is transferred to the serine residue in an en bloc manner, rather than the individual transfer of
each sugar directly onto the protein from a nucleotide diphosphate donor. The glycan structure
is believed to be Gal2Bac, though the stereochemistry of the Bac moiety has not yet been
assigned.83 The PglO OTase does not appear to require a specific glycosylation sequence in the
acceptor protein, and also does not bear close sequence homology to the C. jejuni OTase
PglB."7" Detailed biochemical characterization of this pathway is still required to understand
the basis of glycosylation specificity.
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Figure 1-9: Proposed pathway for 0-linked pilin glycosylation in N. gonorrhoeae.
Glycan Transfer
In contrast to the multimeric OT complex found in most eukaryotes, the transfer of the
bacterial N-linked glycan is carried out by a single protein, the Stt3 homolog PglB.s, 92 PglB is
predicted to consist of a large N-terminal domain made up of 9-13 transmembrane helices, and a
periplasmic C-terminal domain that contains the highly conserved WWDXGX sequence (Figure
1-10). A preliminary crystal structure of the C-terminal domain of PglB was recently reported,
and although this domain is not sufficient to catalyze oligosaccharide transfer, analysis of this
structure coupled with evaluation of genetic point mutations and comparison with other PglB
homologs suggest the importance of the two additional protein motifs, MXXI (residues 568-
571) and XXD (residues 52-54), for catalysis. 99
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Figure 1-10: Predicted membrane topology of the C. jejuni OTase, PglB. The size of the loops
between the transmembrane domains is variable and has not yet been determined.
Recent studies have shown that PglB is able to glycosylate fully folded proteins and
requires the extended glycosylation sequence D/E-X,-N-X 2-S/T, in which an acidic residue
occupies the -2 position.'00 ' 0' Experiments to define the optimal glycosylation sequence
involved testing a library of peptides in which the residues at both X positions were varied;
PglB was found to glycosylate peptides containing a bulky residue at the X, position and a
smaller hydrophobic residue in the X2 position with the greatest efficiency. 0 2 The extremely
high affinity that PglB exhibits for these short acceptor peptides (Km = 1 [M for DQNAT)
suggest that PglB does not require a specific tertiary structure for binding its fully folded protein
substrate. 0 2 In addition, structural analysis of glycosylated proteins PEB3 and AcrA have
confirmed that the glycosylation sequence must be in a fairly exposed region of the protein in
--- ....... . .... . - - :... M.' - - 11-11 ::- ----.. :'.
order to facilitate access by PglB. 0 "04 PglB has also been shown to be more promiscuous than
the eukaryotic OT in regard to the glycan structures that it is capable of transferring to protein.
Experiments in which PglB was substituted for the bacterial LPS O-antigen ligase demonstrated
that PglB was able to transfer distinct O-antigens from both E. coli and P. aeruginosa onto
asparagine residues, highlighting its increased substrate flexibility.105 However, the relative
efficiency of glycosylation for these alternate substrates has not yet been biochemically
determined.
Biological Significance of Bacterial N-Linked Glycans
To date, over 60 distinct glycoproteins have currently been identified in C. jejuni.' These
proteins are associated with a wide variety of biological pathways within the cell, suggesting
that N-linked glycans may play a role in a number of important cellular functions. Initial genetic
studies in which the N-linked glycosylation pathway was disrupted have resulted in impairments
in cell adhesion and host colonization, establishing a strong tie between N-linked glycans and
virulence. For example, early studies of C. jejuni glycoproteins indicated that they were highly
immunogenic when cross-reacted with animal antisera.7 4 In addition, genetic mutants of C.
jejuni that are impaired in glycosylation showed a reduced ability to adhere to and invade
human intestinal epithelial cells, as well as decreased colonization of the intestinal tracts of mice
and chicken. 5'106 Although details about the interactions between C. jejuni and the mammalian
immune system are largely unclear, a recent study revealed that the C. jejuni N-linked glycan is
recognized by the human macrophage galactose-type lectin, a dendritic cell receptor that plays
an important role in intracellular signaling. 0 7 When glycosylation was impaired, C. jejuni was
found to stimulate formation of the cytokine IL-6, suggesting that glycosylation of specific
proteins might help the organism evade the host immune response.
Other roles for the N-linked glycans of C. jejuni are slowly beginning to emerge. The
VirB 10 protein, a component of the type IV secretion system that contains two glycosylation
sites, was found to be incapable of properly forming a complex with other secretion system
proteins when glycosylation of a key asparagine was prevented, implying that the glycan may be
important in modulating protein-protein interactions. 108 Analysis of the recent NMR structure of
the glycoprotein AcrA, part of the C. jejuni multidrug efflux pump, shows that the N-linked
glycan adopts a rigid, rod-like structure that appears to fold back over part of the protein (Figure
1-1 1).104 The orientation and rigidity of the glycan indicate that it may serve to enhance protein
stability and provide protection from proteolysis. N-linked glycans have also been associated
with protection of C. jejuni from osmolytic stress. A recent study revealed that C. jejuni is able
to produce free oligosaccharide in response to variations in osmolarity of the external
environment.10 9 While the mechanism for oligosaccharide release is still unclear, early studies
implicate proteins in the Pgl pathway, particularly PglB, in the accumulation of these structures
in the C. jejuni periplasm.
Figure 1-11: NMR structure of the glycoprotein AcrA, modified with the GlcGalNAc 5Bac. Bac
is colored pink, while the other residues are shown in green. (A) Representative structure of the
glycoprotein; (B) Structural ensemble of the glycoprotein. Figures adopted from Slynko et al.104
N-linked Glycosylation in Archaea
Structural Diversity of N-Linked Glycans
First described by Carl Woese in 1977, archaea are single-celled organisms that share
many common features with both bacteria and eukaryotes, but also possess several
characteristics unique to their kingdom. 10 Like bacteria, archaea are prokaryotes that lack
internal organelles and contain a single, circular genome. However, the manner in which genetic
information is organized, replicated, and transmitted over the course of the archaeal life cycle is
strikingly similar to eukaryotes. Archaea are distinct from both bacteria and eukaryotes in
several respects; for example, archaeal membranes are composed of ether-linked lipids, in
contrast to the ester-linked phospholipids found in bacterial and eukaryotic membranes."' In
addition, archaea inhabit a wide variety of environments compared with other life forms, from
extreme habitats such as hot springs, deep sea thermal vents, and highly saline lakes, to more
familiar regions such as soil, seawater, and the mammalian digestive tract.' 2
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Figure 1-12: Phylogenetic tree depicting the three kingdoms of life.
The first archaeal glycoproteins were discovered in 1976 in the extreme halophile
Halobacterium salinarium.113 In an intriguing study, the structural analysis of the closely related
species Halobacterium halobium revealed that the S-layer protein of the organism was modified
with two very distinct types of N-linked glycans. The first was determined to be a
pentasaccharide made up of sulfated glucose and glucuronic acid (GcA) residues (Figure 1-
13A)." 4 "5 The second glycan discovered is much larger and more complex, with similarities to
the glycosaminoglycans that are found on connective tissues in higher eukaryotes. It involves
the @-linkage of a sulfated GalNAc to the asparagine of the protein, followed by between 10-15
repeating units of a branched pentasaccharide containing sulfated glucose, galacturonic acid
(GalA) and galactosaminuronic acid (GalNAcA) residues, as well as a Gal in the furanose
configuration (Figure 1-13B).'16'117 These long glycans were found to coat the outer surface of
H. halobium, forming an acidic, two-dimensional lattice that surrounds the organism. 1 5
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Since this discovery, many other N-linked glycoproteins have been identified across the
archaeal kingdom. These glycans display an extraordinary structural variety, which may stem
from the diverse habitats of the archaeal species that produce them. The S-layer protein of the
hyperthermophilic methanogen Methanothermus fervidus is modified with an N-linked
hexasaccharide, in which a GalNAc is attached to the Asn residue of the protein (Figure 1-
13C).1 8 The glycan contains three mannose residues followed by two methylated glucose or
mannose residues at the nonreducing end. Another methanogen, the mesophile Methanococcus
voltae, was found to contain glycosylated S-layer proteins and flagella, all labeled with the
trisaccharide GlcNAc--1,3-GlcNAc(3NAc)A--1,4-ManNAc(6Thr)A (Figure 1-13E).11 9 The
terminal ManNAcA residue of this glycan is linked to a threonine through an amide bond at the
C6" position. However, in some strains of M voltae, the trisaccharide is further elaborated with
an unknown hexose in the fourth position.12 0 In Methanococcus maripaludis, the flagella are
modified with a linear tetrasaccharide that is p-linked to the asparagine through a GalNAc
residue (Figure 1-13F). 12 ' GlcNAc(3NAc)A is ligated to the proximal GalNAc sugar, followed
by a highly modified mannosaminuronic (ManNAcA) residue that contains an acetamidino
group at the C3" position and a threonine at the C6" carbon, similar to the M voltae glycan. In
addition, the terminal sugar of this oligosaccharide is the unique 2-acetamido-2,4-dideoxy-5-0-
methyl-hexos-ulo-1,5-pyranose, which represents the first reported example of an aldulose in an
N-linked glycan structure.12 1
In addition to the characterization of the methanogen-derived glycans described above,
two other archaeal N-linked glycans have been annotated in detail. The cytochrome b55/56
protein from the thermophile Sulfolobus acidocaldarius, which grows at optimal conditions of
75-80 C and pH 2-3, is modified with a hexasaccharide linked through a GlcNAc that contains
a 6-sulfoquinovose residue (Figure 1-13D). Thermoplasma acidophiluim produces a complex,
highly branched N-linked glycan composed mainly of mannose that is attached to a surface
membrane protein through a GlcNAc-Asn linkage (Figure I-13G). 2 3 Copies of this large glycan
encapsulate the cell membrane and are proposed to shield the organism from its harsh
surroundings. Initial studies of other archaeal glycoproteins have been reported, including the
those from the hyperthermophile Pyrococcus furiosus and the halophile Haloferax volcanii,
although detailed structures of the respective glycans have not yet been elucidated." For more
information about proposed archaeal N-linked glycans, the reader is referred to a review by
Eichler.12s
Glycan Assembly
Unlike the analogous pathways in eukaryotes and bacteria, many of the details of N-
linked glycan assembly in archaea are still unknown. A recent analysis of the nearly 60
sequenced archaeal genomes indicates that all but two (Aeropyrum pernix and Methanopyrus
kandleri) contain an stt3 homolog, which suggests that in contrast to bacteria, N-linked
glycosylation in archaea may be widespread.126 However, difficulties with genetic manipulation
and large-scale growth of these organisms have hampered genetic and biochemical studies.
Despite these challenges, progress toward uncovering the biosynthesis of archaeal N-linked
glycans has begun to accelerate, particularly in the last five years.
Recent genetic studies in the methanogens M voltae and M maripaludis and the
halophile H. volcanii have provided the first glimpses of the glycan assembly pathways in
archaea; the current working models of N-linked pathways in these organisms are summarized
in Figure 1-14. In all three models, glycan assembly is believed to take place on the cytoplasmic
face of the cell membrane and is catalyzed by a series of Agl glycosyltransferases (archaeal
glycosylation), after which the glycan is flipped to the exterior of the cell and transferred to
asparagine residues of acceptor proteins by the Stt3 homolog AglB.12 7 Early studies in H.
halobium, H. volcanii, and T. acidophilum determined that archaeal membranes contain both the
monophosphate and diphosphate forms of dolichol, where the dolichol is only 11-12 isoprene
units in size. 12 8-130 The presence of both forms of dolichylphosphate is reminiscent of the
eukaryotic glycosylation pathway, in which Dol-P-sugars are utilized as the glycosyl donors for
at least some of the steps of glycan assembly. It is unclear whether archaea also rely on Dol-P
sugars for assembly of the N-linked glycan. The partial characterization of a putative dolichyl-
phosphomannose synthease (DPM) from T. acidophilum lends support to this hypothesis;m3
however, further biochemical evidence is still required to understand the individual roles of the
each dolichylphosphate compound.
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Figure 1-14: Current models of N-linked glycosylation in M voltae, M maripaludis, and H.
volcanii based on recent genetic studies. The exact structure of the H. volcanii N-linked glycan
has not yet been determined, but data suggest that it is a pentasaccharide as indicated.
As shown in Figure 1-14, the first step of the N-linked glycosylation pathway in these
selected archaea involves the transfer of a sugar 1-phosphate onto the dolichyl-linked donor by
the putative phosphoglycosyltransferase AglH (AglJ in H volcanii). Strong evidence for this
H. volcanl
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initial step was provided in a recent study in which the M voltae algH gene was able to
complement a conditionally lethal mutant of the analogous phosphoglycosyltransferase gene in
S. cerevisiae, alg7.13 2 This finding suggests that in M voltae, the glycosyl donor for AglH is
UDP-GlcNAc and the polyisoprenyl carrier is dolichyldiphosphate. In the related methanogen
M maripaludis, a similar enzyme is believed to transfer GalNAc 1-P to Dol-P, though the
candidate gene has not yet been identified. An alternate model for formation of the Dol-PP-
GalNAc intermediate in M maripaludis could involve initial formation of Dol-PP-GlcNAc by a
still undiscovered AglH homolog, followed by the epimerization of Dol-PP-GlcNAc to Dol-PP-
GalNAc. However, this hypothesis has yet to be supported with genetic or biochemical
evidence, although an epimerase that catalyzes the conversion of Und-PP-GlcNAc to Und-PP-
GalNAc in E. coli was recently described along with the proposal of a homologous candidate
epimerase in M maripaludis.133,134
The remainder of the steps involved in glycan assembly remain unclear. Initial genetic
deletion studies suggest two different paths for the transfer of the second sugar
GlcNAc(3NAc)A in both M voltae and M maripaludis, though this finding has not been
verified biochemically. 01 3 ' Transfer of the third sugar is believed to be carried out by AglA or
AglI; interestingly, in both the Methanococcus species, this sugar is a mannuronic acid
derivative modified with a threonine residue at the C6" carboxylate. After completion of the
glycan, it is flipped across the cell membrane into the external environment, where an OTase
presumably catalyzes its transfer to acceptor proteins. Evidence for the localization of
oligosaccharide transfer to the external face of the cell membrane comes from the treatment of
H. salinarium with bacitracin, which inhibited formation of sulfated glycoproteins. 136
Bacitracin, a small molecule that is unable to traverse the archaeal membrane, binds to the
phosphate groups of free Dol-PP that is liberated by the OTase after glycosylation, thus
preventing recycling of the dolichol. 137 However, despite this evidence, a candidate flippase
gene has been yet to be identified in archaea. Further work involving detailed genetic and
biochemical studies is required to answer the many questions that remain about the biosynthesis
of these intriguing glycans.
Glycan Transfer
The archaeal Stt3 homolog AglB is predicted to have a similar overall topology to the
bacterial PglB, containing both a large N-terminal region composed of 11-13 transmembrane
domains and an extracellular C-terminal domain that bears the signature OTase WWDXGX
sequence (Figure 1-10). Recently, the X-ray crystal structure of the C-terminal domain of AglB
from P. furiosus was reported, providing the first insight into the structural organization of a
segment of an Stt3 homolog.12 4 Although it is unclear if this structure represents a biologically
relevant form of the enzyme, as the C-terminal domain alone was unable to catalyze
oligosaccharide transfer, this study revealed that the WWDXGX motif is located in a central p-
helix in close proximity to a highly conserved DXXK motif. Initial biochemical characterization
of the full length AglB using crude mixtures of membrane-associated lipids suggests that the
enzyme alone is sufficient to carry out glycosylation, and that mutations in either the
WWDXGX or DXXK motif impair glycosylation activity.14 These results are consistent with
genetic studies in M voltae and M maripaludis, in which mutations in aglB gene resulted in
flagella with decreased glycosylation and impaired motility.
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In contrast to the bacterial system, the archaeal OTase AgiB does not require an
extended glycosylation sequence beyond the N-X-S/T sequon defined for eukaryotic
glycoproteins. However, a comparative analysis of the amino acid sequence around the
glycosylation site of confirmed archaeal glycoproteins indicates a slight preference for Ala and
Gly at the X+1 position and Ser or Thr at the X position, where X 1-N-X-S/T-X 1.139 As AgIB is
predicted to glycosylate proteins in a posttranslationally, it is proposed that the target
glycosylation site should be located in a flexible, exposed region of the acceptor protein as
described for the protein substrates of PglB; however, structural analysis of glycoproteins is
required to confirm this hypothesis.
Functional Role of N-linked Glycans
As archaea populate a wide range of habitats from the extreme to the more familiar, it is
not surprising that the structures of their respective N-linked glycans mimic this diversity.
Archaea already possess a variety of biological adaptations to equip them for life in chemically
harsh environments. For example, archaea exhibit a unique composition of membrane lipids,
such as diethers, tetraethers, and macrocyclic diethers, which results in the decreased ion
permeability and planar dynamic capacity of their membranes. 140 In addition, thermophilic and
halophilic archaea employ a number of strategies to enhance protein stability at high
temperature and salt concentrations, including increased ion pairing and hydrophobic
interactions, burying polar contacts into the interior of proteins, and decreased entropy of
unfolding. 141-143
The varied structures of N-linked glycans identified in archaea to date likely serve to
equip these species for optimal growth and survival in their diverse surroundings. For example,
the large, highly branched glycan on the surface of the hyperthermophile T. acidophilum is
predicted to protect the organism from the heat and high acidity of its environment by forming
an extensive hydrogen-bonded shell around the organism, providing external strength and
rigidity and limiting access of certain ions and water molecules to the cell membrane.m In
bacteria, these functions are provided by structures such as the LPS and CPS, but as archaea do
not have cell walls, it is hypothesized that perhaps the surface N-linked glycans in species such
as T. acidophilum and H. halobium impart similar protective features. Another important role
for archaeal N-linked glycans is related to cell motility. In the methanogens M voltae and M.
maripaludis, the protein subunits that comprise the flagella are heavily modified with negatively
charged N-linked glycans (Figures 1-13E and 13F). Genetic mutations that disrupt the
glycosylation pathway in these organisms have resulted in impaired motility; in fact, in M.
maripalidus cells, a direct relationship between glycan size and swimming capability has been
established. 1 34 It is unclear exactly how glycans contributes to the proper function of flagella,
although the extensive glycosylation may sheath the structure with negative charge and possibly
impart stability to interactions amongst the individual protein subunits (Figure 1-15). Further
studies are required to gain a deeper understanding of the roles of N-linked glycans in archaea.
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Figure 1-15: Composition of the M voltae flagella. Each of the Fla proteins depicted in blue is
modified with between 1-4 glycans. Figures adapted from Jarrell et al. 127,144
Role of N-linked Glycosylation in Viruses
In recent years, the importance of N-linked glycosylation in virus biology has begun to
emerge, revealing the many ways in which glycans contribute to viral survival and infection.
Human viruses rely on the host cell glycosylation pathway in nearly every step of the viral life
cycle, from host cell recognition, viral replication, protein trafficking and virion packaging.'
Viruses hijack the host cell glycosylation pathways to take advantage of the many benefits
experienced by eukaryotic proteins, including access to the host cell protein folding and quality
control machinery. Nearly all of the viruses studied thus far have utilized the
calnexin/calreticulin cycle to aid in protein folding and trafficking.145 In addition, the rapid
evolution of viral particles often results in an increased number of glycosylation sequences,
introducing diversity and complexity into the viral glycan profile that can ultimately complicate
treatment of infection.
The influenza virus is a common human pathogen of the upper respiratory tract and a
member of the orthomyxovirus RNA virus family; in addition, it is perhaps the most well
studied virus with respect to glycosylation. The virus contains two important capsular coat
glycoproteins, hemagglutinin (HA) and neuraminidase (NA), that utilize N-linked glycans for a
number of important functions such as receptor binding and infection. The dominant surface
protein is HA, which is modified with a heterogeneous, complex glycan that depends on the
viral strain but is indicative of extensive processing in the Golgi. 146' 147 HA is heavily
glycosylated, containing between 5 and 11 glycosylation sites depending on the strain, all of
which are clustered at the globular head of the protein and are important for interaction with a
key sialic acid residue on the host cell receptor. Upon viral replication and release, NA acts to
cleave this sialic acid moiety to promote diffusion of the virus. If blocked, the newly formed
viral particles rebind the host cell receptor and form large aggregates. Increased glycosylation of
HA to improve viral binding requires enhanced activity of NA to mediate viral release, thus
demonstrating the stategic interplay of these two glycoproteins for effective influenza infection.
Another important example of viral glycosylation is the human immunodeficiency virus
(HIV), a highly mutagenic RNA virus from the retrovirus family. The virus is surrounded by the
multiple copies of the envelope protein gp120, one of the most heavily glycosylated structures
found in nature. 148 The structure of the N-linked glycan coating gpl20 was only just recently
characterized and found to be a high oligomannose structure, suggesting that this glycan is only
minimally processed after transfer to gpl20 by OT. 148 A recent analysis of global HIV strains
indicated that the gpl20 protein contains between 18-33 possible N-linked glycosylation sites,
with average of 25 glycans per protein. 149 The vast density of carbohydrates forms a large,
encompassing structure called the glycan shield, which is postulated to protect the virus from
recognition and degradation from the host immune system. In particular, the glycan shield
provides protection from the 2G12 neutralizing antibody, which has been shown to recognize
the virus particle and render it inactive. 5 0 Rapid viral evolution introduces multiple amino acid
substitutions into the gp120 sequence, changing the number and organization of the glycan sites
and thus allowing the virus to persist in spite of increasing pressure from host antibodies.145
N-linked glycosylation has also been found to play an important role in the infection and
stability of other viruses as well, including the West Nile, Ebola, SARS, and Hantaan viruses.14 5
However, further work is required to uncover the mechanisms of host recognition and viral
fusion. In general, a deeper understanding of these viral glycoproteins may provide new
opportunities for development of antiviral therapeutics.
Conclusions
N-linked glycosylation plays an important role in many biological processes across
eukaryotic, bacterial, and archaeal kingdoms. Although the overall architecture of each pathway
shares many features, a comparison of the details of glycan assembly and transfer in each
kingdom reveals a number of intriguing differences. Table 1-1 summarizes the defining
characteristics of each of these pathways.
Table 1-1: Comparison of
Characteristic
Site of glycan
assembly
N-linked glycosylation across the three kingdoms
Eukaryotes Bacteria
ER membrane Inner Cell Membrane
Archaea
Cell Membrane
Isoprene carrier
Glycosyl donor
Asn-linked sugar
Glycan diversity
across kingdom
Flippase
Oligosaccharyl
transferase
Protein recognition
sequence
Timing of
glycan transfer
Glycan Processing
Dol-PP
(14-21 isoprene units)
NDP-sugars,
Dol-P-sugars
GlcNAc
Initially conserved
(Glc 3Man9GlcNAc 2)
Rftl?
OT
multimeric
N-X-S/T
Cotranslational,
Posttranslational (?)
ER, Golgi
Und-PP
(11 isoprene units)
NDP-sugars
Bac
Variable
PglK
PglB
monomeric
D/E-X-N-X-S/T
Posttranslational
None
Dol-P and Dol-PP
(11 isoprene units)
NDP-sugars,
Dol-P-sugars (?)
GlcNAc, GalNAc,
Glc
Highly variable
Unknown
AgIB
possibly monomeric (?)
N-X-S/T
Posttranslational
Unclear
Across all three kingdoms, the biosynthesis of N-linked glycans involves the buildup of
an oligosaccharide onto a polyisoprenyl carrier by a series of glycosyltransferases using a set of
discrete activated glycosyl donors. In eukaryotes, these donors are both nucleotide sugars and
dolichyl-linked sugars, depending on the location of the glycosyltransferases relative to the ER
membrane. In contrast, bacteria have been shown to exclusively rely on UDP-sugars for glycan
donor biosynthesis. The glycosyl donors in archaea have not yet been clearly defined, though
the presence of both dolichylphosphate and dolichyldiphosphate suggest that perhaps archaea
may use a combination of nucleotide- and dolichyl-activated sugars similar to eukaryotes. In all
kingdoms, the polyisoprenyl-linked oligosaccharide is flipped across the membrane prior to its
en bloc transfer to protein. The mechanism of flipping between the two faces of the membrane
remains elusive. Although genetic screens originally implicated Rftl in translocation of the
heptasaccharide intermediate in S. cerevisiae, recent studies have found that this protein does
not appear to be involved after all. The ABC transporter PglK has been identified as the flippase
protein in C. jejuni; however, biochemical confirmation of this activity has not yet been
reported. Interestingly, analysis of complete archaeal genome sequences using either Rftl or
PglK as a search model does not result in any putative flippase candidates, even though it is
clear that the archaeal OTase catalyzes protein transfer on the external side of the cell
membrane. Further work is needed to fully understand this interesting phenomenon.
In all three kingdoms, the action of an oligosaccharyl transferase is responsible for
transferring the assembled oligosaccharide to asparagine side chains within acceptor proteins.
Although the role of each of the subunits within the eukaryotic OT complex is still unresolved,
recent evidence has implicated the Stt3 subunit directly in catalysis. PglB, the Stt3 homolog in C
jejuni, has been shown sufficient to carry out this reaction in vitro, and preliminary studies
involving the archaeal Stt3 homolog in P. furiosus suggest that it may function alone as well,
though further evidence is still required. The simplicity of the prokaryotic OTases in contrast to
the eukaryotic OT complex offers a powerful model system to begin to examine this reaction in
greater depth. One of the major unresolved questions in this area involves the catalytic
mechanism, namely the steps by which the asparagine side chain amide is activated by OT to
affect oligosaccharide transfer. Interestingly, it appears that nearly all N-linked glycan structures
reported to date contain an acetylated amine at the C2" position of the sugar proximal to the
modified asparagine residue; the one exception being the N-linked pentasaccharide of H.
halobium, in which a glucose was found to be the linking sugar (Figure 1-13A). This
observation supports earlier predictions that the 2-acetamido group may play an important role
in the enzyme mechansim.151
As described in this chapter, the N-linked glycans observed in nature display a great deal
of structural diversity. It appears that one of the major differences between the three kingdoms
involves the origin of this diversity; specifically, whether it is introduced during the assembly
process through the use of a variety of glycosyl donors, such as in bacteria, or after assembly
and transfer to protein by the action of processing enzymes, as in the case of eukaryotes. Nearly
all eukaryotes assemble a tetradecasaccharide (Glc 3Man9GlcNAc2 ) that is transferred to
acceptor proteins by OT; however, this core structure is then modified by a series of
glycosidases and glycosyltransferases in both the ER and Golgi to result in the great variety of
eukaryotic N-linked glycans observed in nature. The conservation of this glycan core during the
assembly process enables eukaryotes to engage the calnexin/calreticulin pathway for quality
control of protein folding immediately after glycosylation, while still allowing for
diversification of the glycan through the later steps. In contrast, the N-linked glycan structures
identified on all C. jejuni glycoproteins to date are identical, indicating that the organism does
not modify these oligosaccharides after protein transfer. The involvement of N-linked glycans in
virulence may provide an explanation for the uniformity of bacterial glycoproteins, although the
details about the roles of bacterial N-linked glycans in pathogenesis are still unresolved. It will
be interesting to learn whether archaea reflect the eukaryotic or bacterial pathways in this
regard, or if they derive glycan diversity in a completely unique manner.
In summary, the N-linked glycosylation pathways found in eukaryotes, bacteria and
archaea share a great deal in common, but also exhibit unique differences specific to each
kingdom. Future work in this field will focus on a variety of fronts, including gaining a deeper
understanding of the organization of the eukaryotic OT complex, the interactions of bacterial
glycoproteins with the mammalian immune system, the biochemical details of archaeal glycan
assembly and transfer, and the exploitation of viral glycan profiles for disease treatment.
Overall, it is an exciting time in glycobiology, as the next few years promise to continue to
highlight the important role that N-linked glycosylation plays across all kingdoms of life.
Thesis focus and outline
The overall goal of the work described in this thesis is to gain a deeper insight into the
process of N-linked glycosylation in prokaryotes. In Chapter 2, efforts to identify a suitable
OTase homolog for in depth biochemical characterization in archaea are described. These
studies determined that the OTases from M voltae and M maripaludis exhibited the highest
levels of heterologous expression in E. coli. In order to generate a suitable substrate to probe the
function of these enzymes, we required a robust synthesis of the nucleotide sugar UDP-
GlcNAc(3NAc)A. The chemoenzymatic synthesis of this unique UDP-sugar harnesses the
enzymes WbpB, WbpE and WbpD from the opportunistic pathogen Pseudomonas aeruginosa
PAOI and is outlined in Chapter 3. In Chapter 4, the crystallization and structure determination
of the PLP-dependent aminotransferase WbpE is described as the first step toward gaining
insight into the novel NAD*-recycling pathway involving WbpB and WbpE. Chapter 5
summarizes attempts toward the identification of a functional UDP-GIcNAc(3NAc)A
glycosyltransferase to generate our desired Dol-PP-disaccharide for study of the M voltae and
M maripaludis OTase. Finally, Chapter 6 describes efforts towards the development of an
inhibitor of PglB, the bacterial OTase in C. jejuni.
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Chapter 2 Identification and Characterization of an Archaeal
Oligosaccharyl Transferase for In Depth Study
Introduction
Asparagine-linked glycosylation is a posttranslational protein modification that occurs
across all domains life.' This process plays a critical role in many cellular events, including
protein folding, stability and intracellular targeting in eukaryotes, flagellum assembly in
archaea, and host pathogenicity in bacteria. 2-4 N-linked glycosylation entails the stepwise
assembly of an oligosaccharide onto a membrane-bound polyisoprenyl-linked carrier, followed
by the translocation of the glycan across the membrane and subsequent transfer to protein
(Figure 2-1). The key enzyme of this pathway is oligosaccharyl transferase (OTase), which
catalyzes the en bloc transfer of the oligosaccharide onto asparagine residues within nascent or
fully folded proteins. This enzyme recognizes and modifies asparagine residues that reside
within an N-X-S/T sequon, where X is any amino acid except proline.5
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Figure 2-1: The pathway of N-linked glycosylation in S. cerevisiae.
In eukaryotes, the oligosaccharyl transferase (OT) is a multimeric protein complex
localized in the membrane of the endoplasmic reticulum (ER). While a majority of the genetic
... - ,, . 11 .. .." , , . R_ :..N I - n '% . : : : ............ - . ....... .- .- .- --- -- -I.- -I --I 1 -1 -. 1- 1 - B .: z; -.- ZZZZZ;::-
and biochemical characterization of OT has been achieved in Saccharomyces cerevisiae, the
organization of the complex appears to be remarkably conserved across all eukaryotes, from
yeast to man.6 In S. cerevisiae, the OT complex is composed of at least eight membrane-bound
subunits (Ost3/6, Ost4, Stt3, Ost2, Wbpl, Swpl, Ost5, and Ostl), five of which (Ostl, Ost2,
Stt3, Swpl, and Wbpl) have been shown to be essential for survival (Figure 2-2A).' 8 Although
in depth biochemical examination has been hampered by difficulties involving overexpression,
isolation, and handling of the complex, initial progress has been made toward identifying the
role of each protein subunit.8 The putative binding site of the dolichyl-linked oligosaccharide
was assigned to Wbp 1, as incubation of OT with Dol-PP-GlcNAc 2 was able to prevent alkyation
of a specific cysteine located within the Wbpl subunit.9 The Ost3/Ost6 subunits have been
recently shown to exhibit protein-dependent oxidoreductase activity in vitro, suggesting a direct
role for OT in protein folding.10 In recent years, evidence has begun to emerge implicating Stt3
as the catalytic subunit of the OT complex. Stt3 is the most highly conserved subunit of OT, as
homologs of this protein are found in all eukaryotes and throughout the archaeal and bacterial
kingdoms. Stt3 is composed of a large N-terminal domain containing 11-14 predicted
transmembrane regions, as well as a C-terminal domain localized in the ER lumen that bears the
highly conserved WWDXGX motif, which is found in all known Stt3 homologs in nature.
Genetic mutations introduced into this motif have been shown to abolish glycosylation activity,
strongly suggesting that these residues play a role in catalysis." In addition, the recent cryo-EM
structure of the OT complex at 12 A suggests that Stt3, along with Wbpl and Ostl, line a deep
channel within the complex through which both the dolichyl-linked oligosaccharide and
acceptor protein substrates are predicted to bind.' 2
A B
Cytoplasm Top view
Ost4 Stt3 Ost2 Ost5 Side view
Ost3Ost6
ER Lumen
Wbpl Swpl Nit1/Ost1
Figure 2-2: Subunits of the S. cerevisiae oligosaccharyl transferase complex. (A) Predicted
topology of the individual subunits, where the arrows indicate the N-termini of the individual
proteins; (B) Three-dimensional cryo-EM map of the OT complex, as reported by Li et al.'
In 1999, the first example of a general system of N-linked glycosylation in bacteria was
reported in the human pathogen Campylobacter jejuni.13 This pathway contains a number of
similarities to the glycosylation pathway in S. cerevisiae, in that an oligosaccharide is assembled
onto a polyisoprenyl-linked carrier and then flipped across the inner leaflet of the membrane
before being transferred to acceptor proteins by an OTase (Figure 2-3). However, one of the
most intriguing differences between these two pathways is that the C. jejuni OTase, PglB, is
composed of just a single polypeptide. A comparison of PglB and Stt3 sequences show that the
two proteins are homologous and share a similar topology, wherein the N-termini comprise a
large hydrophobic domain containing 9-13 transmembrane helices, and the hydrophilic C-
termini contain the conserved WWDXGX motif. In pivotal studies, it was demonstrated that
PglB alone is sufficient to catalyze the transfer of the C. jejuni heptasaccharide onto fully folded
acceptor proteins, providing a simpler platform for the in depth study of this reaction. 4 ,15
Further work showed PglB requires an extended glycosylation sequence, D-X-N-X-S/T, in
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which an aspartate is required at the -2 position relative to asparagine, and that it demonstrates a
relaxed oligosaccharide specificity in comparison to the yeast OT. 16-18 However, despite this
progress, efforts to carry out in depth biochemical studies of PglB have been challenged by the
extremely poor expression levels in heterologous systems (< 50 tg/L culture in Escherichia
coli), as well as a rapid loss of activity upon purification of the enzyme from the membrane.19 In
order to begin to unravel the enzymatic mechanism of the oligosaccharide transfer reaction, a
long-standing goal of the Imperiali laboratory, large quantities of a highly pure and active
OTase homolog are required.
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Figure 2-3: The N-linked glycosylation pathway of C. jejuni, highlighting the predicted
membrane topology of PglB.
In an effort to obtain a tractable OTase with improved expression and stability for in
depth examination, we have turned to the N-linked glycosylation pathway in archaea. Archaeal
protein homologs have been long used to aid in analysis of protein structure and function due to
increased expression in heterologous systems as well as enhanced stability compared with their
........................ ......     .......  .....
eukaryotic and bacterial counterparts.2 The harsh environments inhabited by certain archaea,
such as volcanic deep sea vents and acidic coal mines, confer characteristics to archaeal proteins
that can be highly advantageous to researchers working in ambient conditions. As detailed in
Chapter 1, the first archaeal glycoproteins were identified in the early 1970s in Halobacterium
salinarum, an extreme halophile isolated from a highly saline lake in the Michigan Basin.
Although a number of archaeal glycoproteins have been characterized to date that display a
wide variety of glycan structures, the biochemical details of the glycosylation pathways in
archaea are scant. Recent studies suggest that N-linked glycosylation in archaea bears some
similarities to both the bacterial and eukaryotic pathways. As in bacteria, the N-linked glycans
of archaea vary tremendously based on species, and oligosaccharide transfer appears to be
carried out by a single integral membrane protein.22 However, unlike in bacteria, where N-
linked glycosylation is considered a rare event, archaeal N-linked glycoproteins appear to be a
prevalent feature of secretory proteins similar to eukaryotes, appearing in both S-layer and
flagellar proteins.3 In addition, the polyisoprenoid carrier appears to be dolichol, rather than the
fully unsaturated undecaprenol characteristic of bacteria. These findings make the pathway in
archaea an attractive system for in depth biochemical characterization.
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Figure 2-4: Phylogenetic tree depicting the three kingdoms of life: Eucaryota, Bacteria, and
Archaea.2
In this chapter, efforts toward the identification and characterization of a suitable
archaeal OTase are described. An initial search of available and completed archaeal genome
sequences yielded a total of 25 archaeal Stt3 homologs, from which 5 candidates were selected
for further analysis. After cloning these genes into suitable vectors, protein expression levels
were compared in various E. coli cell lines and revealed that the Stt3 homologs from the
methanogen Methanococcus voltae and the extreme halophile Haloarcula marismortui
exhibited the highest overall protein expression yields, representing a nearly 100-fold
improvement over PglB. Further work demonstrated that these proteins could be purified from
the cell membrane; however, efforts to observe function of these proteins were unsuccessful due
to the unavailibity of the natural oligosaccharide substrate of these enzymes. This work
summarizes initial efforts to characterize an archaeal OTase, which is important both to provide
a platform for the detailed understanding of the mechanism of oligosaccharide transfer and also
as a first step towards the elucidation of the archaeal glycosylation pathway that appears to have
elements in common with both the bacterial and eukaryotic systems.
Results and Discussion
Identification ofArchaeal Stt3 Homologs
In order to identify potential archaeal OTase for study, iterative searches of completed
archaeal genome sequences in the public databases (NCBI, GenBank) were performed using the
S. cerevisiae Stt3 protein as the search model. A total of 25 distinct homologs were found with a
local alignment score of 90 or greater, and all contained the WWDXGX motif common to
known oligosaccharyl transferases. A truncated alignment of 16 of these sequences is depicted
in Figure 2-5, and a full alignment is presented in the Appendix (Figure 1).
H. marismortui (551) DFDYQEGQYGVLS IT--TRAE NANP-F
H. volcanii (625) DFDYPDGAYGVMS HWIT--VLGE IPNANP-F
H. walsbyi (635) DFEYPAGTYGVQS IHIT--TQS IPNANP-F
N. pharaonis (558) DFDYQEGQYGVL$ I YIT--TRGE IPVANP-F
M. hungatei (542) SFSYPQNISTVIS I WIL--VLAH IPATSP-F
M. stadtmanae (516) -------- TVLAS HLFT--AVAD QVVFDG--
M. jannaschii (614) -------- SVITC * IYT--YE VTFDG--
M. maripaludis (526) -------- SVVTC IHIYT--WAT VTFDG--
M. voltae (579) -------- SVVT IYT--WAT VTFDG--
P. horikoshii (500) -------- ATATS IYIESSLLG RASADGGH
P. abyssi (501) -------- ATATS YIESSLLGH SADGGH
P. furiosus (461) -------- DIVL I VT--YY SPVAQG--
T. kodakarensis (481) -------- DIV I'WVT--YY VAEL--
A. fulgidus (452) --PYEKPEYSVMS INIL--YVSK VVCNN-F
D. vulgaris (499) -------- SMVWI SAH--HFAH RTIADG--
S. solfataricus (488) --------AFVLY WLE-VLTNRSVIDENNTL
C. jejuni, Pg1B (444) -------- DYVV * PVR-YYSDVUTLVDGGKH
S. cerevisiae, Stt3 (503) -------- SKV A QIG-GMADRTTLVDNNTW
Figure 2-5: Sequence alignment of 16 of the 25 archaeal Stt3 homologs identified in this study,
depicting the region surrounding the critical WWDXGX motif. Fully conserved residues are
highlighted in black, while moderate conservation is indicated in gray. A full alignment of these
homologs is presented in the Appendix (Figure 1).
Each of these protein sequences was further analyzed using the TMHMM server in order
to predict membrane topology (ca.expasy.org/tools).2 Similar to both Stt3 and PglB, these
proteins are all predicted to contain a large N-terminal domain with between 9-12
transmembrane spanning helices, and a soluble C-terminal domain that bears the WWDXGX
motif. Interestingly, the size of the archaeal Stt3 homologs varies widely, from short
(Archaeoglobus fulgidus, 591 residues) to extremely long (Thermoplasma volcanium, 2076
residues). In addition, many of these predicted helices appeared to be more compact than Stt3
and PglB, and the loops between each membrane domain seemed to be shorter in length. In
order to select a few OTase candidates for biochemical analysis, several factors such as protein
size, the thermal and/or salt environment of the parent species (perhaps an indicator of the
stability of the proteins), phylogenetic diversity, and availability of genomic DNA were
considered with the goal of assembling a small panel of proteins from a wide variety of archaeal
strains. To this end, five proteins were selected from the following organisms for further study:
the thermophiles Methanocaldococcus jannaschii and Archaeoglobus fulgidus, the mesophilic
methanogens Methanococcus voltae and Methanococcus maripaludis, and the extreme halophile
Haloarcula marismortui. The predicted membrane topology of these five proteins, as well as
Stt3 and PglB, are compared in Figure 2-6.
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Figure 2-6: Predicted topology of the five selected archaeal Stt3 homologs in comparison with
Stt3 (S. cerevisiae) and PglB (C. jejuni). Topology prediction was generated using the TMHMM
25server (ca.expasy.org/tools).
Molecular Biology and Comparative Analysis of Protein Expression Levels
After genomic DNA from each of the five archaeal species was acquired, either through
purchase (ATCC) or donation from either the Whitman (University of Georgia) and Jarrell
(Queen's University) laboratories, the OTase genes were amplified using the polymerase chain
reaction. All of these genes are large (3-4 kb) and exhibit a high GC content, which can manifest
significant hydrophobic interactions in the genomic DNA that can make finding suitable PCR
conditions a considerable challenge. Initial attempts at PCR were unsuccessful, but after
screening a large number of conditions, including the use of additives such as glycerol, Triton
X-100, and DMSO, and the manipulation of PCR cycle features, amplification of the desired
genes was observed (Figure 2-7). The resulting PCR products were inserted into the pET24a(+)
vector using standard molecular biology techniques to yield proteins with an N-terminal T7 tag
for identification and a C-terminal His6-tag for purification.
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Figure 2-7: Agarose gel (0.8%) of the PCR products resulting from amplification of the stt3
homologs. (1) MW Standard; (2) PCR positive control; (3) M voltae; (4) M maripaludis; (5) A.fulgidus; (6) M jannaschii; (7) H. marismortui.
The resulting PCR products were then transformed into four different E. coli competent
cell lines in order to screen for protein expression. Each of these cell lines possesses a distinct
advantageous trait that may serve to improve the overall yield of the archaeal OT homologs;
BL21(DE3) Gold cells exhibit a high transformation efficiency, while both BL21 CodonPlus
RIL and RP cells contain extra copies of genes encoding for rare tRNAs. BL21(DE3) pLysS
cells confer the transformation efficiency of the BL21(DE3) Gold cells and also lack genes for
several proteases responsible for degrading nonnative proteins. After transformation of the
archaeal OTase genes into each of these strains, along with the empty pET24a(+) vector as a
control, all 20 cell lines were cultured and the proteins overexpressed using isopropyl @-D-l-
thiogalactopyranoside (IPTG) as an inducer. Upon harvesting, the cells were lysed and the
membrane fractions were isolated by centrifugation. The presence of the desired OTase was
determined through Western blot analysis with the Anti-T7 antibody, which recognizes the N-
terminal T7 tag on each protein.
Table 2-1: Summary of the protein expression trials of each archaeal OTase in all four E. coli
competent cell lines. Levels of expression were determined by Western blot analysis, using an
Anti-T7 antibody to detect the N-terminal T7 tag of each protein.
BL21 Gold BL21 RIL BL21 RP BL21 pLysS
A. fulgidus Strong Strong Weak X
M jannaschii X X X X
M voltae Strong Very Strong Strong X
M maripaludis Very Strong Strong Strong X
H. marismortui Weak Very Strong Strong X
Table 2-1 summarizes the results of the archaeal OTase expression screen. As indicated,
high expression levels of the M voltae, M maripaludis, A. fulgidus, and H marismortui OTases
were observed in three out of the four cell lines. Based on Western blot analysis, it was
determined that the BL21 Gold cell line would be optimal for both the A. fulgidus and M
maripalidus proteins, while the BL21 RIL cell line was chosen for expression of the M voltae
and H. marismortui OTases. Interestingly, no expression of the M jannaschii homolog was seen
in any of the cell lines; further attempts to achieve protein expression, such as retransformation
of the competent cell lines and varying the amount of time that the cultures were incubated,
were unsuccessful. In addition, none of the four homologs was expressed in the BL2 1 (DE3)
pLysS cell line, though the reason for this result is unclear.
As a means to directly compare overall expression levels of each protein in the optimal
E. coli strain, proteins from the best expressing cell line for each OTase were analyzed side by
side on the same Western blot, using antibodies for both the N- and C-terminal tags (Figure 2-
8). A sample of PglB at a known concentration was also included in a preliminary attempt to
quantify total protein yield. These results indicated that the M voltae and H. marismortui
OTases exhibited the highest overall expression levels, with a nearly 100-fold improvement
over PglB. The M maripaludis and A. fulgidus OTases were also expressed in high yield,
although these proteins showed a more modest improvement compared with PglB, representing
an approximately 50- and 20-fold increase, respectively. Therefore, these four proteins were
carried forward for further study.
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Figure 2-8: Comparison of the archaeal OTases expression by Western blot, in which each
OTase is expressed in the optimal E. coli cell line as described. Each protein was prepared as a
crude E. coli membrane fraction prior to analysis. (A) Anti-T7 and (B) Anti-His 4 Western blots,
indicating the N- and C-terminal tags. (1) MW standard; (2) M. voltae; (3) M maripaludis; (4)
A. fulgidus; (5) H. marismortui; (6) C. jejuni (PglB).
Purification of Archaeal OTases
In order to obtain a quantitative measurement of overall expression levels, efforts were
made to purify the archaeal OTases from the E. coli membrane using Ni-NTA chromatography.
After overexpression of each OTase in the optimal E. coli cell line, the proteins were prepared
as crude membrane fractions following standard procedures. The OTases were then incubated
with Triton X- 100 detergent (1% final concentration) for 8 hrs at 4 'C to disrupt the membranes.
While Triton X- 100 is often not an ideal detergent for various downstream applications, such as
functional characterization or X-ray crystallography, it has been found to be a powerful agent
for the solubilization of cellular membranes. 26 The detergent-containing samples were subjected
to centrifugation to pellet the membrane fragments, and the solubilized proteins were purified
using Ni-NTA resin. The resulting elution fractions were then quantified using the MicroBCA
assay and analyzed by SDS-PAGE (Figure 2-9). As described in Figure 2-9A, each archaeal
OTase was successfully purified from the E. coli membrane in good yield, indicating a 2-8-fold
S. - ___ - - - OpEft.- - e
increase in total purified protein per liter of E. coli culture compared to PglB. However, the final
yields of the archaeal OTases seemed to be lower than what was predicted from the Western
blot analysis; this discrepancy may be due in part to incomplete solubilization of the archaeal
OTases from the cell membrane by Triton X-100. Nonetheless, it is clear that all four archaeal
OTases are expressed at a considerably higher level in E. coli compared to PglB.
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Figure 2-9: (A) Summary of the overall yield of purified archaeal OTases compared with PglB;
(B) SDS-PAGE analysis of a purified sample of the M voltae OTase. (1) MW standard; (2) M
voltae OTase.
Testing Archaeal OTases for Function: Synthesis of Preliminary OTase Substrates
Based on the results described in the previous sections of this chapter, four archaeal
OTases have been identified that exhibit a substantial increase in protein expression compared
to PglB. In order to utilize these proteins for future in depth study, the function of these proteins
must be demonstrated; thus, the next step of this work required the synthesis of potential OTase
substrates. To date, only the structures of the M voltae and M maripaludis N-linked glycans
have been elucidated (Figure 2-10), and nothing is known of the glycoproteins produced by A.
...... . 
fulgidus or H marismortui.272 The N-linked glycan of M voltae, depicted in Figure 2-1 OA, is a
trisaccharide in which the linking sugar to asparagine is GlcNAc. The next two carbohydrates of
this glycan are 2,3-dideoxy-2,3-diacetamido-glucuronic acid (GlcNAc(3NAc)A) and an N-
acetylmannosaminuronic acid residue (ManNAc(6Thr)A), in which a threonine is linked to the
C6" carboxylate. Neither of these two sugars has been previously identified in N-linked glycan
structures. In Methanococcus maripaludis, the flagella are modified with a linear tetrasaccharide
that is p-linked to the asparagine through a GalNAc residue (Figure 2-1OB).27 GIcNAc(3NAc)A
is ligated to the proximal GalNAc sugar, followed by a highly modified mannosaminuronic
(ManNAcA) residue that contains an acetamidino group at the C3" position and a threonine at
the C6" carbon, similar to the M voltae glycan. In addition, the terminal sugar of this
oligosaccharide is the unique 2-acetamido-2,4-dideoxy-5-0-methyl-hexos-ulo-1,5-pyranose,
which represents the first reported example of an aldulose in an N-linked glycan structure.27 As
the building blocks of these N-linked glycans are not commercially available nor predicted to be
synthesized in a facile manner, we sought to first attempt functional studies using a simplified
glycosyl donor and peptide acceptor; these efforts are outlined below.
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Figure 2-10: N-linked glycans identified in (A) M voltae and (B) M maripaludis. The unique,
highly-modified carbohydrates that comprise these glycans are highlighted in blue.
a. Synthesis of M voltae Flagellar Peptides
As a first step toward probing the function the archaeal OTases, a panel of acceptor
peptides was designed and synthesized based upon the glycoproteins identified in M voltae
(Figure 2-11). Analysis of these protein sequences indicates that unlike PglB, the M voltae
OTase does not appear to require an extended glycosylation sequence beyond the N-X-S/T
motif found in eukaryotes. A series of six peptides was designed based on the S-layer and
flagellar protein sequences, all of which contain three residues on either side of the N-X-S/T
glycosylation sequence in order to optimize binding contacts with the archaeal OTases. In
addition, these peptides are acetylated at the N-terminus and include a C-terminal p-
nitrophenylalanine residue (Nph) to aid in quantification. The peptides were synthesized on
PAL-PEG-PS resin using standard Fmoc-solid phase peptide techniques, purified by RP-HPLC,
and verified by mass spectrometry. The sequences of these peptides are shown in blue in Figure
2-11.
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ESTEQVASGL QISQVMGMHN
GGDIFDNANV EWIKATATKF
GAPGIISFTT PATYLNDSKV
ETTQQVASGL QVVKITGHSV
VRLSTANGTS DIFKYDDVYA
AINIGNIVGE NIGNTITIQG
EPIIDRLTIY
YNFGVIVIQD
EDVVILQ
TDSENITHIV
QVVSLQDFDG
KVVELQ
NSNINKTAIY
GIVVIQDADE
VQLQ
DQYNLDKIAI
IGAWPFEDPT
EVVPEFGAPG
S-layer Protein
VEKIGDVEGF KVIDNGEPTA
ANLKSLLTNG TNDFTELDAG
SVVKDIDPSD WYADKNKAAD
FQRATQVLKE GNRLPFLGEE
KISLQMKDG KVVAEKFDKV
IPDWEVVTIE KDTTTDNTKD
KEDTKLNLFF SMDETKEATL
VGGPVANALT KELADAGKIE
DIVVGSTAAA
KEAFVVAAAD
VATKDYYDQD
YALVKLDTDD
SATSALKMIY
SKMTLSDDKI
AAGQKVTVLN
MTVESPATLA
ADVVSAANVA
SDYSDALINA
GDAVEMLMAT
DIVYLGKEVF
TPGNIGIVVN
TKDNTYGIGL
SDITLSEVMA
VVAGAANGND
AKVGSMMFKE GEAASGSAKL
TTGFANIADN VLYDQAKLAA
VASNDDGKSL TVDEDGVLYA
DGVLKEGDTY NIGDGYELKV
EAWENVGQDY GYGSTLITKD
QYVGDEEDNF KSGKAIKIAK
DAKAPVAFKA PLAVLDTEVS
VLVVAGGDRA ATAEAANALI
TVKASAESDD
AVSLGDLSTL
SIAYDDDNED
VAILKSGDEY
VIALELGEEY
YAELELDDED
LDAANKKLIL
EML
Figure 2-11: Sequences of M. voltae flagella and S-layer glycoproteins. The boldface residues
indicate sites where N-linked glycosylation was observed; the sequences highlighted in blue
represent peptides synthesized for OTase studies. Figure modified from Voisin et al.
.. ...................... ............................................................................................ ................. -   ....... -- --------- - -- -- --- -- --------
b. Synthesis of Dolichyldiphosphate [H]Chitobiose (Dol-PP-[3H]GcNAc2)
In addition to peptide substrates, a suitable glycosyl donor was required to probe the
archaeal OTases for function. Due to the complexity of the M voltae and M maripaludis N-
linked glycan structures (Figure 2-10), a simpler disaccharide substrate was sought for use in the
preliminary examination of enzyme function. Previous work in the Imperiali laboratory has
shown that both the eukaryotic OT and the bacterial PglB are able to accept disaccharide
substrates in the place of the full length oligosaccharides, and that the transfer of these truncated
substrates to acceptor peptides is carried out with nearly complete turnover by the respective
OTases. 15 ,29 Although the exact structure of the M voltae polyisoprenyl-linked glycosyl donor is
unknown, genetic studies in which the M voltae algH gene was able to complement a
conditionally lethal mutant of the analogous phosphoglycosyltransferase gene in S. cerevisiae,
alg7, suggest that the polyisoprenyl carrier in M voltae is dolichyldiphosphate. 30 Therefore, the
synthesis of Dol-PP-[3H]GlcNAc 2 was carried out; this compound bears a tritium label on the
terminal GlcNAc residue and has been routinely used in the Imperiali laboratory for the study of
the yeast OT.
Previous studies have determined that the most efficient method for the synthesis of
Dol-PP-[ 3H]GlcNAc2 involves treatment of Dol-PP-GlcNAc with freshly prepared porcine liver
microsomes and UDP-[ 3H]GlcNAc (Figure 2-12), as expression and in vitro reconstitution of
the Algl3/14 complex in S. cerevisiae has not yet been achieved. To this end, a liver from a
freshly slaughtered pig was obtained and rapidly processed to prepare microsomes, which were
immediately used to carry out the synthesis of Dol-PP-[ 3H]GlcNAc 2. The crude reaction mixture
was purified by silica gel chromatography to yield pure Dol-PP-[3H]GlcNAc 2, which was
verified by testing against the yeast OT complex.
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Figure 2-12: Chemoenzymatic synthesis of Dol-PP-[3H]GlcNAc 2 using freshly prepared
porcine liver microsomes.
Testing the Archaeal OTases for Function
With both the radiolabeled Dol-PP-GIcNAc 2 substrate and peptide acceptor sequence in
hand, the archaeal OTases from M voltae, M maripaludis, A. fulgidus, and H. marismortui
were screened for function. These proteins were overexpressed in E. coli as described
previously and crude membrane fractions were prepared. Blank membrane fractions in which
both BL21 Gold and RIL cells were transformed with an empty pET24a(+) vector were assayed
as well; these samples served as controls for background activity that may be inherent to the E.
coli cell membrane fraction.
A standard assay was used to test these archaeal OTases for activity, based upon that
originally developed for the yeast OT (Figure 2-13).15,31 It involves the incubation of the OTase
with the radiolabeled disaccharide donor and other reaction components, including detergent
and MnCl2. The assay is initiated with the addition of the peptide substrate, and aliquots are
removed at various time points and quenched in an aqueous/organic mixture, which serves to
partition the glycosylated peptide into the aqueous phase and the polyisoprenyl-starting material
in the organic phase. Glycosylation of the peptide substrate by the OT homolog would result in
a net transfer of radioactive counts from the organic phase into the aqueous phase as measured
by scintillation counting.
.i t Aqueous LayerAisquots 3HJGlcNAc 2-Peptide
zII
Figure 2-13: Standard assay for OTase activity. The archaeal OTases are incubated with the
peptide substrate, the radiolabeled glycan donor, and other reaction components and aliquots are
removed over time and subjected to phase extraction. Glycosylation results in the transfer of
radioactive counts from the organic to the aqueous phase.
Unfortunately, none of the archaeal OTases tested showed appreciable activity above the
background (Figure 2-14). While the radioactivity present in the reaction aliquots increased over
time, this increase was later attributed to inherent glycosidase activity present in E. coli cell
membrane, which is supported by the observation of considerable activity in the empty pET
vector control sample. Further analysis of the reaction mixtures by HPLC and mass
spectrometry did not show any evidence of glycopeptide formation. These assays were repeated
numerous times, in which addition of various divalent metals, salts, detergents and reducing
agents were included in the reaction. The temperature and pH of the reactions were also altered;
however, disaccharide transfer to protein was never observed. The Und-PP-Bac[ 3H]GalNAc
substrate of PglB was also utilized as a possible glycosyl donor in these reactions, but no
activity was observed in these reactions either.
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Figure 2-14: Assay data from a representative archaeal OTase activity assay, in which Dol-PP-
(GlcNAc) 2 was used as the glycosyl donor and Ac-YKYNESSYKNph-NH 2 was introduced as
the acceptor peptide.
As an alternative to disaccharide Dol-PP-GlcNAc 2, the monosaccharide Dol-PP-GlcNAc
was also tested as a possible archaeal OTase substrate. It was hypothesized that the eukaryotic
disaccharide donor, in which the two carbohydrates are connected through a P-1,4 linkage, may
not able to efficiently bind to the M voltae or M maripaludis OTase as the native N-linked
glycans in these species feature a P- 1,3 linkage between the first two sugars. In order to test this
hypothesis, the standard OTase assay was performed using Dol-PP-GlcNAc as the glycosyl
donor (Figure 2-15). However, use of this substrate is complicated by the lack of a radiolabel in
the transferred sugar. This difficulty was circumvented through analysis of the OTase reaction
by HPLC and mass spectrometry to identify the presence of glycopeptide.
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Figure 2-15: Archaeal OTase assay, in which the formation of the glycopeptide product is
detected through the use of HPLC and mass spectrometry.
In order to test the monosaccharide as an archaeal OTase substrate, the standard assay
was employed with slight modification. The reaction components were assembled and allowed
to incubate for 8 hrs, after which the entire reaction was quenched and subjected to
aqueous/organic phase separation as previously described. Rather than analyze the aqueous
layer by scintillation counting, the entire mixture was injected onto a C18 RP-HPLC column,
with the goal of separating the glycopeptide product from the peptide starting material. As the
addition of a single sugar was not expected to influence the retention time of the peptide a great
deal, an extremely shallow HPLC gradient was employed, in which the elution solvent was
introduced over the course of 90 mins. However, analysis of each OTase reaction yielded only a
single peak on the HPLC corresponding to peptide (Figure 2-16). Mass spectrometry revealed
only the presence of the peptide starting material, suggesting that glycosylation had not
occurred. A shorter peptide, Ac-NLTNph-NH 2, was also utilized in the OTase reactions in an
effort to aid in the HPLC separation of the potential product from the starting material.
Although this short peptide was expected to make fewer binding contacts with the OTase, thus
resulting in lower glycosylation efficiency, it was proposed that the addition of a single sugar to
this peptide would result in a more dramatic shift in retention time. However, as in the case of
the longer decapeptides, formation of the desired glycopeptides was not observed.
HPLC trace of M. voltae OTase reaction
Figure 2-16: HPLC trace of the M voltae OTase assay. The highlighted peak corresponds to the
peptide starting material; no evidence of the glycopeptide product was observed by mass
spectrometry.
Next Steps: Synthetic Strategy for Generation of a Suitable Archaeal OTase Substrate
As previously described, the archaeal OTases identified in this chapter were unable to
catalyze glycosylation of the acceptor peptides using either Dol-PP-GlcNAc or Dol-PP-
GlcNAc 2 as glycosyl donors. Therefore, in order to probe these OTases for function, it was
proposed that a polyisoprenyl-linked glycan bearing greater similarity to the native M voltae
and M maripaludis N-linked glycans must be synthesized. A retrosynthetic strategy for the
synthesis of two dolichyl-linked glycans, Dol-PP-GlcNAc-GlcNAc(3NAc)A and Dol-PP-
.. . ............................................... ...................
GalNAc-GlcNAc(3NAc)A, is outlined in Figure 2-17 and involves two key transformations.
First, the novel nucleotide sugar UDP-GlcNAc(3NAc)A is prepared by either chemical or
chemoenzymatic means, followed by the coupling of this sugar to Dol-PP-GlcNAc or Dol-PP-
GalNAc using a suitable glycosyltransferase.
O O~ UDP-GIcNAc(3NAc)A
O O-
A N HO OHO AcHN 0-UDP HO OHON
AcHN 0 
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Figure 2-17: Retrosynthetic strategy for the generation of the desired dolichyl-linked
disaccharides, Dol-PP-GlcNAc-GlcNAc(3NAc)A and Dol-PP-GalNAc-GlcNAc(3NAc)A.
In the first step of this strategy, a robust method for the synthesis of UDP-
GlcNAc(3NAc)A is required. Rather than obtain this compound through chemical synthesis, a
laborious process that has since been shown to entail over fifteen steps culminating in a low
final yield,32 we sought out a set of biosynthetic enzymes from the Wbp pathway in the Gram-
negative opportunistic pathogen Pseudomonas aeruginosa PAOL. These enzymes have been
implicated in the assembly of the unique carbohydrate ManNAc(3NAc)A, which is a critical
component of the B-band O-antigen that comprises the lipopolysaccharide (LPS) of the
organism (Figure 2-18). Upon generation of UDP-GlcNAc(3NAc)A, efforts to identify a
suitable glycosyltransferases to ligate this sugar to either Dol-PP-GlcNAc or Dol-PP-GalNAc is
required. To this end, a panel of glycosyltransferases from both M voltae and M. maripaludis
..... .  . .
has been identified, and progress towards the synthesis of the final dolichyl-linked disaccharides
is summarized in Chapter 5.
HO Wbp Enzymes: HO A0A, B, E, 0, IAcHN\.0
AcHN-UDP O-UDP
UDP-GIcNAc UDP-ManNAc(3NAc)A
ManNAc(3NAc)A
B-band 0-antigen
Figure 2-18: The lipopolysaccharide (LPS) of Pseudomonas aeruginosa PAO1 (05), with the
ManNAc(3NAc)A moiety in the B-band O-antigen highlighted in blue. The enzymes WbpA,
WbpB, WbpE, WbpD, and WbpI have been implicated in the biosynthesis of UDP-
ManNAc(3NAc)A, and the desired UDP-GlcNAc(3NAc)A is proposed to be an intermediate in
this pathway. The characterization of these Wbp enzymes is outlined in Chapter 3.
Conclusions
In this chapter, efforts towards the identification and characterization of an archaeal
OTase are described. An initial search of completed archaeal genome sequences yielded a total
of 25 archaeal Stt3 homologs, from which 5 candidates were selected for further analysis. After
cloning these genes into suitable vectors, protein expression levels were compared in various E.
coli cell lines by Western blot analysis. These studies indicated that the OTases from the
................. ... . . .. .. ... .....
.. ................................
methanogen Methanococcus voltae and the extreme halophile Haloarcula marismortui
exhibited the highest overall protein expression yields, representing a nearly 100-fold
improvement over PglB. Further work demonstrated that these proteins could be purified from
the cell membrane; however, efforts to observe function of these proteins using various glycosyl
donors were unsuccessful. It is hypothesized that the lack of activity demonstrated by these
archaeal OTases is due to the use of substrates that differ in carbohydrate linkage and
composition from the native archaeal glycosyl donors; thus, future work will entail the
biosynthesis of a dolichyl-linked substrate containing the unique GlcNAc(3NAc)A. Efforts
towards this goal are summarized in Chapters 3 and 5 of this thesis. In order to begin to unravel
the enzymatic mechanism of the oligosaccharide transfer reaction, a long-standing interest of the
Imperiali laboratory, large quantities of a highly pure and active OTase homolog are required,
and the work described in this chapter represents the first steps towards this goal.
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Experimental Methods
General Information
Unless otherwise noted, all solvents and reagents were obtained commercially and used without
further purification. Genomic DNA was purchased from the American Culture Type Collection
(Manassas, VA) or generously provided by Professors W. Whitman (University of Georgia,
Athens) and K.F. Jarrell (Queen's University). Oligonucleotides were purchased from Eurofin
MWG Operon (Huntsville, AL) or Sigma Life Sciences (St. Louis, MO). Restriction
endonucleases were obtained from New England Biolabs (Ipswich, MA), and competent cell
lines are from Stratagene (Agilent Technologies, Santa Clara, CA). Sequencing of all bacterial
plasmids was conducted by the MIT CCR Biopolymers Laboratory (Cambridge, MA). Fmoc-
protected amino acids and coupling agents were purchased from Novabiochem (Gibbstown, NJ)
and GenScript (Piscataway, NJ). Solvents were obtained from VWR (West Chester, PA) or
Sigma Aldrich (St. Louis, MO). Fmoc-PAL-PEG-PS resin was acquired from Applied
Biosystems (Carlsbad, CA). HPLC was carried out on a Waters Prep LC 4000 or Waters Delta
600 systems, each equipped with a Waters 2487 dual wavelength detector. For analytical HPLC,
a C18 YMC ODS-A 5 tm (4.6 x 250 mm) column was used, and for preparatory HPLC, a C18
YMC-Pack ODS-A 5 [tm (250 x 20 mm) column was employed. ESI-MS was conducted on a
Mariner instrument (Applied Biosystems).
Cloning ofArchaeal stt3 Homologs
The stt3 homolog genes were amplified by the polymerase chain reaction from genomic DNA
from the following organisms and strains: Methanocaldococcus jannaschii DSM,
Methanococcus voltae, Methanococcus maripaludis S2, Archaeoglobus fulgidus (ATCC
490203), and Haloarcula marismortui (ATCC 43049) using the Pfu Turbo polymerase
(Stratagene) and the oligonucleotides listed in Appendix (Table 1). The resulting PCR products
containing both BamHI and XhoI restriction sites (or BamHI and HindIl for H marismortui)
were digested and cloned into the same sites of the pET24a(+) vector (Novagen) via standard
molecular biology techniques. The final gene products encoded proteins with an N-terminal T7-
tag and a C-terminal His6-tag.
Overexpression of Archaeal OTases
The pET24a(+) plasmids containing the desired archaeal stt3 homologs were transformed into
the following E. coli competent cell lines: BL21(DE3) Gold, BL21-CodonPlus(DE3) RIL,
BL21-CodonPlus(DE3) RP, and BL21(DE3) pLysS (Stratagene), using the appropriate
antibiotics for selection. For overexpression, 1 L of Luria-Bertani media supplemented with the
corresponding antibiotics was inoculated at 37 'C while shaking until an optical density (600
nm) of 0.6-0.8 was achieved. The cultures were then cooled to 16 'C and protein expression was
induced by the addition of IPTG (1 mM). After 16 hrs, the cells were harvested by
centrifugation (5000 x g) and the resultant cell pellets were stored at -80 'C until needed.
Preparation of Crude E. coli Membrane Fractions
All steps were performed at 4 'C. A frozen cell pellet of E. co/i expressing an archaeal Stt3
homolog was resuspended in 50 mM HEPES, pH 8.0 / 1 mM EDTA buffer (30 mL)
supplemented with Protease Inhibitor Cocktail III (Calbiochem, 30 [tL). The cells were lysed by
sonication, and the mixture was centrifuged at 6000 x g for 30 mins to remove the cellular
debris. The supernatant was gently decanted and subjected to a second round of centrifugation
(140,000 x g) for 1 hr to collect the membrane fraction. The pellet was washed with 50 mM
HEPES, pH 8.0 / 1 mM EDTA buffer, centrifuged (140,000 x g) for 1 hr, then homogenized in
50 mM HEPES, pH 8.0 / 100 mM NaCl buffer (3 mL). The crude cell membrane fraction was
divided into 100 tL aliquots and stored at -80 C for future use.
Purification of Archaeal OTases
All steps were performed at 4 *C. A 500 [tL aliquot of a cell envelope fraction containing an
archaeal Stt3 homolog was removed from storage and thawed on ice, after which Triton X-100
was added to a final concentration of 1%. The mixture was incubated for 12 hrs with gentle
rocking, after which it was subjected to centrifugation (140,000 x g) to pellet the membranes.
The supernatant was removed and incubated with Ni-NTA agarose resin (Qiagen) for 2 hrs with
gentle rocking, then subsequently poured into a fritted PolyPrep column (BioRad) to collect the
resin. The resin was washed (50 mM HEPES, pH 8.0/300 mM NaCl/25 mM imidazole) and the
protein eluted (50 mM HEPES, pH 8.0/300 mM NaCl/250 mM imidazole). Fractions containing
the desired product were identified by SDS-PAGE and Western blot, using an Anti-T7 antibody
for detection. Protein concentration was detennined by either the Micro BCA kit (Pierce) or UV
absorbance using the appropriate extinction coefficient.
Synthesis of M voltae Flagellar Peptides
All peptides were synthesized using standard solid phase Fmoc-based protocols on Fmoc-PAL-
PEG-PS resin (0.19 mmol/g). The resin was swelled first in CH 2C12 (5 mins) then DMF (5 mins)
prior to synthesis. Deprotection of the terminal Fmoc group was achieved by exposure of the
resin to an excess of 20% 4-methylpiperidine in DMF (3 x 5 mins). Each amino acid was
coupled to the resin by incubation with the amino acid (4 equiv), PyBOP (4 equiv), and DIPEA
(8 equiv) for 45 mins. Between each deprotection and coupling step, the resin was washed with
DMF (5 x 1 min) then CH 2Cl 2 (5 x 1 min). The TNBS test was used to check the resin for
coupling efficiency, in which the formation of red color indicates the presence of a free amine.
All peptides were acetylated at the N-terminus by incubation with acetic anhydride (10 equiv)
and pyridine (10 equiv) in DMF for 30 mins. The side chain protecting groups were removed
and the peptides cleaved from the resin by exposure to a TFA:CH2Cl2:H20:TIS mixture
(90:5:2.5:2.5) for 3 hrs while shaking vigorously, followed by filtration to remove the beads and
solvent evaporation under a stream of nitrogen. The resulting pellet was triturated with cold
Et 20, and the peptides were purified by preparative C18 RP-HPLC using a 45 minute gradient of
5-95% mobile phase B, where the mobile phases are H20 / 0.1% TFA (A) and CH3CN / 0.1%
TFA (B). Purified peptides were characterized by analytical RP-HPLC for purity and either ESI-
MS or MALDI-TOF MS for identity. Peptides were stored as solutions of DMSO and quantified
by UV absorbance using the E280 of Nph (12,500 M 1cm~1).
Preparation of Crude Porcine Liver Microsomes
All steps were performed at 4 'C. A liver from a freshly slaughtered pig (E.M. Blood Company,
Groton, MA) was obtained and sliced into four 100 g sections, mincing each section into small
chunks. Using a blender, 200 g of liver was combined with 200 mL homogenizing buffer (50
mM TrisOAc, pH 7.2 / 250 mM sucrose / 2.5 mM MgCl 2 / 3 mM DTT / 0.1 mM AEBSF) and
mixed until smooth. A slow speed spin was then performed (4,500 x g) to pellet organ debris,
after which the supernatant was decanted into fresh centrifuge tubes and spun again. The
supernatant was then transferred into clean tubes again and centrifuged (140,000 x g) to pellet
the membranes. Each pellet was resuspended in 300 [tL homogenizing buffer, adding glycerol
to a final concentration of 30%. The mixture was divided into 250 [tL aliquots and stored at -80
'C for future use.
Chemoenzymatic Synthesis of Dolichyldiphosphate [H]Chitobiose (Dol-PP-[H]-GlcNAc2)
Dolichyldiphosphate N-acetylglucosamine (1 mg) was dissolved in 3:2 CHCl 3:MeOH (166.66
[tL) to a concentration of 6 mg/mL, and 60 [L of this solution was added to each of 10 clean
glass scintillation vials and dried under a stream of N2. A 1:10 dilution of UDP-N-
[3H]acetylglucosamine (10 uCi) was prepared in 70% EtOH, and 10 pL of this solution was
added to each vial containing the dolichyl-sugar and dried. DMSO (50 [L) and freshly prepared
conversion buffer (800 tL, 50 mM TrisOAc, pH 7.0 / 250 mM sucrose / 5 mM MgCl 2 / 3 mM
DTT / 1% NP-40) were subsequently added to each vial and vortexed. Freshly thawed porcine
liver microsomes (150 iL) were added to this mixture and gently shaken at room temperature
for 30 mins. The reactions were quenched by the addition 3:2:1 CHCl3:MeOH:4 mM MgCl 2 (6
mL), and each vial was centrifuged to achieve separation of the organic and aqueous phases.
The aqueous layer was removed, and the organic layer was twice extracted with theoretical
upper layer (TUP, 3 mL). The aqueous phases were then recorded and quantified with
scintillation counting to determine overall reaction turnover. The organic layers were combined
and dried, and purified with silica gel (72:21:3 CHCl3:MeOH:2.5 mM MgCl 2). Each fraction
was analyzed by scintillation counting, and upon the appearance of radioactivity, the column
was washed 60:25:4 CHCl3:MeOH:2.5 mM MgCl 2 . The fractions containing the desired product
were combined and quantified, and stored in 50,000 DPM aliquots at -20 'C until further use.
O/igosaccharyl Transferase Assays
To a tube of dried Dol-PP-[ 3H]GlcNAc2, DMSO (10 pL), 2X assay buffer (100 tL, 100 mM
HEPES, pH 7.5 / 280 mM sucrose / 2.4% v/v Triton X-100), 1 M MnCl 2 (2 [tL), H20 (53 gL),
and freshly thawed archaeal OTase crude membranes were combined. The assay was initiated
by the addition of 10 tL of a 2 mM stock of the peptide of interest in DMSO. Aliquots of the
reaction mixture (25 tL) were removed every 2 mins and quenched by addition of 3:2:1
CHCl3:MeOH: 4mM MgC12 (1.2 mL). The aqueous layer was then removed and the organic
layer extracted with theoretical upper phase (TUP) with salt (2 x 600 [tL). The aqueous layers
were combined, mixed with 5 mL of scintillation fluid (Ecolite, MP Biomedicals) and subjected
to scintillation counting. In the case of assays involving Dol-PP-GlcNAc, the aqueous layers
were injected onto an analytical C18 RP-HPLC column and purified extended version of the
gradient described above, in which the elution solvent is introduced from 0-50% over the course
of 90 mins. The resulting peaks were collected, dried down, and analyzed by MALDI.
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Chapter 3 Biosynthesis of UDP-GlcNAc(3NAc)A Using Enzymes in the Wbp
Pathway of Pseudomonas aeruginosa PAO1
A significant portion of the work described in this chapter has been published in the following:
Larkin, A. and Imperiali, B. Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and
WbpD: Enzymes in the Wbp Pathway Responsible for O-Antigen Assembly in Pseudomonas
aeruginosa PAO1. Biochemistry 2009, 48, 5446-5455.
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Introduction
The Gram-negative pathogen Pseudomonas aeruginosa is a versatile organism
responsible for infection in immunocomprised individuals.' It is a leading source of hospital-
acquired pneumonia and bacteremia, causes severe inflammation and pulmonary failure in
cystic fibrosis patients, and has emerged as a serious public health threat.- 5 Effective treatment
of P. aeruginosa infection has proved challenging due to the strong inherent resistance of the
organism to traditional antibiotics and the increasing emergence of multidrug resistant strains.'~8
While several vaccines for P. aeruginosa have been described, none thus far have achieved
clinical success.9
One of the major factors affecting the virulence of P. aeruginosa is the composition of
the unique carbohydrates that make up the lipopolysaccharide (LPS). 4," Localized in the
exterior leaflet of the outer membrane of the organism, the P. aeruginosa LPS is composed of
three distinct regions: lipid A, which anchors the structure to the membrane, a core
oligosaccharide, and the 0-antigen, a strand of monosaccharides that is further classified as
either A-band or B-band (Figure 3-1)."-" Unlike the A-band O-antigen, which is a
homopolymer of c-1,3-linked D-rhamnose,14 the B-band 0-antigen is structurally complex and
can vary between strains; this diversity serves as the basis of serological classification of
particular strains of the organism.', 16 In addition, the B-band O-antigen has been shown to play
a critical role in host colonization and provides resistance to both serum sensitivity and
phagocytosis. 12 ' 1,is In P. aeruginosa PAO (serotype 05), the B-band 0-antigen is composed of
repeating units of a trisaccharide containing 2-acetamido-3-acetamidino-2,3-dideoxy-@-D-
mannuronic acid (ManNAc(3Nam)A), 2,3-diacetamido-2,3-dideoxy-@-D-mannuronic acid
(ManNAc(3NAc)A), and N-acetyl-c-D-fucosamine (Fuc2NAc). 9 Interestingly, it has been
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shown that while all three of these carbohydrates are derived from a common precursor, UDP-
GIcNAc, the biosynthesis of each involves a distinct set of genes.2 0
Core oligosaccharide
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Figure 3-1: General structure of the lipopolysaccharide of P. aeruginosa PAO1 (serotype 05),
depicted with one unit of the B-band form of the 0-antigen. ManNAc(3NAc)A is highlighted in
blue.
The assembly of the B-band 0-antigen trisaccharide takes place on the cytoplasmic
surface of the inner membrane of P. aeruginosa, and involves the sequential transfer of each
carbohydrate unit onto an undecaprenyl-phosphate carrier (Und-P, Figure 3-2).12,2' A series of
genetic experiments suggest that the first sugar, Fuc2NAc, is added by the glycosyltransferase
WbpL, followed by the addition of ManNAc(3NAc)A and ManNAc(3NAm)A by WbpH and
WbpJ. After synthesis of the trisaccharide is complete, it is processed in a similar manner to
that described for LPS assembly in Escherichia coli.23 Following this model, the 0-antigen
trisaccharide unit is first flipped into the periplasm by the Wzx translocase, an integral
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membrane protein conserved in all Gram-negative bacteria.24 Individual trisaccharide units are
joined together by the Wzy polymerase, which works in concert with the chain length regulator
Wzz to control the extent of polymerization. In P. aeruginosa PAO1, B-band O-antigen chain
length may vary from 12 to over 100 units in size. 12 2 The means by which Wzy and Wzz
coordinate to control O-antigen chain length is an area currently under investigation;
preliminary evidence suggests that a coiled coil extended from the surface of Wzz interacts with
the growing O-antigen produced by Wzy, resulting in the regulated chain length found in each
serotype of P. aeruginosa.26-28 The completed O-antigen is then transferred to the nascent LPS
by the WaaL ligase, followed by the shuttling of the entire LPS from the periplasm to the outer
membrane through a complex comprised of LptD and LptE."
2
3
1)ManNAc(3NAm)A
Periplasm 0ManNAc(3NAc)A
Fuc2NAc
~ 0.Und-PP
Cytoplasm
Figure 3-2: General scheme of B-band O-antigen biosynthesis in Pseudomonas aeruginosa
PAOl. 1) The O-antigen trisaccharide is synthesized on the cytoplasmic face of the inner
membrane onto an Und-P carrier, then flipped to the periplasm by the Wzx translocase; 2) the
O-antigen chain is lengthened by the Wzy polymerase, controlled by the chain regulator Wzz; 3)
the completed O-antigen is tethered to the nascent LPS by the WaaL ligase.
Previous work involving a combination of genetic and biochemical analyses have
indicated that the UDP-activated form of the second sugar in the B-band O-antigen, UDP-
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ManNAc(3NAc)A, is the product of genes in the Wbp pathway (Figure 3-3). The enzymes
encoded by these genes are thought to convert UDP-GlcNAc to UDP-ManNAc(3NAc)A in a
stepwise fashion, followed by the transfer of the ManNAc(3NAc)A moiety onto an
undecaprenyl carrier by the putative glycosyltransferase WbpH. The biosynthetic pathway
begins with WbpA, previously shown to catalyze the C6"-oxidation of UDP-GlcNAc to give the
corresponding UDP-N-acetyl-D-glucosaminuronic acid (UDP-GlcNAcA).30 It is then
hypothesized that the C3"-dehydrogenase WbpB, aminotransferase WbpE, and acetyltransferase
WbpD sequentially convert UDP-GlcNAcA into UDP-2,3-diacetamido-2,3-dideoxy-D-
glucuronic acid (UDP-GlcNAc(3NAc)A), which is the UDP-activated form of a key
carbohydrate found in both the Methanococcus voltae and Methanococcus maripaludis N-linked
glycans.3'1' 2 Finally, the C2"-epimerase WbpI modifies UDP-GlcNAc(3NAc)A to give the final
UDP-ManNAc(3NAc)A. Genetic mutants of P. aeruginosa in which wbpA, wbpB, wbpE, wbpD
and wbpI have been deleted lack the B-band O-antigen, thus highlighting their critical
importance to pathogenicity.
OH 0~O
HO OH WbpA HO WbpB HO
H cHN HO_____
O-UDP NAD+ O-UDP NAD+/NADP+ 0 O-UDP
UDP-GIcNAc UDP-GIcNAcA UDP-GlcNAc(3keto)A
PLP
L-Glu WbpE ?
0- 0
0NHAc WbpI0? HWbpD ? O
AHNAcHN 44H 2NI~~ ,A~NAP AcH AcHNO-UDP NAD+/NADP+ AcHN O-UDP AcCoA A -UDP
UDP-ManNAc(3NAc)A UDP-GIcNAc(3NAc)A UDP-GIcNAc(3NH2)A
Figure 3-3: Biosynthetic pathway of UDP-ManNAc(3NAc)A in Pseudomonas aeruginosa, as
defined prior to this study.
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As outlined in Chapter 2, our efforts to define the N-linked glycosylation pathway in the
organisms M voltae and M. maripaludis require a robust means for generating UDP-
GlcNAc(3NAc)A. Rather than obtain this compound through chemical synthesis, a laborious
process that has since been shown to entail over fifteen steps culminating in a low final yield,"
we sought to characterize three enzymes from P. aeruginosa PAO 1, WbpB, WbpE, and WbpD,
implicated in the biosynthesis of the desired nucleotide sugar. In this chapter, we present the
overexpression, purification, and biochemical characterization of these three enzymes and
demonstrate that they are responsible for the biosynthesis of UDP-GlcNAc(3NAc)A. We also
identify a novel NAD* recycling mechanism which requires the coupling of WbpB and WbpE,
the dehydrogenase and aminotransferase, to give the WbpE product UDP-GlcNAc(3NH2 )A.
Notably, WbpB, WbpE, and WbpD can be used in conjunction with WbpA and WbpI to convert
UDP-GlcNAc to UDP-ManNAc(3NAc)A in a one-pot reaction. This work completes the
characterization of the UDP-ManNAc(3NAc)A biosynthetic pathway in P. aeruginosa and
provides, for the first time, a straightforward synthetic route to multimilligram quantities of the
rare nucleotide sugar UDP-GlcNAc(3NAc)A, a critical intermediate for future studies of LPS
assembly and the oligosaccharyl transferase in methanogenic archaea.
Results and Discussion
Overexpression and Purification of WbpA, WbpB, WbpE, and WbpD
The wbpA, wbpB, wbpE, and wbpD genes were amplified from P. aeruginosa PAOl
genomic DNA and inserted into suitable plasmids for protein expression in E. coli using
standard molecular biology techniques. The resulting proteins were overexpressed in high yield;
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15 mg (WbpA), 20 mg (WbpB), 110 mg (WbpE), and 15 mg (WbpD) of purified protein was
routinely obtained from 1 L cell culture. The expected molecular weights of WbpA, WbpB,
WbpE, and WbpD, each containing an N-terminal T7 and C-terminal His 6-tag, corresponded to
the observed molecular weights based on SDS-PAGE and Western blot analysis, using
antibodies directed against the T7 and His6-tags (Figure 3-4). The enzymes retained activity
when stored at -20 *C (WbpA, WbpB, and WbpE) or 4 *C (WbpD) for a minimum of three
months.
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Figure 3-4: (A) 10-20% gradient SDS-PAGE and (B) Anti-T7 Western blot. (1) MW standard;
(2) WbpA; (3) WbpB; (4) WbpE; (5) WbpD.
Synthesis of UDP-N-Acetylglucosaminuronic acid (UDP-GlcNAcA)
The first step in generating the desired UDP-GlcNAc(3NAc)A involved the synthesis of
the glucuronic acid, UDP-GlcNAcA. In order to probe the function of the remaining enzymes in
the Wbp pathway, a direct method for generating large quantities of this nucleotide sugar was
required. An initial attempt to synthesize this compound entailed the use of WbpA, the first
enzyme in the biosynthetic pathway, which had been previously characterized by Miller et al."
106
..........
WbpA, a 50.3 kD protein containing one N-terminal transmembrane domain, is homologous to
the UDP-GlcNAc 6-dehydrogenases from Achromobacter georgiopolitanum and Micrococcus
luteus and has been shown to catalyze the oxidation of UDP-GlcNAc to UDP-GlcNAcA,
utilizing 2 molecules of NAD* to convert the C6" hydroxyl group to a carboxylic acid (Figure
3-5).34,35 Kinetic analysis of WbpA revealed that the reaction takes place at an optimal pH of 8.5
and requires the presence of monovalent cations, in particular NH4* or K*.30 These kosmotropic
ions are believed to stabilize the protein and serve to enhance the reaction rate. A crystal
structure of the E. coli fructose-1,6-bisphosphate aldolase, which also requires these cations for
activity, shows a common binding site for both ions;3 6 it is hypothesized that WbpA may contain
a homologous cation binding site, which would explain the requirement of NH4* or K* for
enzyme activity.
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Figure 3-5: Capillary electrophoresis
to UDP-GlcNAcA (2) by WbpA.
26 28 30
chromatogram showing conversion of UDP-GlcNAc (1)
107
To this end, WbpA was incubated with NAD t and UDP-GlcNAc, and reaction progress
was monitored by capillary electrophoresis (CE, Figure 3-5). Although formation of the UDP-
GlcNAcA product was observed, the overall substrate conversion was modest (31%). Further
optimization of conditions, including modifying reaction temperature, additive concentrations,
and quantity of enzyme, provided a marginal increase in overall reaction yield but was still not
sufficient to afford full conversion of substrate to product. It was hypothesized that maximal
substrate turnover did not take place due to inhibition of WbpA by the product, UDP-GlcNAcA.
Rather than struggle with efforts to overcome this obstacle, we sought an alternative means to
obtain our desired compound.
Recently, Field and coworkers reported a direct oxidation of UDP-GlcNAc to UDP-
GlcNAcA in the presence of platinum and oxygen without the use of protecting groups.37 While
this selective oxidation has been previously demonstrated,38 39 this work represents the first time
the methodology has been applied to UDP-GlcNAc and thus provides a useful alternative to the
low-yielding chemoenzymatic route. The reaction involves streaming oxygen gas into a stirring
mixture of UDP-GlcNAc and the activated platinum catalyst in H20 at reflux over the course of
three days (Figure 3-6). After removal of the platinum catalyst by filtration, the reaction mixture
is subjected to anion exchange chromatography to separate the product from the remaining
starting material, followed by further purification by C18 reversed-phase HPLC to desalt the
material and remove small impurities. Optimization of the reaction conditions, including
adjustment of the oxygen flow rate and vigorous stirring of the reaction mixture, has afforded a
reaction yield of nearly 75% on a routine basis, therefore providing a robust means of
generating pure UDP-GlcNAcA for our studies.
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Figure 3-6: CE chromatogram
UDP-GlcNAc (2).
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depicting the Pt/0 2-catalyzed oxidation of UDP-GlcNAc (1) to
Functional Characterization of the Coupled WbpB and WbpE Reaction
With a reliable source of UDP-GlcNAcA in hand, efforts were then made to characterize
the function of the next enzymes in the Wbp pathway, WbpB and WbpE. WbpB, a previously
uncharacterized 35.7 kD protein, was predicted to be a dehydrogenase responsible for oxidation
of the C3" hydroxyl group to afford the ketone product. Primary sequence analysis revealed that
WbpB is a putative member of the GFO/IDH/MocA family of oxidoreductases, containing a
characteristic NAD*/NADP*-binding Rossmann fold.4 However, a search for homologs of
WbpB in the NCBI database only resulted in a few matches, including uncharacterized proteins
from various strains of P. aeruginosa and Bordetellapertussis. The next enzyme in the pathway,
WbpE, is a 38.7 kD protein found to be a member of the broad class of Fold Type I aspartate
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aminotransferases. This class of proteins utilizes the cofactor pyridoxal 5'-phosphate (PLP) and
an amino acid donor to convert a carbonyl group into a primary amine. A search for WbpE
homologs in the NCBI database resulted in over twenty related nucleotide sugar
aminotransferases, including the well-studied proteins DesV (Streptomyces venezuelae) and
PseC (Helictobacter pylori)."42
Initial attempts to characterize the function of WbpB in the presence of UDP-GlcNAcA
and NAD* or NADP* were unsuccessful despite an exhaustive screen of reaction conditions.
Efforts included the addition of various monovalent and divalent cations (Na*, K*, NH4*, Ca2+,
Mg2+, Mn2+), salts (NaH2PO 4, K2HPO 4, (NH4)2 SO 4 , KCl), cofactors (NAD*, NADP*, FAD),
detergents (Triton X-100) and reducing agents (DTT), as well as varying the reaction pH (6.0-
8.5) and temperature (25-37 C). Despite these attempts, no formation of the UDP-
GlcNAc(3keto)A product was observed by CE. In order to account for the unlikely event that
UDP-GlcNAc(3keto)A was indeed formed but was co-eluted with the starting material UDP-
GlcNAcA on the CE, benzylamine was used as a ketone-labeling agent and added to the
reaction mixture after two hours. If the ketone product was generated, it would react with
benzylamine at a basic pH to form the imine adduct and thus be predicted to elute from the CE
at a different retention time. However, incubation of the reaction mixture with benzylamine did
not result in any evidence of WbpB catalysis.
As a last effort to test for activity of WbpB, UDP-GlcNAcA and NAD+ were incubated
with the next enzyme in the pathway, the aminotransferase WbpE, along with PLP and L-
glutamate. Surprisingly, complete turnover of the UDP-GlcNAcA starting material and the
formation of a new peak were observed by CE (Figure 3-7). The treatment of WbpE alone with
UDP-GlcNAcA and obligate cofactors did not result in product formation, implying that both
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enzymes were required for catalysis. The product of the reaction was later identified to be UDP-
GlcNAc(3NH 2)A by mass spectrometry and NMR analysis. In addition, the use of 15N-L-
glutamate as the amine donor resulted in a product with an increase in mass of 1 amu, indicating
that the 1 5N-label was successfully transferred to the molecule. Further investigation of the
coupled WbpB/WbpE reaction showed that the enzymes catalyzed product formation at a wide
range of pH (5.5-10.0) and temperature (4-65 0C). In addition, exogenous NAD* or PLP was not
required for product formation, suggesting that both WbpB and WbpE were purified with their
respective cofactors already bound. However, the addition of 200 tM NAD* and 100 [tM PLP
to the reaction mixture aided in achieving complete turnover of substrate, which implies that the
heterologously expressed proteins were not saturated with cofactor due to the limiting
intracellular levels of both NAD* and PLP in E. coli. Optimal reaction conditions yielding
complete conversion of starting material to product was observed at pH 8.0 and 30 'C, and have
led to the generation of over 20 mg of the desired UDP-GlcNAc(3NH 2)A in a single reaction.
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Figure 3-7: Capillary electrophoresis (CE) chromatogram representing (A) WbpB reaction
alone, indicating no substrate conversion; (B) crude coupled WbpB/WbpE reaction; (C) pure
UDP-GlcNAc(3NH 2)A. (1) NAD*; (2) UDP-GlcNAc(3NH 2)A; (3) UDP-GlcNAcA.
The nucleotide sugar specificity of the coupled WbpB/WbpE reaction was explored by
incubating the enzymes with UDP-GlcNAc, UDP-GalNAc, and UDP-D-glucuronic acid (UDP-
GlcA) in the place of UDP-GlcNAcA. No turnover was observed in the presence of UDP-
GlcNAc or UDP-GalNAc, and only minimal turnover was detected (11%) when UDP-GlcA was
used as the nucleotide sugar substrate. These results confirm that WbpB prefers the
glucopyranose configuration of the sugar as well as the presence of both the carboxylate at C6"
and the acetylated amine at the C2" position. To analyze the amine donor specificity of WbpE,
the WbpB/WbpE coupled reaction was screened with all 20 naturally occurring L-amino acids
as well as D-glutamate, at a concentration of 25 mM. Other than L-glutamate, only the use of L-
glutamine resulted in conversion from starting material to product (10%). This result strongly
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suggests that WbpE is specific for L-glutamate as the amine donor, a result that has been
confirmed for other homologous nucleotide sugar-modifying aminotransferases.4 ' 4 4
Identification of the Nicotinamide Cofactor Bound to WbpB
In order to further characterize the coupled WbpB/WbpE reaction, we sought to
determine whether WbpB utilizes either NAD* or NADP* to catalyze the oxidation of UDP-
GlcNAcA. WbpB was precipitated by treatment with HClO 4 and the pellet washed several times
to recover the bound cofactor. After neutralization and lyophilization, the extract was treated
with either NAD*-specific alcohol dehydrogenase or NADP*-specific isocitrate dehydrogenase
and the formation of NADH/NADPH monitored by UV absorbance at 340 nm. 45'46 As depicted
in Figure 3-8, a sharp increase in absorbance was observed upon the addition of alcohol
dehydrogenase, indicating the presence of NAD* in the extract. Alcohol dehydrogenase is
specific for NAD*, as suggested by the lack of absorbance increase when NADP* was
introduced. In addition, no absorbance increase was seen after treatment of the extract with
isocitrate dehydrogenase, which serves as further evidence that the bound cofactor to WbpB is
NAD*.
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Figure 3-8: Identification of NAD* as the bound cofactor to WbpB by UV analysis. WbpB
extract was treated with either NADt -dependent alcohol dehydrogenase (AD, closed circles) or
NADP*-dependent isocitrate dehydrogenase (ID, open circles) and analyzed for the formation of
NADH/NADPH by absorbance at 340 nm. (1) Enzyme added to extract in cuvette; (2) NADP*
(AD) or NAD* (ID) added to reaction to address specificity; (3) NAD* (AD) or NADP* (ID)
added to reaction to check for activity.
Elucidation of a Novel Pathway for NAD' Recycling by WbpB
Perhaps the most striking finding obtained from the studies described above was that
exogenous NAD* was not required for product formation by the coupled WbpB/WbpE reaction.
In general, NAD*-dependent nucleotide sugar dehydrogenases catalyze oxidation reactions
through the abstraction of a hydride from the carbohydrate, followed by hydride transfer to
NAD* to form NADH. However, in the case of the WbpB/WbpE coupled reaction, the
formation of an equimolar amount of NADH was not observed in the reaction mixture,
suggesting that WbpB efficiently recycles its NAD* cofactor. NAD* recycling by nucleotide
sugar dehydrogenases has been widely observed; for example, in the case of the nucleotide
sugar 4,6-dehydratases, such as Rff (E. coli), the oxidation of the C4" hydroxyl group results in
NADH formation, followed by elimination of H20 to generate an a, p-unsaturated ketone
(Figure 3-9). Delivery of the hydride from NADH to the C6" carbon is coupled with protonation
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at the C5" carbon to regenerate NAD* and prime the enzyme for another round of catalysis.
4 7
,
4 8
Unlike in this instance, the UDP-GlcNAcA substrate is not reduced over the course of the
coupled WbpB/WbpE reaction, which suggests that the required oxidant is already present in
reaction mixture. Therefore, we sought to identify the oxidant for NAD* recycling and proposed
that it might in fact be a-ketoglutarate (a-KG), a product of the WbpE reaction.
OH NAD+ OH NADH 00
HO 'N\HOH .'HO O -I oi. ~ ON
OH I OH IOH I A~OH
O-UDP NADH O-UDP H20 O-UDP O-UDP
dTDP-glucose dTDP-4-keto-6-deoxy-glucose
Figure 3-9: Reaction carried out by the dTDP-glucose 4,6-dehydratase from E coli, Rff, in
which NAD* is regenerated.4 7
In order to determine whether the required oxidant for NAD* regeneration was indeed a-
KG, WbpB was incubated with UDP-GlcNAcA and 10 mM a-KG and the reaction monitored
by CE. Remarkably, complete conversion of the UDP-GlcNAcA starting material to the UDP-
GlcNAc(3keto)A product was observed in the presence of a-KG (Figure 3-10). No turnover was
seen in the absence of either a-KG or WbpE, indicating the addition of a-KG to the WbpB was
sufficient to promote NAD* recycling.
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Figure 3-10: CE chromatogram representing (A) WbpB reaction in the absence of a-KG and
WbpE, depicting no substrate conversion; (B) WbpB reaction containing 10 mM a-KG,
depicting consumption of UDP-GlcNAcA. (1) NAD*; (2) UDP-GlcNAcA; (3) UDP-
GlcNAc(3keto)A.
To confirm that a-KG was in fact being consumed by WbpB, aliquots were removed
from the reaction at specific time points and reacted with o-phenylenediamine (OPD), which has
been previously shown to selectively label a-keto acids.49 50 Analysis of the labeled aliquots by
UV absorbance at 340 nm demonstrated a decrease in a-KG concentration over time, indicating
that it was indeed being consumed (Figure 3-11). However, the use of a lower concentration of
a-KG (2 mM) to maximize the observed signal decrease in the labeling reaction prevented
complete turnover of the UDP-GlcNAcA starting material (70%). The product of a-KG
reduction was identified as 2-hydroxyglutarate (2-HG) by thin-layer chromatography (TLC);
development of TLC plates spotted with the crude reaction mixture followed by staining with
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either dinitrophenylhydrazine, a marker of ketones and aldehydes, or bromocresol green,
specific for carboxylates, revealed the presence of a newly formed product that did not contain a
ketone and ran at the same Rfvalue as an authentic 2-HG standard."
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Figure 3-11: A) Verification of a-KG consumption over the course of the WbpB reaction,
indicating it is the required oxidant for NAD* recycling. Aliquots were removed from the
reaction at selected time points, quenched, labeled with OPD, and analyzed by absorbance at
340 nm. Data represent the average of three experiments; B) the reduction of C-KG to 2-HG by
WbpB allows for efficient regeneration of NAD*.
The necessary coupling of dehydrogenase/aminotransferase pairs in vitro has previously
been reported; for example, the GnnA and GnnB enzymes from the Gram-negative acidophile
Acidithiobacillusferrooxidans must both be present to observe the conversion of UDP-GlcNAc
to the corresponding C3"-modified UDP-GlcNAc(3NH 2).s2 However, unlike GnnA and GnnB,
the coupled WbpB/WbpE reaction does not require exogenous NAD* for product formation,
supporting the claim that the cofactor is efficiently regenerated in situ over the course of the
reaction. While the concomitant reduction of c-KG and oxidation of NADH has been
previously observed in nature, such as the case of SerA 3-phosphoglycerate dehydrogenase," to
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our knowledge this is the first example of a-KG shunting in a nucleotide sugar biosynthesis
pathway, thus representing a novel method of NAD* recycling.
A close comparison of the UDP-GlcNAc(3keto)A and a-KG structures offers insight
into a possible pathway for recycling of NAD*. As depicted in Figure 3-12, the terminal
carboxylate, carbon backbone, and ketone of both molecules spatially overlap, suggesting
similar binding interactions within the active site. One may envision a catalytic cycle in which
initially, UDP-GlcNAcA is converted to UDP-GlcNAc(3keto)A, resulting in reduction of NAD*
to NADH (Figure 3-12, 1). After dissociation of UDP-GicNAc(3keto)A, a molecule of a-KG
enters the active site (2) and is positioned favorably to permit formation of 2-HG and the
oxidation of NADH back to NAD* (3), both completing the NAD* regeneration cycle and
preparing WbpB for catalysis of another molecule of UDP-GlcNAcA.
UDP-GlcNAc(3keto)A a-KG0~0
00
HO
O UPcHN 03
N- N O_ H UDP-3ketoA a- N
0HO 0~
li 0 0N+ H O-UD HN Ho a-KG N2-HG
NAD H2N NADH H2N NADH H2N NAD*
WbPB
Figure 3-12: Comparison of UDP-GlcNAc(3keto)A and a-KG structures, suggesting similar
binding orientations of the carboxylate and ketone moieties in the WbpB active site (pink).
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The underlying necessity for the coupled activities of the dehydrogenase WbpB and
aminotransferase WbpE remains unclear. One hypothesis is that UDP-GlcNAc(3keto)A is labile
at physiological conditions, and thus the pairing of WbpB and WbpE activities allows for the
direct transfer of the ketone intermediate from WbpB to WbpE. In support of this theory, the
ketone has been shown to be unstable in water at room temperature, resulting in hydrolysis of
the UDP moiety within several hours at pH 7. However, though the two enzymes may be in
close proximity to deliver the ketone intermediate from WbpB to WbpE, the observation of
WbpB function in the presence of c-KG implies that there is no required physical interaction
between WbpB and WbpE. Future work in this area will entail evaluation of a putative
WbpB/WbpE complex.
In August 2010, Thoden et al reported the crystal structure of WlbA, a close homolog of
WbpB from Thermus thermophilus that also carries out the oxidation of UDP-GlcNAcA." The
authors present WlbA in complex with NAD* alone, as well as with either UDP-GlcNAcA or a-
KG; interestingly, their structural analysis supports our claim that a-KG is the required oxidant
for NAD* regeneration. As shown in Figure 3-13, both UDP-GlcNAcA and a-KG bind in the
same place within the enzyme active site, with the C3" (UDP-GlcNAcA) and C2 (a-KG)
carbons located within 3 A of the re face of the nicotinamide cofactor. Analysis of the active
site residues implicates Lys 101 and His 185 as playing important roles in catalysis, though more
work is required to confirm this hypothesis. In addition, the authors compare the overall
architecture of WlbA with that of the well-characterized sugar dehydrogenase, glucose-fructose
oxidoreductase (GFOR, Zymomonas mobilis). Like WlbA, GFOR crystallized with a tetrameric
quaternary structure; however, each protomer adopts a drastically different conformation
compared with the other subunits in the complex (Figure 3-13C).55 Also, the WlbA protein
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Figure 3-13: X-ray crystal structure of WlbA, a close WbpB homolog. WlbA bound to NAD(H)
and UDP-GlcNAcA (A) or a-KG (B). A 2(Fo-Fe) electron density omit map contoured at 2.5 a
(left), and the active site residues located within 3.2 A of either UDP-GlcNAcA or a-KG (right).
Water molecules are depicted as red spheres and possible hydrogen bonds are shown as black
lines. (C) Overall architecture of WlbA (left) and GFOR (right), highlighting the remarkable
difference in protein structure. Figures are taken from Thoden et al."
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appears to bind its nicotinamide cofactor in an unprecedented manner, sharing it with two
neighboring subunits. This unique structure helps to establish WbpB as one of the first examples
of a new class of NAD* recycling nucleotide sugar dehydrogenases.
Functional Characterization of WbpD
The next enzyme in the UDP-ManNAc(3NAc)A biosynthetic pathway, WbpD, catalyzes
the AcCoA-dependent acetylation of UDP-GlcNAc(3NH 2)A to give UDP-GlcNAc(3NAc)A.
Previous sequence analysis of WbpD indicated that it was predicted to have a left-handed 3-
helical (L#3H) structure and thus is a member of the hexapeptide acyltransferase superfamily.'' 7
Previously characterized enzymes in this class of acyl- and acetyltransferases include the lipid A
acyltransferase LpxA (E. coli), the glucosamine 1-phosphate N-acetyltransferase GlmU (E.
coli), and the UDP-4-amino acetyltransferase PglD (Campylobacterjejuni), all of which contain
numerous repeats of the hexapeptide motif L/I/V-[G/A/E/D]-X 4-[L/I/V] similar to WbpD.5860
Incubation of WbpD with UDP-GlcNAc(3NH 2)A and AcCoA resulted in the complete
consumption of both UDP-GlcNAc(3NH 2)A and AcCoA and the formation of two new peaks
by CE (Figure 3-14). Using mass spectrometry and NMR analysis, these two peaks were
identified to be CoA and UDP-GlcNAc(3NAc)A. The utilization of [3H]-AcCoA in the place of
AcCoA resulted in [3H]-labeled UDP-GlcNAc(3NAc)A, which was confirmed after purification
and analysis by scintillation counting. As in the case with the WbpB/WbpE coupled reaction,
WbpD was able to catalyze the acetylation of UDP-GlcNAc(3NH 2)A at a broad range of pH
(5.5-10.0) and temperature (4-65 'C), although the optimal reaction conditions for catalysis
were found to be 30 C and pH 7.0 to limit base-promoted hydrolysis of AcCoA.
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Figure 3-14: CE time course analysis of the WbpD reaction. (1) AcCoA; (2) CoA; (3) UDP-
GlcNAc(3NAc)A; (4) UDP-GlcNAc(3NH 2)A. The peak labeled x represents an impurity
present in the AcCoA starting material.
The specificity of WbpD for its nucleotide sugar substrate was investigated by
incubation with UDP-GlcNAcA, UDP-GlcNAc, and UDP-2-acetamido-4-amino-2,4,6-trideoxy-
D-glucosamine, the UDP-4-amino sugar product of the C4"-aminotransferase from C. jejuni,
PglE.6' No appreciable turnover of starting material was observed in any case, signifying the
importance of an amine at the C3" position for acetylation. In addition to exploring substrate
specificity, the kinetic parameters of the WbpD reaction were determined by varying the
concentration of UDP-GlcNAc(3NH 2)A from 0.015-1.5 mM in the presence of fixed
concentrations of AcCoA (1.5 mM) and WbpD (Figure 3-15). At the highest concentration of
substrate, no more than 10% turnover was observed. Data were collected by manual integration
of CE traces and then directly fit to the Michaelis-Menten equation using SigmaPlot (Systat
Software). The conclusion from this analysis is that WbpD exhibits an apparent Km, = 107 ± 15
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[M and kcat = (2.9 ± 0.12) x 103 min- for its nucleotide sugar substrate, UDP-GlcNAc(3NH 2)A
(Figure 3-15).
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Figure 3-15: Michaelis-Menten diagram depicting WbpD kinetic parameters. Reactions were
carried out with AcCoA as the fixed substrate (1.5 mM) and UDP-GlcNAc(3NH 2)A as the
variable substrate (0.015-1.5 mM). Data are the average of two experiments.
Based on these kinetic parameters, it appears that WbpD has a greater affinity for its
nucleotide sugar substrate UDP-GlcNAc(3NH 2)A (apparent Km = 107 ± 16 [M) and catalyzes
acetylation in a moderately rapid fashion (kcat = 2.9 ± 0.12 x 10' min-') when compared with
PglD, the C4" acetyltransferase involved in the biosynthesis of UDP-N,N'-diacetylbacillosamine
(UDP-Bac) from C. jejuni characterized previously (Km = 410 ± 78 RM and kcat = 4.83 ± 0.30
x 105 min-1 ).62 PglD is a highly efficient enzyme (kcat/Km = 1.18 x 106 min- mM-1), and it is
hypothesized that its ability to rapidly carry out acetylation serves to prevent the buildup of
early intermediates produced by the slower preceding enzymes (PglE and PglF) in the
biosynthetic sequence. While the kinetic parameters of WbpB and WbpE have yet to be
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determined, it is clear that WbpD (kcat/Km = 2.69 x 104 min~' mM-1) is in fact more efficient than
WbpA (kcat/Km = 913 min-' mM-1), the first enzyme in the pathway, in turning over its
nucleotide sugar substrate;30 perhaps the increased efficiency of WbpD provides the same
function in this case as well.
In early 2010, Thoden et al published the X-ray crystal structure of WlbB from
Bordetella petrii, a nearly identical homolog of WbpD that also catalyzes the acetylation of
UDP-GlcNAc(3NH 2)A.63 The structure of this protein confirms that WlbB adopts a trimeric
structure, in which each protomer is predominantly composed of a long, left-handed /-helix that
represents the hallmark of the L#3H hexapeptide acyltransferase superfamily (Figure 3-16A).
The authors obtained a crystal structure of the complex between WlbB, CoA, and the UDP-
GlcNAc(3NH 2)A substrate; surprisingly, they note that there are only two hydrogen bonds that
can reasonably occur between the protein backbone and the nucleotide sugar, namely from
Asn84 and Arg94. From this structure, it is unclear which atom or residue plays the role of the
catalytic base in the reaction that would serve to deprotonate the C3" amine. Earlier work by
Olivier et al finds that in the case of PglD, an active site histidine residue was found to behave
as the catalytic base; 60 however, the structure of WlbA shows no histidine within 4 A of the C3"
amine capable of performing the deprotonation. In addition, the sulfur atom of CoA is ideally
positioned in the active site to interact with the C3" amine of the nucleotide sugar (Figure 3-
16C). For this reason, the authors propose a unique reaction mechanism, whereby the sulfur
atom of AcCoA ultimately behaves as the catalytic base required to deprotonate the C3" amine
in a concerted fashion; further evidence to support this hypothesis is still required.
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Figure 3-16: Crystal structure of WbpD homolog, WlbB, in complex with CoA and UDP-
GlcNAc(3NH 2)A. (A) Ribbon representation of the WlbB trimer with the three subunits shown
in red, beige and light blue. (B) A 2(Fo-Fe) omit map contoured at 1.5o, depicting the active site
of a single protomer of WlbB. (C) Amino residues lying within 3.2 of UDP-GlcNAc(3NH 2)A.
Water molecules are depicted as red spheres and possible hydrogen bonds are represented by
dashed lines. Figures are taken from Thoden et al.63
One-Pot Synthesis of UDP-ManNAc(3NAc)A
As a final means to characterize the enzymes in the Wbp pathway, the synthesis of UDP-
ManNAc(3NAc)A was attempted in a single reaction vessel using WbpA, WbpB, WbpE, WbpD
and WbpI. WbpI, the C2" epimerase, was overexpressed and purified in the same manner as the
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other four enzymes in the pathway. All five enzymes were combined with UDP-GlcNAc and the
requisite cofactors; after incubation for 8 hours, CE analysis indicated partial consumption of
the UDP-GlcNAc starting material (15%) and formation of a new peak (Figure 3-17). The crude
reaction mixture was purified by RP-HPLC and the identity of UDP-ManNAc(3NAc)A was
confirmed by high resolution ESI-MS, as well as comparison with a pure sample of UDP-
GlcNAc(3NAc)A by CE. This result demonstrates that by combining WbpA, WbpB, WbpE,
WbpD and WbpI with UDP-GlcNAc and obligate cofactors and substrates in vitro, it is possible
to generate UDP-ManNAc(3NAc)A in a one-pot reaction. This multienzyme biotransformation
now provides a platform for screening the entire sequence of Wbp enzymes for possible
inhibitors in a single reaction vessel.
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Figure 3-17: CE analysis of the (A) crude one-pot reaction of WbpA, WbpB, WbpE, WbpD and
WbpI and (B) purified UDP-ManNAc(3NAc)A, with both NAD* and UDP-GlcNAc(3NAc)A
included as references. UDP-ManNAc(3NAc)A has the same retention time as NADH. (1)
NAD*; (2) UDP-GlcNAc; (3) AcCoA; (4) NADH; (5) UDP-ManNAc(3NAc)A; (6) CoA; (7)
UDP-GlcNAc(3NAc)A. The staffed peaks refer to the starting material (2, UDP-GlcNAc) and
the final product (5, UDP-ManNAc(3NAc)A).
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Conclusions
In conclusion, this chapter describes the biochemical characterization of WbpB, WbpE,
and WbpD, three key enzymes responsible for the formation of UDP-GlcNAc(3NAc)A. It
provides a facile route to the chemoenzymatic synthesis of milligram quantities of this rare
nucleotide sugar that can be used for studying N-linked glycosylation in archaea, and completes
the annotation of the UDP-ManNAc(3NAc)A biosynthetic pathway in P. aeruginosa (Figure 3-
18). Due to the presence of UDP-GlcNAc(3NAc)A and UDP-ManNAc(3NAc)A in related
pathogens, such as Bordetella pertussis, Bordetella bronchiseptica, and other Pseudomonas
strains, we envision that the methods outlined herein may provide useful tools to probe similar
biosynthetic pathways in these organisms. Lastly, as these enzymes play a critical role in the
formation of lipopolysaccharide, they may present new targets for the development of potential
therapeutics for treatment of P. aeruginosa infection.
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Figure 3-18: Biosynthetic pathway of UDP-ManNAc(3NAc)A in P. aeruginosa PAOl.
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Experimental Methods
General Information
Unless otherwise noted, all reagents were obtained commercially and used without further
purification. Oligonucleotides were purchased from Eurofins MWG Operon (Huntsville, AL)
and Sigma Life Sciences (St. Louis, MO). Restriction endonucleases were obtained from New
England Biolabs (Ipswich, MA). UDP-GlcNAc, UDP-GlcA, UDP-GalNAc, AcCoA, PLP,
NAD+ and NADP* and amino acids were purchased from Sigma Aldrich (St. Louis, MO).
[3H]AcCoA was acquired from American Radiolabeled Chemicals (St. Louis, MO), and 15N-L-
glutamate as well as deuterated solvents for NMR spectroscopy were obtained from Cambridge
Isoptope Laboratories (Andover, MA). Shigemi tubes for NMR spectroscopy were purchased
from Shigemi, Inc (Allison Park, PA). Analytical thin-layer chromatography (TLC) was carried
out on silica gel 60 F254 plates (EMD Chemicals). Sequencing of all bacterial plasmids was
performed by the MIT CCR Biopolymers Laboratory (Cambridge, MA). NMR spectra were
acquired using either a Bruker 600 MHz spectrometer equipped with a 5 mm inverse cryoprobe,
a Varian Inova 500 MHz spectrometer with a 5 mm inverse broadband gradient probe, or a
Bruker 400 MHz spectrometer furnished with a 5 mm variable temperature gXH probe.
Chemical shifts (6) are reported in parts per million (ppm) and references to internal standards;
the HOD signal at 4.80 ppm was used as for 1H analysis and the (CH 3 _CH2)3N signal of
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triethylamine at 47.19 ppm was utilized for 13C observation. An external reference of 85%
H3PO 4 was employed for 3 1P NMR. Coupling constants (J) are reported in Hertz (Hz) and
multiplicites are abbreviated as singlet (s), doublet (d), triplet (t), multiplet (in), doublet of
doublets (dd), and doublet of triplets (dt). The terms apparent triplet (tapp) and apparent quartet
(qapp) are used to describe a doublet of doublets (dd) with two similar coupling constants or a
doublet of doublet of doublets (ddd) with three similar coupling constants. High-resolution ESI-
MS was performed by Department of Chemistry Instrumentation Facility at MIT (Cambridge,
MA).
Cloning of wbpA, wbpB, wbpE, and wbpD
The genes were amplified by the polymerase chain reaction from P. aeruginosa PAO1-LAC
genomic DNA (ATCC) using Pfu Turbo polymerase (Stratagene) and the oligonucleotides
described in the Appendix (Table 1). The resulting PCR products containing both BamHI and
XhoI restriction sites were digested and cloned into the same sites of the pET24a(+) vector
(Novagen) via standard molecular biology techniques. The final gene products encoded proteins
with an N-terminal T7-tag and a C-terminal His6-tag.
Overexpression of WbpA, WbpB, WbpE and WbpD
The pET24a(+) plasmids containing either wbpA, wbpB, wbpE, or wbpD were transformed into
E. coli BL21-CodonPlus(DE3) RIL competent cells (Stratagene) using both kanamycin (50
[tg/mL) and chloramphenicol (30 [tg/mL) for selection. For overexpression, 1 L of Luria-Bertani
media supplemented with kanamycin and chloramphenicol was inoculated at 37 'C while
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shaking until an optical density (600 nm) of 0.6-0.8 was achieved. The cultures were then
cooled to 16 'C and protein expression was induced by the addition of IPTG (1 mM). After 16
hrs, the cells were harvested by centrifugation (5000 x g) and the resultant cell pellets were
stored at -80 0C until needed.
Purification of WbpA, WbpB, WbpE, and WbpD
All steps were performed at 4 C. The cell pellets from a 1 L culture were thawed and
resuspended in 50 mL cold lysis buffer (50 mM HEPES, pH 8.0/300 mM NaCl/10 mM
imidazole) with Protease Inhibitor Cocktail Set III (EDTA-free, Calbiochem) added at a 1000-
fold dilution. The cells were disrupted by ultrasonication on ice, and the resulting cell lysate was
then cleared of unbroken cells, cellular debris, and membranes by centrifugation (145,000 x g)
for 65 minutes. The resulting supernatant was incubated with Ni-NTA agarose resin (Qiagen)
for 2 hrs with gentle rocking and subsequently poured into a fritted PolyPrep column (BioRad)
to collect the resin. The resin was washed (50 mM HEPES, pH 8.0/300 mM NaCl/25 mM
imidazole) and the protein eluted (50 mM HEPES, pH 8.0/300 mM NaCl/250 mM imidazole).
Fractions containing the desired product were combined and dialyzed (50 mM HEPES, pH
8.0/100 mM NaCl) to remove the imidazole and lower the salt concentration. Proteins were
stored at either -20 'C (WbpA, WbpB, WbpE) or 4 'C (WbpD) after the removal of precipitate
by filtration and addition of glycerol to a final concentration of 25%. Protein purity was
measured by SDS-PAGE, and protein identity was confirmed by Western blot analysis using
both Anti-T7 (Novagen) and Anti-His4 (Qiagen) antibodies. Protein concentration was
determined by either the Micro BCA kit (Pierce) or UV absorbance using the following
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extinction coefficients at 280 nm: WbpA (32,320 M'cm~ ), WbpB (38,150 M'1cm-1), WbpE
(20,040 M-1cm-1), WbpD (22,340 M 1cm).
Chemical Synthesis of UDP-GlcNAcA
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UDP-GlcNAcA was prepared via oxidation of UDP-GlcNAc as previously described." Briefly,
Adams' catalyst (10 mg) was activated in H20 (1 mL) under H2 for 2 hrs, then flushed with N2 .
The catalyst was then transferred to a stirring mixture UDP-GlcNAc (100 mg, 0.153 mmol) and
NaHCO 3 (25.8 mg, 0.307 mmol) in H20 (5 mL) in a three-necked round bottom flask. A gas
bubbler (medium grade) was inserted into the side neck, and the reaction was refluxed for 72 hrs
in the presence of streaming 02. Three additional aliquots of activated catalyst (10 mg) were
added over the course of the reaction. After filtration to remove the Pt catalyst, the desired
product was purified from the remaining UDP-GlcNAc starting material using a 5 mL HiTrap Q
FF anion exchange column (GE Healthcare), eluting with a linear gradient of 0-0.5 M
NH4HCO 3 over 250 mL. Fractions containing UDP-GlcNAcA were combined, freeze-dried, and
resuspended in H20 for further purification using a Synergi C18 Hydro preparatory RP-HPLC
column (4 rim, 80 A, 250 x 21.2 mm, Phenomenex) for removal of impurities and salt. The
HPLC column was equilibrated with 50 mlM triethylammonium bicarbonate (TEAB, pH 7.1)
and, after loading, the product was eluted using a gradient of 0-50% CH 3CN over 30 minutes.
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Quantification of the product was carried out using the molar extinction coefficient of uridine
(6262nm = 10,000 M-cm~1). The UDP-sugar to be analyzed was dissolved in 150 pL D20 and
freeze-dried several times prior to NMR analysis using a Shigemi tube. The desired UDP-
GlcNAcA was characterized by 1H and 13C NMR spectroscopy and ESI-MS (Appendix). 1H
NMR (600 MHz, D2 0): 6 2.07 (s, C(O)CH3 ), 3.57 (tapp J4",5" = 10.1, H-4"), 3.78 (tapp, J3",4" =
10.0, H-3"), 3.97 (dt, J2",3" = 9.9, J2",p = 2.8, H-2"), 4.13 (d, H-5"), 4.16 (in, H-5'b), 4.19 (in, H-
5'a), 4.23 (in, H-4'), 4.32 (m, H-2' and H-3'), 5.50 (dd, J1",p = 7.3, J1"," = 2.8, H-1"), 5.91 (d,
Js,6= 8.0, H-5), 5.95 (d, J',2 ' 4.4, H-i'), 7.95 (d, H-6); 13C NMR (400 MHz, D2 0): 6 174 (C-
6"), 172.5 (C(O)CH 3), 163 (C-4), 153 (C-2), 143 (C-6), 104 (C-5), 94 (C-1"), 86 (C-i'), 83 (C-
4'), 75 (C-2'), 74 (C-5"), 72 (C-4"), 71 (C-3"), 70 (C-3'), 65 (C-5'), 53 (C-2"), 22 (C(O)CH 3).
HRMS: calcd for protonated acid C17H24N 30 18P2 ([M] 3-): requires m/z = 206.0130, found m/z =
206.0128 (ESI). NMR data were found to be in good agreement with previously reported
values.37
Synthesis of UDP-GlcNAc(3NH 2)A by the Coupled Reaction of WbpB and WbpE
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WbpB/WbpE coupled reactions to produce UDP-GlcNAc(3NH 2)A contained 4.5 mg of each
enzyme, 0.75 mM UDP-GlcNAcA, 0.2 mM NAD+, 25 mM L-glutamate, 0.1 mM PLP, 50 mM
HEPES (pH 8.0), 2.5 mM DTT, and 2 mM MgCl 2 in a total volume of 50 mL. Reactions were
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incubated at 30 'C for 24 hours, during which time the progress of the reaction was monitored
by CE. Protein was removed from the mixture by filtration and the resulting filtrate was frozen
and lyophilized. The crude mixture was resuspended in H2 0 and loaded onto a Synergi Cis
Hydro preparatory RP-HPLC column equilibrated with 50 mM TEAB (pH 7.1). The UDP-
GlcNAc(3NH 2)A product was eluted with a linear gradient of 0-50% CH 3CN over 65 minutes.
For 5N-labeling of UDP-GlcNAc(3NH 2)A, 15N-L-glutamate was utilized in the place of L-
glutamate. For determination of optimal pH, reactions included 50 mM MES (pH 5.5, 6.0, 6.5),
50 mM HEPES (pH 7.0, 7.5 8.0), 50 mM Bicine (pH 8.5), or 50 mM CHES (pH 9.0, 9.5, 10.0).
To study temperature requirements, reactions were incubated at 4, 16, 25, 30, 37, 42, and 65 'C
for the appropriate time. In all cases, the presence of product was confirmed by the addition of
starting material into reaction mixtures and the observation of a new peak by CE. The desired
UDP-GlcNAcA was characterized by 'H and 13C NMR spectroscopy and ESI-MS (Appendix).
'H NMR (600 MHz, D2 0): 8 2.09 (s, C(O)CH3 ), 3.57 (tapp, J3",4" = 10.0, H-3"), 3.80 (tapp, J4",5" =
10.1, H-4"), 4.17 (qapp, J'a,5'b = 11.7, H-5'a), 4.19 (in, H-5"), 4.23 (in, H-5'b), 4.29 (m, H-4'),
4.32 (tapp, J2", = 11.0, H-2"), 4.36 (m, H-2' and H-3'), 5.57 (dd, Ji", p = 7.4, J", 2"= 3.2, H-I"),
5.95 (d, Js,6 = 8.1, H-5), 5.97 (d, J', 2 ' = 4.4, H-i'), 7.94 (d, H-6). "C NMR (400 MHz, D20): 6
174 (C-6"), 172.5 (C(O)CH 3), 163 (C-4), 153 (C-2), 143 (C-6), 104 (C-5), 95 (C-I"), 86 (C-i'),
83 (C-4'), 75 (C-2'), 74 (C-5"), 73 (C-4"), 70 (C-3'), 65 (C-5'), 54 (C-2"), 53 (C-3"), 23
(C(O)CH 3). HRMS: calcd for protonated acid C17H24N4017P2 ([M2-+H]~): requires m/z =
619.0695, found m/z = 619.0686 (ESI); for '5N-incorporation, calcd for protonated acid
C17H24N315N0 7P2 [M~]: requires m/z = 620.0666, found m/z= 620.0687 (ESI).
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Acetylation of UDP-GlcNAc(3H2)A by WbpD
OH OH
For synthesis of UDP-GlcNAc(3NAc)A by WbpD, reactions contained 0.75 mM UDP-
GlcNAc(3NH 2)A, 0.75 mM AcCoA and 50 mM HEPES (pH 7.0) in a final volume of 7 mL.
The reactions were incubated at 30 *C for 2 hours prior to CE analysis. The crude reaction
mixture was filtered, lyophilized, and purified as described for UDP-GlcNAc(3NH 2)A. To
incorporate [3H] into UDP-GlcNAc(3NAc)A, [3H]-AcCoA was used in the place of AcCoA.
Determination of optimal pH and temperature was carried out as described above for the
coupled WbpB/WbpE reaction. The desired UDP-GlcNAcA was characterized by 'H and "C
NMR spectroscopy and ESI-MS (Appendix). 'H NMR (600 MHz, D20): 8 1.97 (s, C(O)CH 3),
2.00 (s, C(O)CH3), 3.64 (tapp, J4",5" =9.8, H-4"), 4.13 (tapp, J2",3" - 10.1, H-2"), 4.16 (tapp J 3",4" -
9.8, H-3"), 4.19 (in, H-5'a), 4.24 (in, H-5'b and H-5"), 4.29 (in, H-4'), 4.37 (in, H-2' and H-3'),
5.54 (dd, Jr, p = 7.1, Jr, 2" = 2.7, H-i"), 5.96 (d, J5,6 = 8.1, H-5), 5.99 (d, J',2' = 4.4, H-i'), 7.95
(d, H-6). 13 C NMR (400 MHz, D20): 6 176.0 (C-6"), 175.6 (C(O)CH 3), 175.4 (C(O)CH3 ), 167.1
(C-4), 152.7 (C-2), 142.5 (C-6), 103.5 (C-5), 94.6 (C-1"), 89.0 (C-i'), 84.2 (C-4'), 74.6 (C-2'),
74.2 (C-5"), 70.9 (C-4"), 70.6 (C-3'), 65.9 (C-5'), 59.5 (C-3"), 53.0 (C-2"), 22.9 (C(O)CH3 ),
22.7 (C(O)CH 3). HRMS: calcd for protonated acid C1 9H2 5N4018 P2 ([M3-+2H]~): requires m/z
661.0801, found m/z = 661.0790 (ESI).
134
Analysis of Reaction Products by Capillary Electrophoresis
CE was performed using a P/ACE MDQ system (Beckman Coulter) equipped with a UV
detector. Bare silica capillary (75 [tm x 80 cm) was utilized with detection at 72 cm and 25 mM
sodium tetraborate (pH 9.5) as the running buffer. Prior to each run, the capillary was
conditioned sequentially with 0.1 M NaOH, H20, and running buffer for 2 minutes. Samples
were introduced to the capillary by pressure injection for 15 seconds at 30 mbar and separation
was performed at 22 kV and monitored by UV absorbance at 254 nm. In general, samples were
prepared by filtration with a 5K MWCO membrane (Millipore) and diluted (2x) with H20.
Manual peak integration was carried out using Beckman 32 Karat software suite.
Verification of a-Ketoglutarate as the Required Oxidant for WbpB Function
To identify if c-KG was the required oxidant for NAD* regeneration by WbpB, a reaction
containing 0.75 mM UDP-GlcNAcA, 50 mM HEPES (pH 8.0), 10 mM c-KG, and 5 pg WbpB
in a total volume of 60 uL was assembled. The reaction was incubated at 30 'C for two hours
prior to analysis by CE. After removal of the enzyme by filtration, thin-layer chromatography
was utilized to observe the formation of 2-hydroxyglutarate (2-HG) in the crude reaction
mixture. Samples were run on silica gel 60 F25 4 plates in a butanol/formic acid/H 20 mixture
(8:3:2), air-dried, and developed either directly with dinitrophenylhydrazine or heated at 120 'C
and stained with bromocresol green.
In order to confirm the consumption of c-KG by WbpB, a similar reaction containing 0.75 mM
UDP-GlcNAcA, 50 mM HEPES (pH 8.0), 2 mM c-KG and 2.5 [tg WbpB in a volume of 250
[tL was prepared. Aliquots (25 pL) were removed from the reaction at several time points,
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quenched in 225 ptL 1 M H3PO4, and split into two 125 ptL fractions. A solution of o-
phenylenediamine (OPD, 30 [tL), a specific labeling agent for a-keto acids, 49,50 was then added
to one 125 pIL fraction, while the other was kept as an unlabeled control. The freshly prepared
OPD solution consisted of 1 mg OPD in 1 mL H3PO 4 (adjusted to pH 2 with 1 M NaOH) and
2.5 ptL p-mercaptoethanol. All OPD-labeled samples were boiled for 5 minutes and then cooled
to room temperature prior to analysis by UV absorbance at 340 nm. The absorbance
measurements of the unlabeled fractions were subtracted from readings of the corresponding
OPD-labeled samples; the resulting data represent the average of three experiments.
Identification of the Cofactor Bound to WbpB
In order to identify whether WbpB utilizes NAD* or NADP* as the preferred tightly bound
cofactor, procedures previously outlined were employed with slight modification. 454 6 Briefly,
500 [g of purified WbpB (in 2 mL 50 mM HEPES, pH 8.0/100 mM NaCl) was precipitated by
incubation with 10 ptL 60% aqueous HClO 4 on ice for 20 minutes followed by centrifugation
(7,000 x g). The supernatant was removed and the precipitate washed twice with 250 mL cold
HEPES/NaCl buffer and spun down. The combined supernatants were neutralized with
saturated NaHCO 3 and freeze-dried. The dried extract was then resuspended in 300 piL alcohol
dehydrogenase buffer (45 mM glycine/75 mM sodium pyrophosphate, pH 9.0/170 mM EtOH)
and transferred to a cuvette. NAD*-specific alcohol dehydrogenase (10 [tg, 445 units/mg,
Sigma-Aldrich) was added and NADH formation was monitored by UV absorbance at 340 nm.
After 10 minutes, NADP* (20 RM) was added to assess cofactor specificity and 5 minutes later,
NAD* (20 [M) was introduced as a control for enzyme activity. The same procedure was
performed using the NADP*-specific isocitric dehydrogenase (20 [tg, 95 units/mg, Sigma-
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Aldrich), using a solution containing 6 mM isocitric acid and 50 mM HEPES (pH 7.0) to
dissolve the WbpB extract.4 6
Determination of Kinetic Parameters of WbpD
For determination of UDP-GlcNAc(3NH 2)A kinetics, all reactions contained 0.5 ng of freshly
purified WbpD, 1.5 mM AcCoA, 50 mM HEPES (pH 7.0), 5 [tg bovine serum albumin as a
carrier protein, and varying concentrations of UDP-GlcNAc(3NH 2)A (0.015-1.5 mM) in a total
reaction volume of 30 ptL. The reactions were incubated at 30 'C for 45 minutes, boiled for 2
minutes to inactivate the enzyme, and analyzed by CE to determine the amount of UDP-
GlcNAc(3NAc)A produced. The kinetic parameters were determined from linear regression
analysis and are the average of two experiments.
One-Pot Synthesis of UDP-ManNAc(3NAc)A
In order to synthesize UDP-ManNAc(3NAc)A in a one-pot process, 50 [tg each of WbpA,
WbpB, WbpE, WbpD and WbpI was incubated with 0.75 mM UDP-GlcNAc, 2.0 mM NAD*,
100 mM (NH4)2SO4, 25 mM L-glutamate, 0.1 mM PLP, 0.75 mM AcCoA, 2.5 mM DTT, 2 mM
MgCl 2, and 50 mM HEPES (pH 7.0) in a total reaction volume of 2 mL. The reaction was
incubated at 30 'C for 8 hours, filtered, and purified by RP-HPLC. Formation of the desired
product was confirmed by high resolution ESI-MS and the observation of a distinct peak by CE
when compared to a sample of UDP-GlcNAc(3NAc)A. WbpI was previously characterized and
cloned, overexpressed, and purified as described above for WbpA, WbpB, WbpE, and WbpD.64
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Structural Analysis of WbpE from Pseudomonas aeruginosa
PA01: A Nucleotide Sugar Aminotransferase Involved in
O-Antigen Assembly
A significant portion of the work described in this chapter has been published in the following:
Larkin, A.; Olivier, N.B.; Imperiali, B. Structural Analysis of WbpE from Pseudomonas
aeruginosa PAOl: A Nucleotide Sugar Aminotransferase Involved in O-Antigen Assembly.
Biochemistry 2010, 49, 7227-7237.
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Chapter 4
Introduction
Pseudomonas aeruginosa is a Gram-negative pathogen responsible for severe infection
in immunocompromised individuals. In recent years, it has emerged as a major source of
hospital-acquired infections, such as bacteremia, pneumonia and febrile neutropenia, and leads
to inflammation and pulmonary failure in cystic fibrosis patients. 5 While there are several
standard antibiotics currently used to combat P. aeruginosa, the rapidly increasing occurrence
of multidrug resistant strains has complicated treatment and highlighted the need for alternative
6-8drug design strategies. - One of the most promising targets for improved treatment is the
bacterial lipopolysaccharide (LPS), found in the exterior leaflet of the outer membrane of the
organism. The LPS of P. aeruginosa contains the B-band O-antigen unit, a critical virulence
factor that has been shown to play a key role in host colonization and evasion of immune
defenses. 9-" Genetic mutants of P. aeruginosa deficient in B-band O-antigen have exhibited
greatly increased sensitivity to phagocytosis and serum-mediated killing.12
In P. aeurginosa PAO1 (serotype 05), the B-band O-antigen is composed of repeating
units of a trisaccharide containing 2-acetamido-3-acetamidino-2,3-dideoxy-#-D-mannuronic
acid (ManNAc(3NAm)A), 2,3-diacetamido-2,3-3-D-mannuronic acid (ManNAc(3NAc)A), and
N-acetyl-a-D-fucosamine (Fuc2NAc) (Figure 3-1).13 As outlined in Chapter 3, recent studies
have shown that the central saccharide unit, ManNAc(3NAc)A, is synthesized by five enzymes
in the Wbp pathway (WbpA, WbpB, WbpE, WbpD, and WbpI) starting from the common
precursor, UDP-GlcNAc (Figure 4-1).14 In the first step, WbpA oxidizes the C6" hydroxyl
group to afford UDP-GlcNAcA. This is followed by the coupled action of the dehydrogenase
WbpB and aminotransferase WbpE to yield UDP-GlcNAc(3NH 2)A through a unique NAD*
recycling pathway, in which the a-ketoglutarate product of WbpE is utilized by WbpB to
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regenerate NAD*.1 5 Finally, the acetyltransferase WbpD and epimerase WbpI provide the final
UDP-ManNAc(3NAc)A donor, which is then transferred to an undecaprenyldiphosphate carrier.
After completion, the trisaccharide is flipped into the bacterial periplasm by the Wzx translocase
and then ligated to the growing O-antigen by the coordinated action of the Wzy polymerase and
the chain length regulator Wzz.16
00 0
HO HWbpA HO WbpB HO
HAO HO
AH)AcHN AcHN
O-UDP O-UDP O ACHN O-UDP
2 NAD+ 2 NADH NAD* NADH
UDP-GIcNAc UDP-GIcNAcA UDP-GlcNAc(3keto)A
2-HG a-KG --------- a-KG PMP
L~GUXPP)WbpE
L-Glu PLP
0- 0- 0-
0 ~HAc 0p Wbp
HOWbpl HO HO
O-UDP AcHN 0-UDP CoA AcCoA AcHN O-UDP
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Figure 4-1: Biosynthetic pathway of UDP-ManNAc(3NAc)A in P. aeruginosa PAOl.
WbpE is a pyridoxal 5'-phosphate (PLP)-dependent aminotransferase responsible for the
conversion of UDP-GlcNAc(3keto)A and L-glutamate to UDP-GlcNAc(3NH 2)A and a-
ketoglutarate (a-KG), respectively. It is a member of the broad class of Fold Type I aspartate-
aminotransferase (AAT) enzymes, which harness the powerful electron-sink properties of PLP
to carry out a wide variety of transformations, including transaminations, eliminations,
decarboxylations, and epimerizations. 17'8 The general mechanism of this class of enzymes has
been worked out in great detail, and is divided into two discrete half reactions that cycle
between the PMP and PLP forms of the cofactor (Figure 4-2). The reaction begins with imine
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formation between the ketone-bearing sugar and PMP, followed by abstraction of a C4' proton
of PMP by the catalytic lysine residue of the protein. The resulting quinoid intermediate then
accepts a proton from the lysine at the C3" carbon of the pyranose, which serves to set the
stereochemistry at this position and results in the external aldimine intermediate. Release of the
nucleotide sugar amine product is facilitated by transimination to afford the internal aldimine. In
the second half of the catalytic cycle, the reaction steps are repeated in the reverse order
resulting in regeneration of PMP through conversion of L-glutamate to a-ketoglutarate.
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Figure 4-2: Proposed reaction mechanism of WbpE.
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The first crystal structure of a Fold Type I aminotransferase reported was that of
aspartate aminotransferase (AAT), an enzyme that catalyzes the conversion of L-aspartate and
a-keotglutarate to oxaloacetate and L-glutamate.19 Found in high levels in the mitochondria of
hepatic cells, the upregulation of this enzyme is often correlated with liver inflammation and is
20,21
used as a standard clinical biomarker of disease. In 1980, AAT was crystallized by the
Jansonius group as a homodimer in complex with its PLP cofactor (Figure 4-3A);22 since the
publication of this landmark paper, over forty crystal structures of Fold Type I
aminotransferases of have been elucidated and deposited in the Protein Data Bank (PDB).
Comparison of these structures reveals several defining features that enable PLP-binding and
catalysis of the wide variety of reactions carried out by these enzymes. For example, a large
number of these enzymes are compact oligomers, often homodimers, in which the PLP-binding
sites are open to face one another. In addition, nearly all known Fold Type I aminotransferases
contain a unique central #-sheet comprised of seven #-strands, with a topology in which the
seventh strand runs antiparallel to the remaining six (Figure 4-3B).
A B
1 7 4J{J4Z 3
Figure 4-3: (A) Crystal structure of aspartate aminotransferase, with the PLP cofactor shown as
sticks and the central p-sheet colored pink (PDB code: 1ASM); (B) Organization of #-strands
within the canonical /-sheet found in the Fold Type I family of aspartate aminotransferases.
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In recent years, the crystal structures of several Fold Type I enzymes that catalyze the
transamination of nucleotide sugars in bacteria have been described. 3 2 8 Despite the similarities
observed in the overall protein scaffold of these structures, several questions regarding substrate
binding and specificity still remain. In particular, it is unclear how these enzymes achieve their
exquisite specificity for both the nucleotide sugar and donor amino acid substrates, as the
residues lining the active sites of these proteins are quite similar. Several hypotheses have been
put forth to explain this finding, including the existence of a conformational change in the
enzyme structure upon substrate binding, as well as an increased affinity for certain substrates
due to induced fit.18 However, comparison of these structures in the apo state with those in
complex with the nucleotide sugar substrate do not show significant evidence of a
conformational change and are not suggestive of an induced fit, thus casting doubt on these
hypotheses.29 Therefore, further work is required to gain a better picture of the determinants that
affect binding and specificity of this class of enzymes.
In this chapter, we present the crystal structure of the aminotransferase WbpE from P.
aeruginosa PAOl in complex with three different ligands: PMP, PLP, and the external aldimine
of PLP with the reaction product, UDP-GlcNAc(3NH 2)A. This work presents the first structure
of an aminotransferase that binds a nucleotide sugar modified at the C2", C3", and C6"
positions, and thus provides a glimpse into the means by which such a highly functionalized
nucleotide sugar is accommodated in the enzyme active site. In addition, it was confirmed that
the dimeric structure of WbpE observed in the crystal structure is also present in solution using
sedimentation velocity analytical ultracentrifugation. In order to gain a broader understanding of
nucleotide sugar specificity across this class of aminotransferases, the WbpE structure in
complex with the external aldimine is compared to other nucleotide sugar-bound
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aminotransferase structures. Efforts toward obtaining a crystal structure of a putative complex of
both the dehydrogenase WbpB and WbpE are also summarized, with the goal of gaining
structural insight into the interactions between these two enzymes that facilitate the novel NAD*
recycling behavior outlined in Chapter 3. We envision that this work will add to the growing
body of knowledge about nucleotide sugar aminotransferases and may also present a novel
target for the development of antimicrobial treatments to combat P. aeruginosa.
Results and Discussion
Overexpression, Purification, and Crystallization of Native WbpE
The wbpE gene was amplified from P. aeruginosa PAO 1 -LAC genomic DNA and
inserted into a modified form of the pET32a vector using standard molecular biology
techniques. The resulting protein contained an N-terminal His6-tag followed by a tobacco etch
virus (TEV) protease cleavage site and was overexpressed in very high yield, with over 85 mg
of purified WbpE obtained from 1 L cell culture. After purification by Ni-NTA resin, the N-
terminal His6-tag was removed by incubation with TEV protease at 4 'C. The removal of the tag
was confirmed by Western blot analysis with an Anti-His 4 antibody, and the protein then
subjected to size-exclusion chromatography to achieve highly pure, monodispersed protein. The
final product was analyzed by SDS-PAGE to confirm purity prior to setting up crystal trays.
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Figure 4-4: A) 12% SDS-PAGE of purified WbpE, with increasing amounts of protein (2, 4,
and 6 [tL) loaded; (B) Anti-His 4 Western blot, depicting WbpE before (2) and after (3) TEV
cleavage to remove the His6-tag. The band in Lane 3 corresponds to His 6-tagged TEV protease
present in the reaction; (C) Size-exlcusion chromatogram representing WbpE after TEV
cleavage. Fractions eluting between 85 and 100 minutes represent monodispersed protein and
were utilized for crystallography.
Crystallization conditions for WbpE were identified by initially surveying several
commercially available sparse matrix screens. In general, samples of WbpE were prepared at
concentrations of 10, 15, and 20 mg/mL and were set up at a 1:1 ratio of protein to
crystallization condition in a 96-well sitting drop format at 25 *C. Crystal trays were monitored
daily, and after two weeks, the formation of small, square crystals was observed for several
conditions. Optimization of these conditions led to large, oval-shaped crystals that diffracted to
1.4 A. These crystals were transferred to a cryoprotectant solution containing 20% glycerol prior
to X-ray data collection; representative crystals are depicted in Figure 4-5.
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Figure 4-5: Crystallization of native WbpE. (A) Initial crystals of WbpE obtained from a sparse
matrix screen, which were optimized to obtain diffraction quality crystals shown in (B); (C) A
sample diffraction pattern of native WbpE (1.6 A).
Obtaining Phasing Information to Solve the WbpE Structure
All attempts to solve the crystal structure of native WbpE using molecular replacement
with homologous nucletotide sugar aminotransferases, such as DesV (Streptomyces venezuelae,
sequence identity = 41%) and PseC (Helicobacter pylori, sequence identity = 27%),24,26 as the
initial search models were unsuccessful. Therefore, an alternative method for obtaining phasing
information was sought. As a first attempt, native WbpE crystals were soaked in various
solutions of heavy atoms from a commercially available screen with the goal of solving the
structure using the method of multiple isomorphous replacement (MIR). MIR is a widely used
means of gaining phasing information through the use of heavy atom derivatives, in which a
heavy atom such as gold, mercury, or lead replaces another atom in a macromolecule to produce
an isomorphous derivative. Traditionally, these derivatives are generated by either soaking a
native crystal in a solution containing heavy atoms or co-crystallizing the protein with the
solution of choice. The basic principle behind this method involves combining structure factors
from the native data set with those obtained from heavy atom data sets and identifying the
differences with the aid of Patterson maps.3 1 Despite an extensive screen of soaking conditions,
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in which the concentration of heavy atom, time, and cryoprotectant concentration were varied, a
solution of WbpE was not obtained (Table 4-1). In all cases, either the WbpE crystals were
either unable to withstand the soaking conditions and rapidly disintegrated, or the heavy atom
signal was not observed upon data set analysis with the software programs SOLVE or
SHELXD.32,33
Table 4-1: Summary of heavy atom soaking trials of WbpE crystals for MIR
Heavy Atom Diffraction Outcome'
Soaka Quality
SrCl 2  very poor unable to use data set
Na2SeO 4  good only slight incorporation of Se
K2Pt(CN)4  good no evidence of Pt by FES
K2PtCl6  good no evidence of Pt by FES
KAuCl 4  no diffraction no evidence of Au by FES
PbOAc 2  good only slight incorporation of Pb
HgOAc 2  no diffraction no evidence of Hg by FES
HgEtH2PO 4  no diffraction no evidence of Hg by FES
(NH4)2WS 4  poor no evidence of W by FES
TICI poor no evidence of TI by FES
K2IrCl 6  poor no evidence of Ir by FES
HoCl3  good evidence of Ho by FES
aSoaking conditions involved incubation of native WbpE crystals in
solutions containing increasing concentration of the heavy atom. Crystals were
initially soaked for 10 mins while monitoring crystal appearance; further soaks
were carried out for incubation times up to 48 hours.
bFES = fluorescence energy scan
As an alternative to MIR, phasing information was sought through the incorporation of
selenomethionine (SeMet) into the protein sequence. Pioneered by Wayne Hendrickson in the
early 1990s, 34 this method allows for the replacement of native methionine residues with SeMet,
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thus allowing for structure determination by multiple anomalous dispersion (MAD). It is
generally accepted that in most cases, SeMet is able to replace methioinine without causing a
noticeable disturbance in the overall protein structure.3 s In addition, knowledge of exact
selenium atom locations in the protein sequence serves as a significant aid in model building.
Over the past two decades, several procedures have been developed in order to generate
SeMet-derivatized protein; 36 three of these methods were attempted in order to introduce SeMet
into the WbpE sequence. The first method was initially described by Guerrero et al, and
involved the inoculation and growth of E. coli cells transformed with the WbpE-pET32a
plasmid following standard procedures in Luria-Bertani (LB) broth. After reaching the
appropriate culture density, the cells were transferred to a minimal medium in which L-SeMet
was provided. WbpE was purified from these cells after induction with isopropyl #-D- 1-
thiogalactopyranoside (IPTG) followed by overnight expression, and efficiency of SeMet
incorporation was analyzed by MALDI mass spectrometry. Although the level of SeMet
labeling was near 100%, the overall protein yield was poor (< 3 mg/L) and thus alternate means
of protein expression were explored.
A second attempt to achieve expression of a SeMet-derivative of WbpE involved the use
of a methionine auxotroph. The B834 (DE3) E. coli cell line, which contains a lesion in the
metA gene and thus is unable to synthesize methionine, was obtained from a commercial source
and transformed with the WbpE-pET32a plasmid. The cells were then cultured in LB media in
the presence of SeMet following standard protocols. As in the case with the previous method,
MALDI mass spectrometry analysis showed nearly full incorporation of SeMet, but the overall
protein yield was prohibitively low (1 mg/L) and thus prevented crystallization efforts.
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A third and ultimately successful method of incorporating SeMet into WbpE involved
the process of metabolic inhibition. Previous work has shown that high levels of certain amino
acids, such as leucine, isoleucine, and lysine, serve to shut down the native methionine
biosynthesis pathway in bacterial cells through the inhibition of aspartokinases, thus rendering
the cells more likely to take up SeMet from exogenous sources.36 In the last two decades,
several protein structures were solved using this technique, including FKBP-1238 and UDP-
acetylenylpyruvylglucosamine reductase." The basic procedure involves the inoculation and
growth of standard BL21(DE3) RIL E. coli cells transformed with the WbpE-pET32a plasmid
in LB media until the appropriate culture density is reached. At this point, a combination of
seven amino acids (L-isoleucine, L-leucine, L-valine, L-threonine, L-phenylalanine, and L-lysine,
and L-SeMet) were added to the culture flask to initiate inhibition of methionine biosynthesis;
after 20 mins, IPTG was introduced to the culture to induce expression of the SeMet-labeled
protein. Using this procedure, SeMet-WbpE was overexpressed in very high yield, with over 45
mg of protease-treated, purified protein obtained from a 500 mL cell culture. Analysis of the
labeled WbpE by MALDI mass spectrometry indicated full occupancy of SeMet.
Crystallization of SeMet-WbpE was performed in the same manner as that described for
native WbpE, in which a purified protein sample was surveyed with commercially available
sparse matrix screens in a sitting drop 96-well plate format at 25 'C. Optimization of initial
crystallization conditions involved varying the pH and precipitant concentration as well as the
use of an additive screen; it was found that the addition of 10 mM SrCl 2 into the crystallization
drop helped to generate large, oval-shaped crystals similar to those seen for native WbpE.
Diffraction quality crystals were then obtained in a well solution comprised of 0.2 M NH40Ac,
0.1 M Bis-Tris (pH 5.5), 10 mM SrCl 2, and 25% PEG 3350 and diffracted to 1.8 A.
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Data Collection and Structure Determination
Diffraction data were collected at 110 K on beamline X6A at the National Synchrotron
Light Source at Brookhaven National Laboratory (Upton, NY). For the SeMet derivative of
WbpE, data were accumulated at the selenium peak (12667 eV), absorption edge (12660 eV)
and remote energies (12867 eV). Data sets were both indexed and scaled using HKL2000, and
the scaled intensities were converted to structure factors using the program TRUNCATE in the
Collaborative Computational Project Number 4 (CCP4) suite of programs. 4 0'4 1 Data collection
parameters are summarized in Table 4-2.
The structure of the WbpE-SeMet derivative was solved using the method of
multiwavelength anomalous diffraction (MAD) as previously described.34 Using data collected
at the selenium peak and truncated to 2.5 A, the program SOLVE was employed to locate the
heavy atom sites and generate experimental phases. 2 A total of four out of five selenium atoms
were located for each protein subunit. The initial model was built using the prime-and-switch
phasing feature of RESOLVE to minimize model bias and contained the basic framework of the
model, 4 2 ,4 3 except for sizeable gaps between residues 116-142 and 196-233. The PMP-bound
structure was then solved by molecular replacement using Phaser with the SeMet derivative as
the initial search model.44 Further model building and refinement were carried out using Coot
and Refmac.45'46 Five percent of the data were used to calculate the Rfree values for cross-
validation of the refinement process.4 7 The structures of the PLP and external aldimine
complexes were subsequently solved by molecular replacement in the same manner, using the
completed PMP-bound structure with the cofactor removed as the input model. Water molecules
were added using both ARP/warp and Coot, and ligands were modeled into each structure after
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the Rfree value was below 30%.48 All refined structures were validated using PROCHECK,
SFCHECK, and MolProbity, 4 9-51 and the final refinement statistics are presented in Table 4-2.
Table 4-2: Data Collection and Refinement Statistics
PMP PLP External Aldimine SeMeta
Data Collection
Space group P21212 P21212 P21212 P21212
Unit cell dimensions (a, b, c) (A) 78.28, 149.29, 54.90 77.79, 148.72, 53.22 78.29, 149.67, 55.12 77.81, 149.03, 53.29
Resolution (A) 50.0-1.95 20.0-1.50 20.0-1.83 50.0-1.93
Observed reflections 45,308 94,182 46,379 46,078
Rmerge (%)"c 7.3(42.0) 9,1(66.2) 7.1(49.2) 8.2(41.9)
I/allC 53.4(9.2) 35.8(3.0) 36.3(4.1) 36.7(5.8)
Completeness (%)c 99.8 99.7 98.6 100
Redundancyc 14.6(14.5) 7.9(7.0) 7.3(6.7) 7.5 (7.2)
Refinement
Resolution (A) 35-1.95 20-1.50 20-1.90
Rvork/Rfre (%)7e 19.8/24.6 17.9/22.2 18.7/24.5
Total Number of Atoms 5837 5880 6027
Protein 5428 5471 5401
Water 377 409 516
Ligands 32 32 110
B-factors (A 2)
Overall 28.2 20.5 19.8
Protein 28.3 19.1 19.3
Water 29.4 22.7 27.4
Ligand 15.0 16.9 34.8
Ramachandram plot (%J 96.8/2.8/0.4 97.1/2.7/0.3 96.0/3.8/0.3
r.m.s. deviations
Bond lengths (A) 0.010 0.011 0.016
Bond angles (*) 1.245 1.250 1.350
PDB code 3NU7 3NU8 3NUB
a Data reported for the SeMet derivative refer to those collected at the selenium peak wavelength.
b The number in parathenses represents the highest resolution bin; 1.98-1.94, 1.55-1.5, 1.86-1.83 and 2.01-1.93 A, for the data sets of
PMP, PLP, external aldimine and the SeMet derivative, respectively.
c Rmerge = IIII-<I>|/II, where I is the intensity of a reflection, and <I> is the mean intensity of group of equivalent reflections.
d R.ork = hlIF(h)obs-F(h)cle ll/XhIF(h).bSI
Rfree was calculated for 5% of the reflections randomly excluded from the refinement.
J'Ramachandran plot statistics are given as core/allowed/generously allowed and are for both chains.
Overall Architecture of WbpE
WbpE crystallized in the orthorhombic space group P2 1212, with two molecules in the
asymmetric unit and approximate unit cell dimensions of 75 A x 150 A x 50 A (Figure 4-6). As
predicted, the overall scaffold of WbpE is similar to that of other members in the Fold Type 1
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aspartate aminotransferase family.19,22 As in the case of AAT, each monomer of WbpE can be
divided into two major domains: a large N-terminal PLP-binding region and a smaller C-
terminal domain, shown in purple and green in Figure 4-6C. The N-terminal portion (residues
Ilel4-Glu243) is composed of a total of eleven p-strands, seven of which make up a central 3-
sheet that exhibits the canonical strand order p-1, P-9, P-8, #-5, 6-4, p-2, #-3, where #-9 is
antiparallel to the others. This #-sheet is bordered on the top and bottom faces by seven a-
helices. After strand #-9, a short stretch of residues (Gln209-Arg229) extends out from the
monomer structure to form a large domain-swapped /3-hairpin (/3-10 and /3-11) that interacts
with the active site of the other monomer. Another smaller #-hairpin (residues Alal63-Serl70,
#-6 and #-7) protrudes from the top face of the central #-sheet and interacts with the C-terminal
region in the same subunit. The C-terminal portion of the protein (residues Metl-Arg13, Ile244-
Asn359) is made up of two short #-strands and six a-helices that are oriented away from each
other in a V-shape. The entire C-terminal region of the protein is closely aligned to the N-
terminal domain on the top face of the monomer, yet opens to reveal a deep channel on the
opposite face of the subunit, allowing solvent access to the enzyme active site (Figure 4-6B). In
addition, this domain of the protein contains a non-prolyl cis amide bond between residues
His308 and Tyr309.
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DFigure 4-6: Crystal structure of the WbpE-PMP complex. (A) Structure of the homodimer,
with each subunit colored individually and the PMP cofactor shown as sticks. (B) Space-filling
model, where the PMP cofactor can be observed at the end of a deep cavity. (C) Stereodiagram
of a single subunit, with the N- and C-terminal domains colored green and purple, respectively.
The p-strands comprising the central #-sheet are highlighted in cyan, and the domain-swapped
#-hairpin is colored magenta. (D) Stereodiagram of the homodimer, with the various domain
features colored as described for panel C.
158
................. ...... .
......... ... 
The interface between the subunits of the dimer is extensive and comprises an area of
approximately 7500 A2, which represents nearly 25% of the total surface area of a single
subunit. The two active sites of the dimer are open to one another and are spaced roughly 30 A
apart. The most striking interaction between the two monomers is the presence of the domain-
swapped /-hairpin that crosses over the dimer interface and lines the entrance to the active site
tunnel of the neighboring subunit. Other notable interactions between the monomers include the
stacking of two homologous antiparallel a-helices from each monomer, both comprising
residues Ile14-His28, as well as the loop residues Cys189-Gly193 from one subunit that nestle
beneath residues Gly29-Leu33 from the other (Figure 4-6).
Sedimentation velocity analytical ultracentrifugation studies were undertaken in order to
establish whether the dimerization of WbpE observed in the crystal structure correlates with the
oligomeric state present in solution. The sedimentation coefficient was found to be 4.72
Svedberg units and the molecular mass was calculated as 79.3 kD using a single species model
fit. As each monomer of WbpE has a theoretical molecular weight of 38.9 kD, the data suggest
that WbpE associates as a dimer in solution (Figure 4-7). This finding is in keeping with other
members of the Fold Type 1 aminotransferase family, which have been found to exist primarily
as homodimers or other higher-order oligomers in mutiples of two.18 In addition, this result
suggests that the dimeric structure of WbpE observed in the crystal structure correlates with the
native structure of the enzyme in solution.
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Figure 4-7: Sedimentation velocity analytical ultracentrifugation data. (A) Time derivative
(g(s*)) plot of WbpE depicting a sedimentation coefficient of 4.72 svedbergs. (B) Time
difference residual for WbpE. The raw data (1), corresponding model (2), and residuals of the fit
(3) for two pairs of scans taken over the course of the experiment.
Cofactor Binding Site
During structure refinement, both the SeMet derivative and native form of WbpE were
discovered to contain the cofactor bound to the enzyme active site despite the fact that it was not
exogenously introduced over the course of protein expression or purification. The electron
density of the cofactor was unambiguous and thus modeled into the native structure at full
occupancy (Figure 4-8A). It was determined that the cofactor was present in the PMP form due
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to the retracted position of the catalytic lysine residue (Lys 185) as well as the lack of electron
density between the C4' carbon of the cofactor and the lysine nitrogen atom, indicating that
there was no covalent bond present. In addition, the UV spectrum of purified WbpE possessed
the spectral characteristics of PMP, namely the presence of an absorbance maximum at 340 nm
compared with that at 420 nm indicative of PLP. In order to obtain the PLP-bound form of the
enzyme (internal aldimine), PLP was incubated with WbpE for 1 hr prior to setting up crystal
trays. In contrast to the PMP-bound crystals, the PLP-bound structure showed an extended
conformation of Lys185 and clear electron density between the side chain and the cofactor,
serving as evidence that the cofactor was held in place by a covalent bond (Figure 4-8B).
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The cofactor-binding site resides within a deep cleft in the interior of each monomer at
the far end of the joined active sites. The cofactor is oriented such that the pyridinium ring is
facing inward, resting above the central fl-sheet of each monomer unit, while the phosphate
moiety points toward the entrance of the cleft and is located 20 A from the phosphate group in
the other subunit. The pyridinium ring is flanked on the top face by Tyr85, with which it is
interacting in a r-c stacking fashion, and the bottom face by Ala 158. The C5' hydroxyl group of
the cofactor is within hydrogen-bonding distance of Glni59 and Tyr309, while the C6' methyl
group is in close proximity (3.3 A) to Vall30. The NI nitrogen of the pyridinium ring is held in
place by a salt bridge with the carboxylate of Asp 156 that serves to enhance the electron-sink
properties of the cofactor. This aspartate residue is conserved in all Fold Type I
aminotransferases and is crucial for maintaining the cofactor in its protonated state.17 In the
PMP-bound form of the enzyme, the C4' amine does not appear to interact with any specific
residues, as the closest atom is the oxygen of a water molecule more than 4 A away.
Examination of a space-filling model of the PMP-bound form of WbpE shows that the C4'
amine lies at the bottom of the deep solvent tunnel leading to the outside of the active site,
making it accessible for reaction with incoming substrate (Figure 4-6B). The phosphate group of
the cofactor protrudes into the entrance to the active site in the opposite direction and is held in
place by several hydrogen-bonding and charge stabilizing interactions, including those with
Ser180, Thr60, Gly59, Asn227 of the #-hairpin from the other subunit and three well-ordered
water molecules.
An analysis of the residues surrounding the cofactor in both the PMP and PLP-bound
structures indicate that there is very little conformational change in the overall architecture of
WbpE upon formation of the internal aldimine (Figure 4-8); the root mean square deviation of
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these two structures is 0.32 A. Differences include the slight upward shift of the pyridinium ring
into the active site due to the presence of the imine bond as well as small changes in the
orientation of the Tyr85 side chain. In addition, the domain-swapped #-hairpin stretches closer
toward the active site in the PLP-bound structure; slight changes can be seen in the side chain
orientations of Gln215 and Arg212 that reflect this movement.
Nucleotide Sugar Binding Site
Crystals of WbpE complexed with the external aldimine were obtained by incubating the
enzyme with both PLP and the UDP-GlcNAc(3NH 2)A product on ice for 1 hr prior to
crystallization. The presence of the external aldimine in the enzyme active site implies that the
reaction proceeded in reverse upon exposure to the aminated product; this intermediate was
previously observed in other nucleotide sugar-bound aminotransferase structures as well.24 25,28
The external aldimine is bound in both subunits of the dimer, and electron density between the
cofactor pyridinium C4' carbon and the C3" position of the hexose ring indicates the existence
of a covalent bond (Figure 4-9A). As in the case of the WbpE complexes with PMP and PLP,
the electron density for the cofactor portion of the ligand is very strong; however, the density for
the nucleotide sugar component is weaker, with an average temperature factor <B> of 42.8 A2
compared with that for the cofactor (26.8 A2) and nearby protein atoms (21.6 A2). The weakest
regions of electron density in the external aldimine structure are surrounding the C4" hexose
carbon as well as the C2' and C3' carbon bond in the ribose moiety. This observation suggests
that the nucleotide sugar region of the aldimine is not as firmly held in place as the cofactor and
may experience some thermal motion within the crystal. For this reason, atoms comprising the
nucleotide sugar were refined at 50% occupancy.
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BFigure 4-9: Stereodiagram of the external aldimine-bound structure. (A) External aldimine of
PLP and UDP-GlcNAc(3NH 2)A in the active site of WbpE. The 2(F-Fe) electron density map
is contoured at 1.5- and was calculated with atoms of the external aldimine omitted. Residues
within a 4 A radius of the ligand are indicated, and water molecules are depicted as red spheres.
(B) Space-filling model of the WbpE external aldimine complex, highlighting the manner in
which the uridine moiety extends up through the deep cavity to the solvent. In both figures, the
subunits of the dimer are colored blue and yellow.
The glucopyranose ring of the ligand is bound to the cofactor through the C3" carbon
and, as depicted in Figure 4-9, many interactions take place between this highly functionalized
sugar and the protein to accommodate it within the active site. The aromatic side chains of
Tyr85 and Phe 182 are stacked above and below the glucopyranose ring, presumably forming a
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barrier to prevent solvent access throughout the course of catalysis. In addition, these residues
may serve to stabilize the positively charged reaction intermediates through cation-wr
interactions. The C2" acetamido oxygen appears to participate in hydrogen bonds with both the
side chain phenol of Tyr309 as well as the C5' hydroxyl group of the cofactor pyridinium ring,
while the C4" hydroxyl is within hydrogen-bonding distance of the cofactor phosphoryl group.
The C6" carboxylate is coordinated to a well-ordered water molecule that is hydrogen-bonded to
both the phosphate group and the imidazole ring of His213, which is part of the domain-
swapped #-hairpin from the neighboring protein subunit. In addition to this water molecule, the
carboxylate is held in place by a salt bridge with the guanidinium moiety of Arg229, also from
the /3-hairpin domain.
The pyrophosphate of the nucleotide sugar extends away from the glucopyranose
through the deep protein cavity that leads to the exterior of the protein, and is anchored by
interactions with Ser184, His308 and at least two well-ordered waters. The uridine emerges
from this channel and is fully exposed to the solvent, making van der Waals contacts with one
a-helix from each of the dimer subunits and residues from both monomer units on the bottom
face and several water molecules from above. The ribose 3'-OH group participates in hydrogen
bonds with the N-terminal region of the protein, including the side chain of Glu3 and the
backbone carbonyl of Ile5, while the uracil is in close proximity to numerous residues in the
neighboring subunit, including Gly29, Tyr31 and Ile32. Comparison of the WbpE complexes
with PMP and the external aldimine reveals that as in the case with the internal aldimine
structure, no major conformational change is observed in the overall architecture of the protein
upon substrate binding. Analysis of the overlaid cofactor and external aldimine-bound structures
indicates only small differences between the two forms of the enzyme (r.m.s.d. = 0.33 A), with
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the most notable changes within the domain-swapped /3-hairpin shifting slightly around the
enzyme active site.
Perhaps one of the most interesting findings from this study is the coordination of an
active site arginine, Arg229, with the C6" carboxylate of the external aldmine ligand. This
arginine residue is commonly found in Fold Type I aminotransferases and has been shown to
coordinate with the carboxylate of L-glutamate and a-KG in the first half of the catalytic
cycle.18 In the second half of the cycle, this arginine side chain is often found flipped out of the
active site in order to make room for the second substrate, which often requires more space than
L-glutamate or a-KG (Figure 4-10A). This back and forth movement has been called "arginine
switching," and has been studied in other Fold Type I aminotransferases, such as tyrosine
aminotransferase from Paracoccus denitrificans.18,5 2 In the case of the nucleotide sugar
aminotransferase ArnB from Salmonella typhimurium, a crystal structure of the protein in
complex with a-KG and PLP shows the arginine positioned out of the active site, switched in
the "off' position to make room for the nucleotide sugar substrate (Figure 4-1OB).23 Comparison
of the WbpE active site with homologous protein structures implicates Arg229 as the arginine in
question. However, unlike these other proteins, it appears that this Arg229 of WbpE does not
possess a switching capability, for it is bound to the nucleotide sugar when it would be predicted
to be oriented out of the active site. Presuming that a-KG is present in the same location in
WbpE as it is in AmB, it can then be inferred that Arg229 of WbpE interacts with both enzyme
substrates (L-glutamate and UDP-GlcNAc(3keto)A), playing a critical role in both halves of the
catalytic cycle. This alignment of a-KG and the UDP-GlcNAc(3keto)A substrates within the
active site of WbpE complements previous work in our laboratory on this pathway, in which we
postulated that the unique NAD* cofactor regeneration exhibited by the dehydrogenase WbpB
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was facilitated by the overlap of a-KG and UDP-GlcNAc(3keto)A within the substrate-binding
pocket (Chapter 3).15
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Figure 4-10: Examination of arginine-switching in Fold Type I aminotransferases. (A) Basic
concept of switching behavior, wherein the arginine interacts with the L-glutamate substrate but
moves out of position to accommodate the nucleotide sugar substrate. (B) Crystal structure of
ArnB from S. typhimurium in complex with a-KG and PLP, showing the Arg229 residue
oriented out of the active site in the "off'' position after the first half of the catalytic cycle,
primed for binding to the incoming nucleotide sugar substrate. Figure adopted from Noland et al
(PDB code: lMDX).2
Analysis of the Effect of Point Mutations on the Activity of WbpE
Comparison of the cofactor and nucleotide sugar-bound structures of WbpE led to the
identification of eight key amino acid residues that appear to play a critical role in substrate
binding. These residues are found in both subunits of the dimer and contact the cofactor and/or
substrate either through hydrogen bonding (Thr 60, Gln1 59, Ser 180, Asn227, His308, Tyr309)
or a salt bridge (Asp 156 and Arg229). The conservation of many of these residues in the binding
sites of other nucleotide sugar aminotransferases also suggests that they may be crucial for
enzyme function.24 ,28 In order to explore whether these residues were indeed critical for
catalysis, a panel of nine WbpE alanine mutants were generated using site-directed mutagenesis.
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In addition to eight residues identified above, a mutant in which the catalytic lysine (Lys 185)
was replaced with alanine was prepared as well. All mutants were overexpressed and purified to
high yield, and then tested for activity using the WbpB/WbpE coupled enzyme assay as
previously described.' 5 As anticipated, the activity of the Lys185Ala mutant was completely
abolished, but the other eight mutants exhibited nearly complete turnover of substrate to product
under these reaction conditions, suggesting that the loss of binding affinity of any one of these
residues may be compensated for by the cumulative efforts of the others (Figure 4-11).
Individual reaction rates were not determined due to the difficulty in isolating the extremely
labile ketone substrate of WbpE as well as the need for using the coupled WbpB/WbpE assay,'
which would mask the effect of a point mutation on the aminotransferase alone.
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Figure 4-11: Overall activity of the WbpE alanine mutants, as determined through the use of the
coupled WbpB/WbpE assay. Crude reaction mixtures were analyzed by capillary
electrophoresis to determine total percent of UDP-GlcNAc(3NH 2)A formation; data represent
the average of two experiments.
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Comparison of WbpE External Aldimine with Other Aminotransferases
To date, there have been three other reported crystal structures of Fold Type I
aminotransferases bound to their nucleotide sugar substrates as the external aldimine (Figure 4-
12). The first published complex was that of PseC, an aminotransferase from H. pylori involved
in the biosynthesis of pseudaminic acid. Shortly thereafter, the structures of both DesI, a key
enzyme in the S. venezuelae desosamine biosynthesis pathway, and QdtB, an aminotransferase
required for synthesis of TDP-Quip3NAc in Thermoanaerobacterium thermosaccharolyticum,
25,28
were presented. Taken together, these structures provide an opportunity to gain a deeper
understanding of the substrate specificity that governs the function of these enzymes.
0 0 ~ \ 0 0 0.-
HO HO W0H > HO
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H2N -\~O HO O HO-
HO O HO H2N H2N
O-UDP O-dTDP O-dTDP O-UDP
Figure 4-12: Reactions carried out by homologous nucleotide sugar aminotransferases PseC (H.
pylori), DesI (S. venezuelae), QdtB (T thermosaccharolyticum), and WbpE (P. aeruginosa). All
reactions require PLP and involve the concomitant conversion of L-glutamate to C-
ketoglutarate.
A comparison of the active site orientations of the external aldimines in the four known
structures (WbpE, PseC, DesI and QdtB) is presented in Figure 4-13. It can be seen that while
the ligands are positioned quite differently within the binding sites depending primarily on the
functional groups on the hexose rings, the structures do share some common features. As
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expected, the PLP cofactors are positioned in the same basic orientation. Also, each of the four
hexose substrates contains a hydroxyl group at either the C3" (QdtB and WbpE) or C4" (PseC
and DesI) position, and these hydroxyls are all situated on the same side of the active site near
the catalytic lysine and the cofactor phosphate or an asparagine, in the case of Des!.
Interestingly, all four hexoses seem to be bordered on the top and bottom faces by aromatic side
chains, effectively sealing them off from the surrounding environment. One explanation for this
observation is that association with these aromatic rings may serve to both stabilize the
positively charged reaction intermediates through cation-c interactions and also prevent
unwanted water molecules from entering into the active site and interfering with catalysis.
The many differences in nucleotide sugar orientation within the active sites depicted in
this analysis provide a glimpse into the requirements for substrate binding and specificity. In
general, the hexose rings with smaller functional groups and less polarity are in contact with
fewer atoms within the active site. This is rather unexpected, as often substrate binding causes
conformational changes within the enzyme active site to create an induced fit. For example,
while the nucleotide sugars bound to QdtB and WbpE are both anchored to the cofactor through
the C3" position, the QdtB ligand makes far fewer contacts to the active site atoms because of
the smaller hexose modifications than the highly functionalized WbpE ligand. Similarly, the
C6" hexose carbons of the QdtB, PseC and WbpE ligands are all pointing in the same general
direction, yet while there are no atoms within 4 A of the QdtB and PseC C6" methyl groups, the
C6" carboxylate of WbpE is coordinated to both the Arg229 in the /3-hairpin domain as well as
to a well-ordered water molecule. It is tempting to propose a relationship between increased
space around the ligand hexose ring and decreased enzyme specificity. In their study of QdtB,
Thoden et al made a preliminary effort to address this theory by showing
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Figure 4-13: Comparison of WbpE (A), PseC (B), DesI (C), and QdtB (D) in complex with the
corresponding external aldimines. For each structure, residues from subunit 1 are colored gray
and those from subunit 2 are colored green. Interactions within 3.6 A of the ligand are shown as
black lines, and residues lining the top face of the enzyme were removed for the sake of clarity.
All four complexes are positioned with the PLP cofactor in the same orientation to highlight the
differences in ligand conformation in each active site. In addition, the basic residue important
for a-KG binding (Arg or Lys) is labeled (PDB codes: 3NUB, 2FNU, 2PO3, 3FRK).
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that QdtB accepts the C4" epimer of its natural substrate, presumably due to the lack of protein
contacts between the C4" position of the hexose and the active site.28 However, further
biochemical and biophysical studies are required to explore this hypothesis.
Identification of a Non-Prolyl Cis Amide Bond in the WbpE Ligand Binding Site
A close analysis of the WbpE structure revealed that the enzyme a contains non-prolyl
cis amide bond between residues His308 and Tyr309 (Figure 4-14). The side chains of both of
these residues line the active site of the protein and participate in important contacts with the
nucleotide sugar to orient it properly. Studies of the prevalence of non-prolyl cis amide bonds
within protein structures deposited in the Protein Data Bank indicate that they are extremely rare
due to the increased steric strain between the neighboring Ca atoms. Interestingly, the location
of these cis bonds is often found within functionally important regions of the protein. In
addition, more than one-third of the characterized proteins containing cis amide bonds are
present in carbohydrate-binding proteins.53 As depicted in Figures 4-6 and 4-13, both His308
and Tyr309 participate in key hydrogen bonds with the external aldimine intermediate, framing
the upper region of the active site. However, it is clear that these residues are not absolutely
crucial for catalysis, as our studies using alanine mutations at these positions still yielded
functional enzyme (Figure 4-11). The close proximity of both His308 and Tyr309 to the hexose
and pyrophosphate moieties held in place by the cis amide bond suggests that perhaps these
residues impart specificity to the enzyme, effectively allowing only substrates of a certain shape
to fit in the active site. Further biochemical analysis is required to explore this hypothesis, but
difficulty in obtaining the ketone substrate of WbpE complicates these efforts.
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Figure 4-14: The non-prolyl cis amide bond between His308 and Tyr309 in the external
aldimine-bound structure of WbpE. (A) The location of the amide bond within the homodimer,
where the boxed area indicates the region shown in the stereo figure. (B) A close-up view of the
cis amide bond in stereo. The electron density represent a 2(Fo-Fe) map contoured at 2.5cr in
which the His and Tyr residues were omitted from the calculation.
Discovery of WbpE Homologs in Related Bacterial Pathogens
While eukaryotes utilize only a limited set of carbohydrates as the basic building blocks
for protein glycosylation, prokaryotes routinely incorporate a far greater number of sugar
structures in order to maintain the sheer complexity and diversity of their glycans."
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Biochemical evidence has suggested that despite this structural diversity, diacetylated
aminuronic acids such as ManNAc(3NAc)A are exceedingly rare. This class of highly
functionalized sugars has primarily been identified in the complex cell wall matrices of a few
pathogenic bacteria, such as P. aeruginosa and B. pertussis, as well as the flagellar
glycoproteins of certain methanogenic archaea.ss's6 However, an analysis of the rapidly growing
database of newly sequenced prokaryotic genomes suggests that perhaps these aminuronic acids
are more prevalent than previously suspected. A recent search for WbpE homologs resulted in
over fifty matches with high sequence identity (> 40%); the eleven closest homologs are
presented in Figure 4-15, with a full sequence alignment is provided in Figure 4-16.
Pseudomonas aeruginosa Acinetobacter
Legionella pneumophilia baumanndi
Vibrio cholerae
Parachlanydia Bordetella pertussis
Coxiella burnetti
Brucella Campylobacter
neotomae jejuni
Clostridium Arcobacter Helicobacter cinaedi
botinulum butzleri
Figure 4-15: Phylogenetic tree indicating homologs of WbpE from pathogenic bacteria. Each
homolog has a sequence identity of > 40% with respect to WbpE.
Interestingly, these homologs are all found in pathogenic bacteria, most of which have
not been subject to in depth biochemical characterization. The presence of WbpE homologs in
these organisms may imply that a ManNAc(3NAc)A-type carbohydrate exists in the cell wall
matrix, where it could play a contributing role in modulating virulence and evasion of host
defenses, though more work is required to characterize the cell wall components of these
organisms to confirm their chemical makeup. Nevertheless, the protein structures reported in
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this study may offer insight into the biosynthetic enzymes in other pathogenic organisms and
provide a unique opportunity for identification of important new targets for antibacterial drug
development.
Efforts Towards Obtaining a Structure of the WbpB/WbpE Complex
As described in Chapter 3, recent work has revealed that the dehydrogenase WbpB and
aminotransferase WbpE work together to catalyze formation of UDP-GlcNAc(3NH 2)A from
UDP-GlcNAcA using a novel NAD* recycling mechanism. In this pathway, the c-KG product
of WbpE is shunted back to WbpB, where it is reduced to 2-hydroxyglutarate (2-HG) as a
means to regenerate NAD* from NADH, thus preparing WbpB for another round of catalysis.
The underlying reason for why the activities of these two enzymes are coupled together is
currently unclear. One hypothesis is that the UDP-GlcNAc(3keto)A intermediate is labile, and
thus coordinating the activities of WbpB and WbpE serves to bring these two enzymes into
close physical proximity to limit the exposure of ketone to the surrounding aqueous
environment. However, as described in Chapter 3, the presence of both enzymes is not required
for WbpB catalysis, as addition of c-KG to the WbpB reaction mixture was sufficient to drive
product formation (Figure 3-10). Current work entails collaboration with the Allen laboratory
(Boston University) to obtain a crystal structure of a complex containing both WbpB and WbpE.
Analysis of this structure could uncover the nature of the interaction between these two enzymes
that enables efficient transfer of the UDP-GlcNAc(3keto)A intermediate and a-KG.
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Figure 4-16: Sequence alignment of WbpE with closely related homologs from pathogenic
bacteria. Homologs were obtained using BLAST, and the alignment performed with ClustalW.
Conserved residues are highlighted in black and similar residues are indicated in gray.
Secondary structure was determined from analysis of the PMP-bound WbpE structure using
PROCHECK. The GenBank accession numbers of each homolog are listed, along with
sequence identity to WbpE.
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Conclusions
In this chapter, the structure of WbpE in complex with three different ligands, PMP,
PLP, and the UDP-GlcNAc(3NH 2)A product as the external aldimine, is presented. These
studies describe the first structure of an aminotransferase that binds a nucleotide sugar modified
at the C2", C3", and C6" positions, and details the means by which such a highly functionalized
substrate is accommodated in the enzyme active site. In addition, the dimeric structure of WbpE
observed in the crystal structure is confirmed to also exist in solution by sedimentation velocity
analytical ultracentrifugation. In order to achieve a broad perspective of substrate specificity
among this class of aminotransferases, the external aldimine structure is compared to that of
homologous transferases bound to their substrates; this analysis reveals that highly
functionalized nucleotide sugar substrates make more contacts with their respective enzyme
active sites, which may have an implication on substrate specificity. Future work in this area
will focus on gaining structural insight into the interactions between WbpB and WbpE that
facilitate the novel NAD* recycling behavior outlined in Chapter 3.
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Experimental Methods
General Methods
Unless otherwise noted, all reagents were obtained commercially and used without further
purification. Oligonucleotides were purchased from Sigma Life Sciences (St. Louis, MO), and
restriction endonucleases were obtained from New England Biolabs (Ipswich, MA). Sequencing
of all bacterial plasmids was performed by the MIT CCR Biopolymers Laboratory (Cambridge,
MA). Amino acids, including L-SeMet, were purchased from Sigma Alrich (St. Louis, MO).
Crystal screening kits were obtained from Hampton Research (Aliso Viejo, CA) and Emerald
BioSystems (Bainbridge Island, WA). Crystal trays and other crystallography equipment were
purchased from Hampton Research. MALDI-TOF mass spectrometry was performed on the
Voyager system (Applied Biosystems), and capillary electrophoresis was carried out on the
P/ACE MDQ instrument (Beckman Coulter) as detailed in Chapter 3.
Cloning of WbpE
The wbpE gene was amplified from Pseudomonas aeruginosa PAO1-LAC genomic DNA
(ATCC) by the polymerase chain reaction as previously described, using primers to introduce 5'
BamHI and 3' XhoI restriction sites that are outlined in the Appendix (Table 1).15 The resulting
oligonucleotide was then inserted into a modified pET32a vector (Novagen) using standard
molecular biology techniques. Site-directed mutagenesis was performed using the QuikChange
protocol from Stratagene with the wbpE-pET32a plasmid as a template. All constructs yielded
proteins with an N-terminal His6-tag followed by a TEV site for tag removal.
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Overexpression of WbpE
The wbpE-pET32a plasmid was transformed into E. coli BL21-CodonPlus(DE3) RIL
competent cells (Stratagene) for heterologous expression, using both kanamycin (50 pg/mL) and
chloramphenicol (30 pg/mL) for selection. The cell culture was grown to an optical density (600
nm) of 0.8-1.0 at 37 'C in Luria-Bertani broth; the culture was subsequently cooled to 16 'C and
protein expression was induced through the addition of IPTG (1mM). After 16 h, the cells were
harvested by centrifugation (5000g) and the resulting cell pellets were stored at -80 'C for future
use.
Incorporation of Selenomethionine Into WbpE
Incorporation of selenomethionine was accomplished using the method of metabolic inhibition
described elsewhere with slight modification.' 8 Briefly, 0.5 L of M9 medium supplemented with
1 mM MgSO 4, 3 mM FeSO 4, 0.4% (w/v) glucose, 0.5% (w/v) thiamine, kanamycin (50 pg/mL)
and chloramphenicol (30 pg/mL) was inoculated with 5 mL starter culture and allowed to
incubate at 37 'C until the desired optical density (0.8-1.0) was obtained. Prior to induction, the
following amino acids were added to the flask and the culture was incubated for 20 minutes to
allow for the inhibition of methionine biosynthesis: L-lysine (100 mg/L), L-phenylalanine (100
mg/L), L-threonine (100 mg/L), L-isoleucine (50 mg/L), L-leucine (50 mg/L), L-valine (50
mg/L), L-selenomethionine (60 mg/L). After addition of IPTG (1 mM) to induce protein
expression, the culture was handled as described above.
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Purification of WbpE
All steps were performed at 4 'C. WbpE was purified from cell pellets using Ni-NTA resin
(Qiagen) as previously described.15 After overnight dialysis to remove the imidazole and lower
the salt concentration, the N-terminal His6-tag was removed by proteolysis with TEV over the
course of three days while stirring in dialysis buffer (50 mM HEPES, pH 8.0/100 mM NaCl/4%
glycerol/0.5 mM EDTA/5 mM DTT); the removal of the tag was confirmed by Western blot
analysis using an Anti-His 4 anitbody (Qiagen). The protein was then subjected to size-exclusion
chromatography using a Superdex 200 16/60 column (GE Healthcare) in running buffer
composed of 25 mM HEPES, pH 8.0/100 mM NaCl/0.5% glycerol. Fractions containing
monodispersed protein were pooled and analyzed by SDS-PAGE for purity and MALDI mass
spectrometry to quantify selenomethionine incorporation. Purified protein was routinely utilized
within 24 hrs to prevent aggregation.
Sedimentation Velocity Analytical Ultracentrifugation
Experiments were conducted in an Optima XL-I ultracentrifuge (Beckman Coulter) using an
An60 Ti rotor at 4 'C with a rotor speed of 42,000 rpm. Data were acquired by monitoring
absorbance at 280 nm through quartz cell windows. A sample of WbpE (36 pM) was dialyzed
against 25 mM HEPES, pH 8.0/100 mM NaCl/0.5% glycerol for 24 h prior to the experiment;
the centrifugation run also included dialysis buffer as a blank. Data were analyzed with the
software package SEDNANAL 5 7 to determine the oligomeric state of the protein in solution.
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Crystallization of WbpE
Prior to setting up crystal trays, WbpE was concentrated to 10 mg/mL in the size-exclusion
running buffer. For crystallization in the presence of ligands, PLP and/or UDP-GlcNAc(3NH 2)A
were added to the protein solution at a final concentration of 500 pM and 10 mM respectively
and allowed to incubate on ice for 1 h. Crystals were obtained at 25 'C from a hanging drop by
mixing 1.5 pL protein solution with 1.5 pL reservoir solution. All crystals except for the SeMet
derivative were grown in a reservoir solution containing 0.1 M Bis-Tris, pH 5.5, 0.2 M
ammonium sulfate and 25% PEG 3350. SeMet crystals were grown in a reservoir solution
containing 0.1 M Bis-Tris, pH 5.5, 0.2 M ammonium acetate, 10 mM SrCl 2 and 25% PEG 3350.
Crystals were cryoprotected in the corresponding reservoir solution supplemented with 20%
glycerol and substrate as necessary.
Data Collection
Diffraction data were collected on beamline X6A (National Synchrotron Light Source,
Brookhaven National Laboratory, Upton, NY) at 110 K, using an Si( 11) channel cut
monochromator and a toroidal focusing mirror. Reflections were recorded with an ADSC
Quantum 270 detector, with an active area of 270 mm 2 and a pixel size of 65 [tm in a 4084 x
4084 array. For the SeMet derivative, data were collected at the selenium peak (12667 eV),
absorption edge (12660 eV) and remote energies (12867 eV). Data sets were indexed and scaled
using HKL2000, and the scaled intensities were converted to structure factors using the program
TRUNCATE in the CCP4 suite of programs. 40'41 Data collection parameters are summarized in
Table 1.
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Structure Determination and Refinement
The structure of the WbpE-SeMet derivative was solved using the method of multiwavelength
anomalous diffraction.34 Using data collected at the selenium peak and truncated to 2.5 A, the
program SOLVE was employed to locate the heavy atom sites and generate experimental
32
phases. A total of four out of five selenium atoms were located for each protein subunit. The
initial model was built using the prime-and-switch phasing feature of RESOLVE to minimize
model bias.42,43 The PMP-bound structure was solved by molecular replacement using Phaser
with the SeMet derivative as the initial search model.44 Further model building and refinement
were carried out using Coot and Refmac.45'46 Five percent of the data were used to calculate the
Rfree values for cross-validation of the refinement process.47 The structures of the PLP and
external aldimine complexes were subsequently solved by molecular replacement in the same
manner, using the completed PMP-bound structure with the cofactor removed as the input
model. Water molecules were added using both ARP/wARP and Coot, and ligands were
modeled into each structure after the Rfpee value was below 30%.48 All refined structures were
validated using PROCHECK, SFCHECK, and MolProbity, 4 9-51 and the final refinement
statistics are presented in Table 1. All molecular images were generated using PyMOL.58
Functional Characterization of WbpE Alanine Mutants
Enzyme mutants were analyzed for function using the coupled WbpB/WbpE assay slightly
modified from that described elsewhere. 5 In brief, 2.5 pg of each WbpE mutant was incubated
with UDP-GlcNAcA (0.75 mM), NAD* (0.2 mM), L-glutamate (25 mM), PLP (0.1 mM), DTT
(2.5 mM), MgCl 2 (2 mM) and 2.5 pg of WbpB in 60 pL of 50 mM HEPES buffer (pH 8.0) for 2
h at 30 *C. Capillary electrophoresis (P/ACE MDQ System, Beckman Coulter) was used to
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monitor enzyme activity as outlined previously, and the presence of product was confirmed by
the addition of starting material into the reaction mixtures and the observation of a new peak on
the CE chromatogram.
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Chapter 5 Efforts Towards the Development of Dolichyl-Linked
Disaccharide Substrates for the Study of Archaeal OTases
190
Introduction
The vast complexity of oligosaccharide structures found in nature is derived in part from
the enzymatic action of glycosyltransferases, which catalyze glycan assembly through the
addition of individual carbohydrate units.! Although the most common glycosyl substrates of
these enzymes are nucleotide diphosphate sugars (UDP-Glc, UDP-Gal, GDP-Man),
glycosyltransferases recognize a wide variety of other activated carbohydrate substrates as well,
including nucleotide monophosphate sugars (CMP-NeuAc), lipid phosphates (DoJ-P-Man), and
2
unsubstituted phosphates. A recent survey of the CAZy database indicates that over 12,500
unique glycosyltransferases have been identified; these proteins are further classified into 91
subfamilies based on sequence analysis, making glycosyltransferases one of the most numerous
enzyme classes in nature.
Although the function of glycosyltransferases was originally described in the early
1970s, difficulties with protein expression and purification have complicated efforts to examine
these enzymes in great detail.'' 5 The first X-ray crystal structure of a glycosyltransferase was
reported in 1994 for the bacteriophage T4-glucosyltransferase; 6 to date, over 100 X-ray crystal
structures of glycosyltransferases representing 23 distinct subfamilies have been deposited in the
Protein Data Bank (PDB). Interestingly, a comparative analysis of these structures indicates that
while these enzymes do not exhibit high sequence homology, they feature a surprising level of
structural homology such that only two main structural folds have been identified, termed GT-A
and GT-B.2 Both glycosyltransferase types are composed of cu/p/a sandwiches, with GT-A
members containing a single Rossmann fold where the active site is located between two 1-
sheets, and GT-B types comprising two Rossmann folds that surround the catalytic active site
(Figure 5-1).5 In addition, glycosyltransferases that do not fit into either category have been
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recently described, such as the CstII sialyltransferase from Campylobacter jejuni;7 however,
these classifications have not been verified biochemically. The conserved structural homology
among known glycosyltransferases suggests that a majority of these enzymes evolved from a
small number of progenitor sequences.2 In contrast, glycosidases, which are responsible for the
hydrolysis of glycosyl bonds, have been shown to adopt a wide variety of folds, including all a,
all P, or mixed c/p structures, and thus cannot be classified into a small number of structural
classes.s'8
A B
Figure 5-1: Representative structures of the two major glycosyltransferase folds. (A) GT-A
fold, mouse EXTL2 a-1,4-N-acetylhexosaminyl transferase complexed with UDP-GalNAc
(PDB code 1OMZ); (B) GT-B fold, Escherichia coli MurG P-1,4 N-acetylglucosamine
transferase complexed with UDP-GlcNAc (PDB code INLM). Figure modified from Breton et
al.'
In recent years, a great deal of progress has been made towards understanding the
catalytic mechanism of glycosyltransferases. In general, these enzymes are categorized as either
inverting or retaining, based upon the stereochemistry of the newly formed bond relative to the
anomeric center of the glycosyl donor (Figure 5-2).9 Based on biochemical studies, the
mechanism of inverting glycosyltransferases is proposed to involve an SN2-type displacement of
the activating group of the glycosyl donor by a nucleophilic moiety within the glycosyl
192
........ ..  
.......  ...
acceptor, facilitated by an active site base. In contrast, the mechanism of retaining
glycosyltransferases is less clear, as both double displacement and SN1-type reaction
mechanisms have been suggested.2 Further mechanistic studies are required in order to
determine how these enzymes achieve retention of the glycosyl donor configuration.
0 +
HO O- + H
0-P-OR OR||
Glycosyl Donor 0 Glycosyl Acceptor
Inverting 2- Retaining
- RPO4
HO O OR HO~ O
OR
Figure 5-2: General scheme depicting the stereochemical outcomes of the two main functional
classes of glycosyltransferases, inverting and retaining.2
As outlined in Chapter 1, the biosynthesis of asparagine-linked glycans in all three
kingdoms of life requires the action of many glycosyltransferase for oligosaccharide assembly.
One of the most interesting aspects of this process is the formation of the polyisoprenyl-linked
disaccharide, which is the product of the second glycosyltransferase in the pathway (Figure 5-3).
In the yeast Saccharomyces cerevisiae, two proteins (Alg 13 and Alg 14) have been shown to be
required for formation of the Dol-PP-GlcNAc 2 disaccharide. A combination of biochemical and
structural studies has revealed that the C-terminal domains of both Alg 13 and Alg 14 interact to
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Figure 5-3: Comparison of polyisoprenyl-linked disaccharide formation in N-linked glycan
biosynthesis across all three kingdoms of life. The two models proposed in the archaea M
voltae and M maripaludis have not yet been subject to biochemical verification.
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form a functional glycosyltransferase capable of catalyzing GlcNAc transfer. 0 11 In contrast, the
analogous reaction in the bacterium Campylobacter jejuni has been shown to require only the
single protein, PglA.1 Although the steps involved in the biosynthesis of the dolichyl-linked
disaccharide in archaea have not yet been biochemically characterized, early genetic studies
have proposed two different models for this reaction. In the first model described in
Methanococcus voltae, two proteins (AglC and AglK) are implicated in this role, similar to the
pathway in eukaryotes.13 In the second model, genetic studies suggest that disaccharide
formation is carried out by a single glycosyltransferase in Methanococcus maripaludis, AglO,
which is reminiscent of the bacterial glycosylation system.14 As these two methanogens are very
closely related, it seems unlikely both models are in fact true; further studies are required to
determine which (if any) model accounts for disaccharide formation in the archaeal kingdom.
The overall focus of the work in this thesis is directed at gaining a deeper understanding
of the last step of N-linked glycan biosynthesis, namely the reaction catalyzed by the
oligosaccharyl transferase (OTase). Early work toward this goal involved the identification of a
highly-expressing OTase from the archaeon M voltae, which was produced in E. coli at a 100-
fold improvement over the bacterial OTase PglB from C. jejuni (Chapter 1). In order to begin to
characterize the function of this OTase, a suitable dolichyl-linked disaccharide substrate is
required (Figure 5-4). To this end, we have achieved the chemoenzymatic synthesis of the
unique nucleotide sugar UDP-GlcNAc(3NAc)A using a series of enzymes in the Wbp pathway
of the opportunistic pathogen Pseudomonas aeruginosa, outlined in Chapter 3. In this chapter,
efforts towards coupling this sugar to a dolichyl-linked monosaccharide in order to generate the
desired disaccharide substrates are described. Four different glycosyltransferases from the
archaea M voltae and M maripaludis that have been proposed to catalyze this reaction were
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cloned, overexpressed, and evaluated for function. Despite testing these enzymes in a wide
variety of reaction conditions, we have been unable to observe transfer of the GlcNAc(3NAc)A
donor onto the dolichyl-linked monosaccharide acceptor. The synthesis of a suite of dolichyl-
linked monosaccharides to further probe these putative glycosyltransferases is also described, in
which the size of the dolichol and the identity of the monosaccharide is varied. Ultimately, these
novel dolichyl-linked disaccharides will aid in detailed biochemical studies of the mechanism of
oligosaccharide transfer, which has been a long-standing interest of the Imperiali laboratory.
HO UDP-GIcNAc(3NAc)A
HOH
HO 0 O- AcH AcHN
AcN 0 HO O-UDP HO OH
cHN 0 HOAcHNAcH
AcHNACHNI
-O 0
O-P-O-P-O O-P-0-P-O
n=7-15 n = 7-15
Dol-PP-GcNAc/GaNAc-GIcNAc(3NAc)A Dol-PP-GIcNAc/GaINAc
Figure 5-4: Retrosynthetic strategy for the generation of the desired dolichyl-linked
disaccharides for the study of the archaeal OTases, Dol-PP-GlcNAc-GlcNAc(3NAc)A or Dol-
PP-GalNAc-GlcNAc(3NAc)A.
Results and Discussion
Characterization of Putative GlcNAc(3NAc)A Glycosyltransferases
In order to generate the desired dolichyl-linked disaccharide substrates Dol-PP-GlcNAc-
GlcNAc(3NAc)A and Dol-PP-GalNAc-GlcNAc(3NAc)A for study of the M voltae and M
maripaludis OTases, a general method for coupling GlcNAc(3NAc)A to Dol-PP-GlcNAc or
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Dol-PP-GalNAc was required. While this reaction could be achieved using chemical synthesis,
the activation of either the GlcNAc(3NAc)A donor or the dolichylphosphate monosaccharide
acceptor entails multiple steps mainly involving protecting group manipulation and was
predicted to be low-yielding; therefore, a chemoenzymatic method was pursued. In this
approach, the desired @-1,3 linkage between the two monosaccharide residues could be installed
by an appropriate enzyme without the use of protecting groups. In addition, it was envisioned
that this method could be scaled up to generate preparative quantities of the final product for use
in further studies.
Over the past four years, the Jarrell laboratory has identified four possible
glycosyltransferases that may be responsible for the transfer of a GlcNAc(3NAc)A donor onto
either Dol-PP-GlcNAc or Dol-PP-GalNAc using a series of genetic knockout studies; these
proteins are summarized in Table 5-1. Three of these glycosyltransferases, Mv155, AglC, and
AglK, are from M voltae, and the fourth, AglO, is found in M maripaludis. Due to problems
with genetic manipulation of M voltae, the Jarrell lab has made several different claims as to
the identity of the second glycosyltransferase required in N-linked glycan biosynthesis. First, the
Mv155 protein was implicated as the GlcNAc(3NAc)A transferase; 5 however, two years later,
this sequence was retracted from the NCBI database and replaced with AglC.16 In 2009, the
group reported that the transfer of GlcNAc(3NAc)A required AglK in addition to AgIC,
although biochemical evidence for this proposal is still lacking. Also in 2009, the genes
responsible for N-linked glycan biosynthesis in the more genetically tractable yet closely related
methanogen M maripaludis were reported. In this organism, it appeared that only a single gene,
aglO, was required to add the GlcNAc(3NAc)A to the growing dolichyl-linked glycan in
contrast to the proposed involvement of both aglC and aglK in M voltae. In general, all four
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putative GlcNAc(3NAc)A transferases identified are predicted to be in the GT-2 subfamily and
to exhibit the GT-A structural fold based on protein sequence. In comparison, the second
glycosyltransferase required in both the yeast S. cerevisiae and the bacterium C. jejuni are
members of the GT- 1 subfamily and thus are characterized by GT-B type structure. A summary
of these glycosyltransferases is shown in Table 5-1, and the predicted topologies of these
proteins using the TMHMM server (ca.expasy.org/tools) are depicted in Figure 5-5.17
Table 5-1: Summary of proteins implicated in GlcNAc(3NAc)A transfer (AglC, AglK, Mv155,
and AglO) compared with Algl3/14 from S. cerevisiae and PglA from C. jejuni, which have
been shown to be responsible for polyisoprenyl-linked disaccharide formation in eukaryotes and
bacteria, respectively.
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Glycosyltransferase MW (kDa) GT family GT fold type
M voltae AgiC 37.3 GT family 2 GT-A
M voltae AgiK 28.2 GT family 2 GT-A
M voltae Mv155 41.0 GT family 2 GT-A
M maripaludis AglO 32.4 GT family 2 GT -A
S. cerevisiae Alg13 126.1 GT family 1 GT-B
S. cerevisiae Alg14 24.2 GT family 1 GT-B
C. jejuni PglA 42.7 GT family 1 GT-B
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Figure 5-5: Predicted topology of the putative GlcNAc(3NAc)A transferases AgiC, AglK,
Mv155, and AglO from M voltae and M maripaludis, as well as Algl3 and Algl4 from S
cerevisiae and PglA from C. jejuni. Topology predictions were generated using the TMHMM
server.17
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M. voltae Mv1 55
In order to test these proteins for GlcNAc(3NAc)A transferase activity, each gene was
chemically synthesized by a commercial vendor to contain optimal codons for bacterial
expression, then inserted into one of three vectors for protein expression: pET24a(+), which
yields a final protein containing an N-terminal T7 tag and a C-terminal His6 tag; pGEX, which
results in a N-terminal glutathione S-transferase (GST) fusion protein; and pGBH, providing a
final protein that contains an N-terminal GB1 tag and a C-terminal His6 tag. The resulting
plasmids were transformed into two different E. coli competent cell lines to screen for optimal
protein expression. As each putative glycosyltransferase is predicted to either contain
transmembrane domains or to associate with the cell membrane through hydrophobic regions on
the protein surface, all four proteins were prepared as crude membrane fractions or purified
using the His6 or GST tags and compared by Western blot analysis. It appeared that the
pET24a(+) constructs expressed in E. coli BL21(DE3) RIL cells gave the highest overall yields
for each glycosyltransferase (Figure 5-6). In addition, the AglC protein appeared to associate
with the cell membranes, while AglK was found in both the membrane and soluble fractions.
Mv 155 and AglO behaved as soluble proteins.
kDa
250
148
98
64
50
36
22
16
1 2 3 4 5
Figure 5-6: Anti-T7 Western blot of the putative GlcNAc(3NAc)A transferases described in
this chapter. (1) MW standard; (2) Mv 155; (3) AglC; (4) AgiK; (5) AglO. AglC was prepared as
a crude membrane fraction, while the other proteins were purified using Ni-NTA as outlined.
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After purification (or isolation of the crude membrane fraction in the case of AglC), each
protein was then tested for GlcNAc(3NAc)A transferase activity. The standard assay for
function involved the incubation of Dol-PP-GlcNAc and UDP-[3H]GlcNAc(3NAc)A with the
enzyme in question for 2 hrs, after which the reaction was quenched and subjected to an
aqueous/organic phase separation. Analysis of the organic layer by scintillation counting
indicated whether the radiolabeled GlcNAc(3NAc)A was transferred from the aqueous phase
into the organic phase. A large panel containing over 60 different reactions conditions, in which
variables such as reaction temperature (4, 25, 30, 37, 65 C) and pH (6.5, 7.0, 7.5, 8.0, 8.5) were
altered and additives including detergents (Triton X- 100, DDM, CHAPSO, LDAO), salts (NaCl,
KCl, (NH4)2SO4), and metals (MnCl 2, MgCl 2, CaCl2) was utilized to screen each protein.
Despite this exhaustive screen, transfer of GlcNAc(3NAc)A to Dol-PP-GlcNAc was not
observed. Interestingly, in the case of AglO, a low level of activity (-8%) was detected, despite
the use of Dol-PP-GlcNAc as the glycan acceptor instead of the native Dol-PP-GalNAc.
However, the poor turnover exhibited by AglO was too low to be of preparative use.
It is unclear why we were unable to observe glycosyltransferase activity. One hypothesis
is that these proteins may have exquisite specificity for their dolichyl-linked monosaccharide
substrates, and that the C85-C95 Dol-PP-GlcNAc employed in the initial screen of conditions is
not utilized by these enzymes as the glycosyl acceptor. An early study in the archaeon
Halobacterium halobium suggested that the C55-C60 form of dolichol was recognized as the
polyisoprenol carrier in archaea, as opposed to the longer C85-C95 dolichols found in yeast and
higher eukaryotes. In addition, it may be possible that these proteins have been misannotated.
A recent BLAST search using various glycosyltransferases in the S. cerevisiae N-linked
glycosylation pathway as a probe indicated that both AglC and AglK bear more similarities with
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dolichyl-phosphoglucose synthase (DPG, Alg5), the enzyme required for formation of the Dol-
P-Glc glycosyl donors in the ER lumen, than with Algl3/14. 19 Further work in this area is
required to determine whether these proteins catalyze GlcNAc(3NAc)A transfer, and what
substrates are required for this reaction.
Synthesis of Dolichyl-Linked Monosaccharides for Further Study
In an attempt to further characterize the glycosyltransferases described in this study, the
synthesis of a small panel of four dolichyl-linked monosaccharides was pursued (Figure 5-7).
The size of the dolichyl moiety was altered through the use of the shorter C55 form. In addition,
the identity of the monosaccharide was varied by employing either GlcNAc or GalNAc.
OH HO OH
HO OO
HOAcHN HOAcHN
0- 0 0- 0
O-P-O-P-O~ O-P-O-P-O~
- - . l i .- .I1 Il
n O O " 0 0
--- 2 n=7,13-15 --- 2 n=7,13-15
n = 7, GlcNAc 3 n = 7, GalNAc
2 n = 13-15, GlcNAc 4 n = 13-15, GaNAc
Figure 5-7: Desired dolichyldiphosphate-linked monosaccharides.
The synthesis of these dolichyl-linked monosaccharides involved the coupling of either
GlcNAc-l-P or GalNAc-l-P to both forms of dolichylphosphate, C55 or the C85-C95 mixture.
As a first step in this synthetic scheme, the phosphorylation of the C85-C95 dolichol was carried
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out using phosphoramidite chemistry as previously reported (Figure 5-8);2,2 the C55 dolichol
was obtained as the dolichylphosphate from Professor E. Swiezewska (Polish Academy of
Sciences, Warsaw, Poland).
0-
OH a, b O-P-OH
n n0
2 n = 13-15 2 n = 13-15
5 6
Figure 5-8: Chemical phosphorylation of dolichol. Reagents and conditions: (a) Bis-(2-
cyanoethyl)-N,N'-diisopropyl phosphoramidite, tetrazole, dry THF, rt; (b) 1% H20 2, -78 0 C,
then 1% NaOMe/MeOH.
The synthesis of the sugar phosphates is outlined in Figure 5-9, and began with the
global acetylation of D-glucosamine (7) and D-galactoasmine (8) with acetic anyhydride in
pyridine to afford the tetraacetates. The anomeric hydroxyl group of each sugar was then
selectively deprotected by treatment with dimethylamine to give 9 and 10 as a mixture of both
the c and P anomers. Incubation of the triacetylated sugars with dibenzyl NN'-phosphoramidite
and 1,2,4-triazole resulted in the desired phosphites, which were oxidized to the corresponding
protected phosphates 11 and 12 through exposure to a 1% solution of H20 2 . Deprotection of the
sugar phosphates was achieved through hydrogenation in the presence of Pd(OH) 2/C. The sugar
phosphates 13 and 14 were then activated by incubation with 1,1'-carbodiimidazole (CDI),
followed by coupling to both the long (C85-C95) and short (C55) forms of dolichol to yield the
desired dolichyl-linked monosaccharides 1, 2, 3, and 4. Screening of the putative
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glycosyltransferases described in this chapter with the panel of dolichyl-linked monosaccharides
can now be conducted in an effort to generate the desired Dol-PP-GlcNAc-GlcNAc(3NAc)A or
Dol-PP-GalNAc-GlcNAc(3NAc)A, which will then be used to probe the archaeal OTases from
M voltae and M maripaludis for function.
OHHQI
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AcHN OH
7 GIcNAc
8 GaINAc
f, g
OAcAcO I
a,b O
AcHN OH
9 GIcNAc
10 GaINAc
AcO OAc
c , d ,0c OO
AcHN 0
O-P-OBn
OBn
11 GIcNAc
12 GaINAc
AcO OAc
e AcO O OAcHN n-
0-P,-O NEt3
OH
13 GIcNAc
14 GaINAc
h
n = 7, 13-15n = 7, 13-15
15 n = 7, GIcNAc
16 n = 13-15, GIcNAc
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2 n = 13-15, GIcNAc
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Figure 5-9: Synthesis of dolichyl-linked monosaccharide. Reagents and conditions: (a) Ac 2 0,
pyr; (b) HN(CH 3)2, CH3CN; (c) dibenzyl NN-phosphoramidite, 1,2,4-triazole, CH2Cl2 ; (d) 1%
H20 2, -78 C; (e) Pd(OH)2/C, H2, NEt3 ; (f) CDI, DMF; (g) MeOH, then Dol-P (C55 or C85-
C95, CH2Cl 2 ; (g) 1% NaOMe/MeOH.
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Conclusions
In this chapter, efforts towards the synthesis of a dolichyl-linked disaccharide substrate
for the in depth study of an archaeal OTase are summarized. Earlier work involved the
chemoenzymatic synthesis of the unique nucleotide sugar UDP-GlcNAc(3NAc)A using a series
of enzymes in the Wbp pathway of the opportunistic pathogen Pseudomonas aeruginosa
(Chapter 3). In an attempt to couple this sugar to dolichylphosphate (C85-C95), four different
glycosyltransferases from the archaea M voltae and M maripaludis that have been implicated
in this reaction through genetic experiments were cloned, overexpressed, and evaluated for
function. Despite testing these enzymes in a wide variety of reaction conditions, we have been
unable to observe transfer of the GlcNAc(3NAc)A donor onto the dolichyl-linked
monosaccharide acceptor. To broaden the scope of the polyisoprenyl acceptor substrates used to
probe these putative glycosyltransferases, the synthesis of a suite of dolichyl-linked
monosaccharides was also described, in which the size of the polyisoprene and the identity of
the monosaccharide are varied. Future work will involve completion of these dolichyl-linked
disaccharide substrates, which ultimately will aid in detailed biochemical studies of the
mechanism of oligosaccharide transfer that has been a long-standing interest of the Imperiali
laboratory.
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Experimental Methods
General Information
Unless otherwise noted, all solvents and reagents were obtained commercially and used without
further purification. Genes were optimized for bacterial codon usage and chemically synthesized
by GenScript (Piscataway, NJ). Oligonucleotides were purchased from Eurofin MWG Operon
(Huntsville, AL) or Sigma Life Sciences (St. Louis, MO). Sequencing of all bacterial plasmids
was conducted by the MIT CCR Biopolymers Laboratory (Cambridge, MA). Solvents were
obtained from VWR (West Chester, PA) or Sigma Aldrich (St. Louis, MO). Analytical TLC
was performed on silica gel 60 F254 plates (EMD Chemicals) and visualized with either UV or
staining with ceric ammonium molybdate. Flash column chromatography was performed using
forced flow of the indicated solvent on silica gel 60, particle size 0.043-0.063 mm (EMD
Chemicals). ESI-MS was conducted on a Mariner instrument (Applied Biosystems). NMR
spectra were acquired on a Varian Inova 500 MHz spectrometer with a 5 mm inverse broadband
gradient probe or a Bruker 400 MHz spectrometer furnished with a 5 mm variable temperature
gXH probe. Chemical shifts (8) are reported in parts per million (ppm) and referenced to the
CDCl3 signal at 7.27 ppm for 'H analysis and an external reference of 85% H3PO4 for "P NMR.
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Cloning of mv]55, agC, aglK, and aglO Glycosyltransferase Genes
The mv]55, ag/C, aglK, and aglO genes were optimized for bacterial codon usage and
chemically synthesized by GenScript. The resulting genes containing both BamHI and XhoI
restriction sites were digested and cloned into the same sites of either the pET24a(+), pGEX or
pGBH vectors (Novagen) via standard molecular biology techniques. The final gene products
encoded proteins with an N-terminal T7-tag and a C-terminal His6 tag (pET24a(+)), an N-
terminal GST-tag (pGEX), or an N-terminal GB1 tag and a C-terminal His6 tag (pGBH).
Overexpression of Glycosyltransferases
The bacterial plasmids containing either the mv155, aglC, aglK, or aglO genes were
transformed into E. coli BL21-CodonPlus(DE3) RIL or E. coli BL21-CodonPlus(DE3) RP
competent cells (Stratagene) using the appropriate antibiotics for selection. For overexpression,
1 L of Luria-Bertani media supplemented with antibiotics was inoculated at 37 'C while shaking
until an optical density (600 nm) of 0.6-0.8 was achieved. The cultures were then cooled to 16
C and protein expression was induced by the addition of IPTG (1 mM). After 16 hrs, the cells
were harvested by centrifugation (5000 x g) and the resultant cell pellets were stored at -80 'C
until needed.
Preparation of Crude Membrane Fractions
As all of the enzymes described in this chapter are predicted to either contain a transmembrane
domain or associate with the cell membrane through hydrophobic regions on the protein surface,
each protein was prepared as a crude membrane fraction at some point over the course of this
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study. As a general procedure, a frozen cell pellet of E. coli expressing the glycosyltransferase
in question was resuspended in cold 50 mM HEPES, pH 8.0 / 1 mM EDTA buffer (30 mL)
supplemented with Protease Inhibitor Cocktail III (Calbiochem, 30 [tL). The cells were lysed by
sonication, and the mixture was centrifuged at 6000 x g for 30 mins to remove the cellular
debris. The supernatant was gently decanted and subjected to a second round of centrifugation
(145,000 x g) for 1 hr to collect the membrane fraction. The pellet was washed with 50 mM
HEPES, pH 8.0 / 1 mM EDTA buffer, centrifuged (145,000 x g) for 1 hr, then homogenized in
cold 50 mM HEPES, pH 8.0 / 100 mM NaCl buffer (3 mL). The crude cell membrane fraction
was aliquoted and stored at -80 'C for future use.
Purification of Soluble Glycosyltransferases
All steps were performed at 4 'C. The cell pellets from a 1 L culture were thawed and
resuspended in 50 mL lysis buffer (50 mM HEPES, pH 8.0/300 mM NaCl/10 mM imidazole)
with Protease Inhibitor Cocktail Set III (EDTA-free, Calbiochem) added at a 1000-fold dilution.
The cells were disrupted by ultrasonication on ice, and the resulting cell lysate was then cleared
of unbroken cells, cellular debris, and membranes by centrifugation (145,000 x g) for 65
minutes. The resulting supernatant was incubated with Ni-NTA agarose resin (Qiagen) for 2 hrs
with gentle rocking and subsequently poured into a fritted PolyPrep column (BioRad) to collect
the resin. The resin was washed (50 mM HEPES, pH 8.0 / 300 mM NaCl / 25 mM imidazole)
and the protein eluted (50 mM HEPES, pH 8.0 / 300 mM NaCl / 250 mM imidazole). Fractions
containing the desired product were combined and dialyzed (50 mM HEPES, pH 8.0 / 100 mM
NaCl) to remove the imidazole and lower the salt concentration. Proteins were stored at 4 *C
after the addition of glycerol to a final concentration of 25%. Protein purity was measured by
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SDS-PAGE, and protein identity was confirmed by Western blot analysis using either the Anti-
T7 (Novagen) or Anti-His 4 (Qiagen) antibodies. Protein concentration was determined by either
the Micro BCA kit (Pierce) or UV absorbance using the appropriate extinction coefficient at 280
nm.
General Glycosyltransferase Assay
Dolichyldiphosphate N-acetylglucosamine (Dol-PP-GlcNAc, 5 nmol) was added to a 1.5 mL
eppendorf tube and dried under a stream of nitrogen. After solubilization in DMSO (3 [tL)
followed by Triton X-100 (14.3%, 7 [tL), 1 mM MgCl 2, 2.5 mM DTT, 100 mM NaCl, 50 mM
HEPES, pH 8.0, and 35 [tL glycosyltransferase (as a crude membrane fraction or purified
protein) were combined in a final volume of 200 [tL. UDP-[3H]GlcNAc(3NAc)A (25 nmol,
200,000 DPM total) was added to the mixture to initiate the reaction. The reaction was
incubated at room temperature for 2 hrs, after which it was quenched by the addition of
CHCl3:MeOH (2:1, 1.3 mL). The organic layer was extracted with pure solvent upper phase
(PSUP, 3 x 300 tL) then dried under a stream of nitrogen. After resuspension in Solvable (200
[tL), the mixture was diluted with Formula 989 scintillation fluid (5 mL) and analyzed by
scintillation counting to determine reaction turnover.
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Synthesis of Dolichylphosphate
0-
O-P-OH
n
-
2 n = 13-15
6
Dolichylphosphate was prepared following previously published protocols.2, Dolichol (C85-
C95, 50 mg in hexanes (7 [tmol) was placed in a round bottom flask and dried under vacuum for
3 hrs, after which tetrazole (0.027 mmol), anhydrous bis-(2-cyanoethyl)-NN-
diisopropylphosphoramidite (0.011 mmol), and freshly distilled THF (1.3 mL) were added. The
reaction was stirred under argon for 2 hrs, then cooled to -78 'C for 10 mins. H20 2 (30%, 44
pL) was then added to a final concentration of 1%, and the mixture was allowed to stir for 15
mins before warming to room temperature over the course of 15 mins. The reaction was diluted
with EtOAc (5 mL), quickly washed with 1% Na2 SO3 (5 mL) and saturated NaCl (5 mL), dried
over Na2 SO 4, then concentrated under vacuum. After solubilization in NaOMe/MeOH (1%, 5
mL) to remove the cyanoethyl protecting groups, the reaction was stirred for 48 hrs at room
temperature and monitored by TLC. Dolichylphosphate was purified by DE-52 anion exchange
resin, eluting with a stepwise gradient of NH 40Ac in MeOH (15 mM, 25 mM, 37.5 mM, 50
mM, 100 mM) to yield roughly 25 mg (-50%) of the desired product 6. 'H and "P- NMR data
matched previously reported values.
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Synthesis of Dolichol-Linked Monosaccharides
AcO OAc
O
AcO
AcHN OH
9 GIcNAc
10 GaINAc
a. 3,4,6-Tri-O-acetyl-2-deoxy-2-acetamido-a,p-D-glucose (9) and galactose (10): To a solution
of D-glucose (7) or D-galactose (8, 1.0 g, 4.52 mmol) in pyridine (25 mL), acetic anhydride
(4.26 mL, 45.2 mmol) was added. The reaction was stirred overnight at room temperature, after
which the solvent was removed under vacuum and the crude reaction mixture was recrystallized
from EtOH. In order to deprotect the anomeric hydroxyl group, a solution of the tetracetate (2.5
g, 6.42 mmol) and dimethylamine (16.0 mL, 32.1 mmol) was stirred in CH3CN (100 mL) at
room temperature for 24 hrs. The mixture was diluted with EtOAc (40 mL) and washed with
H2 0 (40 mL) and NaCl (40 mL), and then dried (Na2 SO4). The product was purified over silica
gel with 9:1 CH2Cl 2:MeOH to give the desired triacetylated sugars 9 and 10 as a mixture of a
and P anomers. 'H NMR and ESI-MS data match published values.24
Ac OAc
A O
ACHN liO-P-OBn
OBn
11 GIcNAc
12 GaINAc
b. Dibenzyl 3,4,6-tri-O-acetyl-2-deoxy-2-acetamido-a-D-glucose phosphate (11) and
-galactose phosphate (12): Dibenzyl NN-diethylphosphoramidite (0.86 g, 7.2 mmol) was added
to a stirring solution of the triacetylated glucose (9, 1.0 g, 2.9 mmol) or galactose (10, 1.0 g, 2.9
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mmol) and 1,2,4-triazole (0.8 g, 11.5 mmol) in anhydrous CH 2Cl 2 under a nitrogen atmosphere
at room temperature. The mixture was allowed to stir for 2 hrs before being diluted with Et2 O.
The mixture was then washed with cold NaHCO 3, NaCl, and H20, dried (Na2 SO 4), and
concentrated under vacuum. To oxidize the phosphite, the reaction mixture was resuspended in
THF (40 mL) and cooled to -78 OC. H20 2 (30%, 8 mL) was added to the stirring solution in a
dropwise manner, after which the reaction was chilled for an additional 15 mins, then allowed to
warm to room temperature over the course of 90 mins. The reaction mixture was diluted with
Et 20 and washed with cold NaHCO 3, NaCl, and H2 0 in succession, dried (Na2SO4 ), and
concentrated under vacuum as described above. The crude product was purified over silica gel
with 1:4 EtOAc:hexanes to give the desired phosphate (11 or 12). 1H and 31P NMR and ESI-MS
data match published values.24
Aco OAc
AcO ~O
O- P-O NEt3
OH
13 GIcNAc
14 GaINAc
c. 3,4,6-tri-O-acetyl-2-deoxy-2-acetamido-a-D-glucose phosphate (13) and -galactose
phosphate (14): The dibenzyl phosphates 11 and 12 (1.0 g, 1.8 mmol) were subjected to
hydrogenation over 5% Pd(OH)2/C (150 mg) in EtOH (30 mL) and 10% NaHCO 3 (20 mL) for
12 hrs at room temperature. The mixture was filtered, and the filtrate concentrated under
vacuum. The residue was treated with a solution of 1:1 MeOH:H 20 in 10% Et3N, then
concentrated to give the phosphates 13 and 14. 'H and 3 1P NMR and ESI-MS data match
24published values.
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n = 7, 13-15
15 n = 7, GcNAc 17 n = 7, GaNAc
16 n = 13-15, GcNAc 18 n=13-15,GaNAc
d General procedure for coupling of sugar phosphates with dolichylphosphates: To a solution
of the sugar phosphate (12.0 mg, 0.02 mmol) in dry DMF (1 mL) at room temperature was
added 1,1'carbonyldiimidazole (CDI, 0.2 mmol). After 6 hrs, MeOH was added to the reaction
in a dropwise manner to quench excess CDI, and the mixture was incubated for 30 mins.
Dolichylphosphate (either C55 or C85-C95, 0.014 mmol) in CH2 Cl 2 (1 mL) was then added, and
the reaction was allowed to stir for 8 days at room temperature and monitored by TLC. Upon
completion, the crude mixture was concentrated under vacuum and purified by silica gel
chromatography (85:14:1 CHC13:MeOH:2M NH 40H) to give the pure triacetylated dolichyl-
linked monosaccharides 15, 16, 17, and 18. 31P NMR data match published values. 23
HO OH
OOHOAcHN
0- O
O-P-O-P-o-
- -n H 110 0
-- 2 n,= 7, 13-15
2 n = 7, G IcNAc 3 n = 7, GaNAc
2 n = 13-15, GlcNAc 4 n = 13-15, GalNA c
e. General procedure for deprotection of acetylated dolichyl-linked monosaccharides: The
protected dolichyl-linked monosaccharides were dissolved in MeOH (1 mL) and a solution of
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25% NaOMe/MeOH (40 [tL) was added dropwise to a final concentration of 1% NaOMe. The
solution was stirred at room temperature for 30 mins, then neutralized with Dowex 50WX8-200
ion exchange resin (pyridinium form) and concentrated under vacuum to yield the desired
dolichyl-linked monosaccharides 1, 2, 3, and 4. 3P NMR values (162 MHz, 5:1 CDCl 3:CD 30D)
are as follows:
Dolichyldiphosphate(C55)-N-acetyl-a-D-glucosamine (1): 6 -5.8, -8.6
Dolichyldiphosphate(C85-C95)-N-acetyl-a-D-glucosamine (2): 6 -17.7, -18.9
Dolichyldiphosphate(C55)-N-acetyl-a-D-galactosamine (3): 6 -5.3, -8.1
Dolichyldiphosphate(C85-C95)-N-acetyl-a-D-galactosamine (4): 6 -16.3, -17.8
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Chapter 6 Efforts Towards the Inhibition of PglB, the Oligosaccharyl
Transferase from the Bacterial Pathogen Campylobacterjejuni
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Introduction
Asparagine-linked glycosylation is a posttranslational protein modification that occurs in
all domains of life.1-3 This process entails the stepwise assembly of an oligosaccharide onto a
polyisoprenyl-linked carrier, followed by the en bloc transfer of the glycan to asparagine
residues of nascent or fully folded proteins (Figure 6-1). In eukaryotes, this process is carried
out by the multimeric enzyme complex oligosaccharyl transferase (OT), localized in the lumen
of the endoplasmic reticulum. As outlined in Chapter 2, OT transfers the tetradecasaccharide
(GlcNAc 2Man9Glc 3) from dolichyl-pyrophosphate to nascent proteins, in which the Asn residue
is found within an Asn-Xaa-Ser/Thr sequon (where Xaa is any amino acid except proline) and
aligned in an Asx turn.4,5
UDP- Dolichyl
SUDP (n=7-15)
UDP UDP- 0 OT
cytopasm~ .-. .
PerIP~asm i.. 0 I0.7- Undecaprenyl
Oligosa caride
.AO. (species dependent)
Figure 6-1: General pathway of N-linked glycosylation.
Although OT has been the subject of intense investigation over several decades, a
detailed understanding of the reaction mechanism of this complex has remained elusive. One of
the most intriguing questions concerning this mechanism involves the nucleophilicity of the
asparagine side chain; it is still unclear how the amide nitrogen, a stable and fairly unreactive
moiety, is activated for catalysis within the enzyme active site. There have been several
proposals put forth to describe this decisive step, as summarized in Figure 6-2. The first
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proposal, described by Marshall (Figure 6-2A), suggests that deprotonation of the amide
nitrogen is enhanced by a hydrogen bond between the Asn side chain carbonyl and the hydroxyl
group of the required Ser/Thr residue.6 A second model by Bause and coworkers states that the
amide nitrogen behaves as a hydrogen bond donor, and is activated through deprotonation by
the Ser/Thr hydroxyl oxygen atom (Figure 6-2B). 7 In contrast to these two models, the proposal
put forth by Imperiali highlights the importance of the peptide backbone conformation in the
reaction mechanism, specifically by describing the critical role of the Asx turn (Figure 6-2C).8
This motif is believed to provide a series of key hydrogen bonding interactions that aid in
deprotonation of the amide nitrogen to form an imidol intermediate, which then reacts with the
dolichyl-linked oligosaccharide to catalyze glycosyl transfer.
A A YONH
H
N O
H- HNH
H HO N
0
DoI-P-P- Oligosacoharide
B:
HN
Asx-turn
B T
O NHH
H
H H-I
H.
(:B-l
D P o1
DoI- P-P- 01igosaccharide
O NH R
N 0
0
H .O.H-N H
S0 N
\BH O
Dol-P-P-Oligosaccharide
Figure 6-2: Three mechanistic proposals for the activation of the amide side chain nitrogen of
asparagine by OT. (A) Marshall; (B) Bause; (C) Imperiali.
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A powerful method for studying enzyme mechanism is through the use of substrate-
based inhibitors. This classical approach involves the design and synthesis of molecules that
mimic an intermediate along the reaction pathway, thus competing with the natural substrate to
bind to the enzyme and resulting in a reduced overall reaction rate. Previous work in the
Imperiali group has yielded a number of peptide-based inhibitors that exhibit low nanomolar
affinity for OT. The structures of these compounds are based upon the Asn-Xaa-Ser/Thr
tripeptide glycosylation sequence (1) derived from the native protein substrates (Figure 6-3).
Early studies determined that the use of isosteres in the place of the Asn residue resulted in
competitive inhibition of OT; these isosteres are substituted for the asparagine side chain yet
prevent glycan transfer to the peptide.9 It was determined that the Bz-Dab-Ala-Thr-Val-Thr-
Nph-NH2 peptide (2), in which the Asn residue is replaced by 2,4-diaminobutanoic acid (Dab),
was a potent inhibitor of the OT complex in Saccharomyces cerevisiae in vitro (Ki = 62 nm).11
In addition, constraining the peptide into an Asx-turn resulted in increased affinity for the
enzyme, as in the case of 3, which highlights the importance of the Asx turn for enzyme
catalysis. Other efforts to develop OT inhibitors led to the generation of the glycopeptide
mimetic (4),12 as well as the dolichyl-linked disaccharide (5), in which the 2-acetamido group of
the first GlcNAc residue is replaced by a fluorine atom." Studies of OT activity using 5
indicated that it was not accepted as a glycosyl donor, providing the first evidence that the 2-
acetamido group on the proximal sugar is necessary for substrate turnover; this requirement has
since been confirmed for OT homologs in prokaryotes.14 However, despite the wealth of
information acquired using these inhibitors, difficulties in obtaining highly pure OT has
complicated efforts to gain a detailed biochemical characterization of the enzyme mechanism.
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Figure 6-3: Previous OT inhibitors developed by the Imperiali laboratory.
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In 1999, a general system of N-linked glycosylation was identified in the pathogenic,
Gram-negative bacterium Campylobacter jejuni.15 C. jejuni is a human gut mucosal pathogen
that is a leading cause of bacterial gastroenteritis, 1617 and the presence of N-linked glycoproteins
has been found to play a key role in virulence.' 8 As described in Chapter 1, the C. jejuni
oligosaccharyl transferase PglB catalyzes the transfer of the heptasaccharide (BacGalNAcsGlc)
from an undecaprenyl-pyrophosphate donor onto the amide side chain nitrogen of acceptor
proteins.19 Unlike the multimeric OT complex found in eukaryotes, PglB is a single polypeptide
composed of two domains, a large N-terminal region made up of roughly 9-13 transmembrane
helices, and a soluble C-terminal domain that contains the canonical WWDXGX motif, which is
conserved in the catalytic subunit of the eukaryotic OT, Stt3p, as well as all putative OT
homologs.2 0 While PglB recognizes the N-X-S/T sequon for glycosylation of the target
polypeptide, similar to OT, it also has the additional requirement of the negatively charged
residues D/E at the -2 position. Despite these subtle differences, it is proposed that the
mechanisms of both OT and PglB are highly similar, and thus the study of PglB provides a
simpler system that is more suitable for in depth biochemical characterization.
OH OH
HO % OH
O
0 OH
C~op~sm 4q~ PIH q~ PgI4:>O ~ O N ~ ACHN ?p 0UDP§ Up-M PM UP-§ VDP0 0OH AH
Pg1K PgB =
10 N -Daeaioloa.in (Bac) a C 0 Glcoe(Gc
N N-Acetylgalactosamine(GaINAc) Undecaprenyldiphosphate
Glycoprotein
Figure 6-4: N-linked glycosylation in C. jejuni.
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In this chapter, efforts to gain insight into the enzymatic mechanism of the bacterial
oligosaccharyl transferase PglB are described. A major focus to this end involved the synthesis
and testing of over forty potential peptide-based inhibitors, many of which incorporated
isosteres of asparagine. However, despite trying a wide variety of reaction conditions, no
inhibition of PglB was observed using these peptides. In an alternative approach, the use of a
panel of small molecule enzyme alkylating agents is described in an attempt to identify key
amino acids involved in the mechanism of PgIB. This study revealed that diethylpyrocarbonate
(DEPC), a histidine-specific alkylating agent, was able to selectively inhibit the enzyme in a
time and concentration dependent manner. A series of PglB point mutations was then prepared,
in which each of the five histidines found in the protein sequence was sequentially mutated to
alanine, in an effort to identify the critical histidine residue in question. This work summarizes
efforts towards the search for PglB inhibitors, which we envision would be a powerful tool to
gain insight into the mechanism of the oligosaccharide transferase as well as a starting point in
the design of novel therapeutics against the human mucosal pathogen C. jejuni.
Results and Discussion
Peptide-based Inhibitors of PglB
In order to study the active site requirements of PglB, a series of peptide-based inhibitors
was designed, synthesized, and tested against the enzyme. Each of these peptides is based on the
Asp-Xaa1-Asn-Xaa2-Ser/Thr-Nph scaffold, where Xaa1 is Phe/Gln, and Xaa2 is Ala/Val (Figure
6-5). Previous work in the Imperiali group found this peptide sequence to be optimal for
glycosylation by PglB. 2 1 These peptides are acetylated at the N-terminus and include a C-
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terminal p-nitrophenylalanine residue (Nph) to aid in quantification. All peptides were
synthesized on PAL-PEG-PS resin using standard Fmoc-solid phase peptide techniques, purified
by RP-HPLC, and characterized by mass spectrometry.
R O k KPeptide cleavage AOH 0 ROH
O and deprotection O OH O NH2OR
0 H0 H 0 H 0 H 0 H O0OO NPAL-PEG O N N N H2
NO2 N
Figure 6-5: General scheme for synthesis of PglB peptide inhibitors on PAL-PEG-PS resin.
Residue Xaa1 is Phe or Gin and Xaa2 is Ala or Val, and R is either -H (Ser) or -CH 3 (Thr).
A standard assay was used to screen PglB for activity, based upon that originally
developed for the yeast OT (Figure 6-6). 19,22 It involves the incubation of PglB with the
radiolabeled disaccharide donor Und-PP-Bac-[3H]GalNAc and other reaction components,
including detergent and MnCl 2. The assay is initiated with the addition of the peptide substrate,
and aliquots are removed at various time points and quenched by aqueous/organic mixture,
which serves to partition the glycosylated peptide into the aqueous phase and the isoprenyl-
starting material into the organic phase. Glycosylation of the peptide substrate by PglB results in
a net transfer of radioactive counts from the organic phase into the aqueous phase as measured
by scintillation counting. In order to screen potential PglB inhibitors for activity, PglB first is
incubated with the inhibitor peptide (50-200 [tM), the radiolabeled glycan donor, and other
reaction components at room temperature for 10-30 minutes. The glycosylation reaction is then
initiated by the addition of the peptide substrate (10-50 FM), and the assay is carried out as
described above. Comparison of reaction rates of PglB incubated with and without the potential
inhibitor is then performed in order to determine whether inhibition has taken place.
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Figure 6-6: Assay for PglB activity. PglB is incubated with the peptide substrate, the
radiolabeled glycan donor, and other reaction components and aliquots are removed over time
and subjected to phase extraction. Glycosylation results in the transfer of radioactive counts
from the organic to the aqueous phase. In the case of PglB inhibition, fewer counts are
transferred to the aqueous phase corresponding to less overall activity.
a. Asparagine isosteres
The majority of peptides synthesized and tested for inhibition of PglB contain isosteres
of asparagine, in which the peptide scaffold remains unchanged but the asparagine side chain
amide is altered in some way (Figure 6-7). By modifying only the asparagine amide, the peptide
can presumably maintain extended binding contacts with the enzyme, but can no longer serve as
a glycan acceptor. Each of the isosteres included in this study was designed to test a particular
feature of the requirements for glycosylation; for example, the length of the side chain is varied
through incorporation of glutamine (6), while the tolerance for charge is explored in 9 and 11. In
the case of peptides 12-14, the amide bond is preserved, but the asparagine is extended with
nonpolar (12) or polar (13) and nucleophilic (14) moieties. For peptides 15-23, moieties that
mimic the stereoelectronic properties of asparagine were used in the place of the side chain
amide. The synthesis of these peptides was accomplished through one of three ways: a)
incorporation of a commercially available amino acid during peptide synthesis (6, 7, 9, 10, 21-
23); b) synthesis of the isosteric amino acid, followed by its inclusion into the peptide
framework (11, 15-17, 19, 20); or c) introduction of the isostere after completion of the peptide
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backbone (8, 12-14, 18). The following sections summarize the design and synthesis of these
isosteric peptides.
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Figure 6-7: PglB peptides containing asparagine isosteres outlined in this study.
L-Oxonorvaline (15)
Several classes of inhibitory molecules, such as those directed against proteases, often
contain peptidyl ketone and aldehyde functionalities.23 These molecules utilize the electrophilic
carbonyl center as a trap for nucleophiles located within the enzyme active site. In order to
produce a similar trap for PglB, a methyl ketone moiety was desired as a side chain replacement
of the asparagine amide. It was postulated that if the catalytic mechanism of PglB involves
deprotonation of the amide as an initial step, one might envision the formation of the reactive
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enolate that may be useful for mechanistic studies. A synthesis of the methyl ketone amino acid
was modified from previously published procedures (Figure 6-8),24,25 starting with the readily
available L-Boc-Asp-OtBu amino acid (24). Conversion to the primary alcohol (25) was
achieved via the mixed anhydride, followed by reduction with NaBH4 in H20. The Swern
oxidation was then employed to give the aldehyde (26) in good yield, followed by alkylation
using diazomethane to afford the ketone (27). After deprotection of the amine and ion exchange
with Dowex (Cl-) resin, the Fmoc protecting group was installed to yield the desired product
(29), which was incorprated into the PglB peptide scaffold using standard Fmoc peptide
chemistry as described. No inhibition was observed when this peptide was tested with PglB.
o OH 0
OH a, b C H d
NBoc OtBu 
BocN OtBu
H H H
O 0 0
24 25 26
0 0 0
CH3  e, f CH3  9 CH 3
Boc,N OtBu C+ OH FmocN OH
N CI H3N N
H HO O0
27 28 29
Figure 6-8: Synthesis of the methyl ketone amino acid, Fmoc-L-oxonorvaline-OH (29).
Reagents and conditions: (a) CH3CH20COCl, NEt3, THF, -5 'C; (b) NaBH 4, H20, 10 "C; (c)
ClCOCOCl, DMSO, DIPEA; (d) CH 2N2, CH2Cl2 ; (e) TFA, CH 2Cl 2 ; (f) Dowex (Cl-), MeOH;
(g) Fmoc-OSu, NaHCO 3, 1,4-dioxane/MeOH.
L-Aminoserine (11)
Another asparagine isostere of interest was L-aminoserine (Ams, 6), which contains a
nucleophilic oxyamine functionality in the place of the side chain amide. The oxyamine retains
the hydrogen bond donor capabilites of the amide nitrogen, but is compromised in its ability to
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accept a hydrogen bond compared with amide carbonyl, which may affect formation of the
required Asx turn. In addition to its role as an asparagine isostere, it was envisioned that this
compound could serve as a handle for the chemoselective ligation of carbohydrates and other
aldehyde-bearing compounds of interest. The Ams amino acid was previously synthesized in
the Imperiali group, and peptides incorporating this amino acid residue exhibited a Ki value of
34 tM against the yeast OT.26 The aminoserine amino acid was synthesized according to the
scheme outlined in Figure 6-9, and involves the Fmoc-protection of the N-terminal amine of L-
cycloserine (30), followed by acid-promoted ring opening and protection of the oxime nitrogen
with Boc20 to yield the final product (33)." The amino acid was then incorporated into the
PglB peptide sequence for testing against the enzyme; however, no inhibition of the enzyme was
observed.
NH3CI HNBoc
o H 0
H2N, Fmoc-NO.. 0 O
N a CNNH ,NH b ' FmocN OH FmocN OH
0 N N
30 31 32 33
Figure 6-9: Synthesis of Fmoc-L-aminoserine(Boc)-OH (32). Reagents and conditions: (a)
Fmoc-OSu, NaHCO 3, 1,4-dioxane/H 20; (b) 2M HCl, H20/THF; (c) Boc20, DIPEA, DMF.
L-Thioasparagine (17)
Another isostere explored for potential inhibition of PglB was the thioasparagine (17).
Thioasparagine is a very close isostere of asparagine, wherein the carbonyl is replaced with the
bulky, nucleophilic thionyl; as expected, the pKa values of these two side chains are predicted to
be quite similar (15.1 for acetamide and 13.4 for thioacetamide).28 ,29 Although this amino acid
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was previously synthesized by the Imperiali group and found to be accepted as a substrate for
OT (Km = 250 pM), the procedure involved the conversion of a cyano group to the thioamide
using a harsh combination of H2S and NH3 gases. In an effort to avoid this potentially dangerous
reaction, we instead sought to synthesize the desired amino acid as summarized in Figure 6-10.
Protection of the C-terminal carboxylate of Fmoc-Asn-OH (34) as the paramethoxybenzyl ester
(PMB, 35) was followed by thiolation of the carbonyl with P2S5 and sonication. Removal of the
PMB group and subsequent protection of the thioamide side chain with a xanthenyl moiety
afforded the desired amino acid (38).
o 0 S
NH2  NH2  NH2
Fmocs, OH a Fmoc, OPMB b Fmocs OPMBN N N
H H H
o 0 0
34 35 36
S S
, Xan
NH2  d HFmoc'N OH - Fmoc'N OHN N
H H
37 38
Figure 6-10: Synthesis of Fmoc-thioasparagine(Xan)-OH (37). Reagents and conditions: (a)
ClCH2PhOMe, DIPEA, Nal, DMA, N2, rt; (b) P2S5, THF, Ar, sonication; (c) thioanisole, EDT,
TFA; (d) 9-hydroxanthene, HOAc, 85 0C.
Despite several attempts, efforts to incorporate this amino acid into the peptide
framework proved unsuccessful. A variety of peptide coupling agents, including PyBOP,
PyAOP, HATU, DIC, HBTU, and HOAt were utilized to activate the carboxylate, but the
coupling of this amino acid to the peptide scaffold was not achieved. It was hypothesized that
perhaps the bulkiness of both the xanthydrol and Fmoc protecting groups were preventing
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activation of the carboxyl terminus through steric hindrance. An alternate strategy for generating
the desired peptide involved the synthesis of an asparagine-containing peptide, followed by
selective conversion of the side chain amide to the thioamide using Lawesson's reagent (Figure
6-11). HPLC analysis of the free peptide indicated only minimal conversion of the carbonyl to
the thionyl (17); however, just enough material was achieved in order to test PglB for inhibition.
Unfortunately, as in the case with other asparagine isosteres described in this section, this
peptide was neither a substrate nor an inhibitor of the PglB reaction.
0 0 0 S
OH NH2 0 OH 00 OH NH2  OH0 oo o
H H a H H NH2
O = H = 0 - N 0  - N
17
Figure 6-11: Synthesis of the thioasparagine-containing peptide. Reagents and conditions: (a)
Lawesson's reagent, THF:DMSO (1:1), sonication, 8 hrs.
L-Methyl Sulfoxide (18)
An asparagine isostere bearing a methyl sulfoxide side chain (18) was also prepared.
This amino acid differs from asparagine in several ways, including the larger size of the sulfur
atom compared to carbon and the weaker electron donating capability of the sulfoxide oxygen,
and may also serve as an electrophilic trap for active site nucleophiles. The decreased acidity of
a methyl sulfoxide (pKa ~ 33) compared with a carboxamide (pKa = 15.1 for acetamide)
suggests that this peptide would not be glycosylated, particularly if the mechanism of
glycosylation involves deprotonation as a first step; therefore, it could be a useful competitive
inhibitor. The synthesis of 18 began with the incorporation of L-(S-methyl)-cysteine into the
peptide scaffold using standard peptide chemistry techniques. This peptide (39) was then
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released from the solid support and deprotected with acid treatment, purified, and oxidized to
the sulfoxide (18) with NaIO 4 (Figure 6-12).3"" HPLC purification of the reaction mixture
allowed for resolution of both diastereomers, which were formed in an approximate 1:1 ratio.
Both the methyl cysteine and sulfoxide peptides were then tested for inhibition activity against
PglB.
Oo 0
0 H0 SC3 OH 0 OH OH 3  OH0 0 0 H0
HN NNH a N>N N ,kNH 2N - H ) NH, o~k ',Ao 1''
H0 H0H *HHo3 NO2  0 = 0 0 18 NO2
Figure 6-12: Synthesis of the methyl sulfoxide-containing peptide (18). Reagents and
conditions: (a) NaIO4, MeOH/H 20, 0 C (1 hr), then 25 'C (24 hrs).
Extended Asparagines: L-MethylAsn (12), L-HydroxyAsn (13), L-HydrazidoAsn (14)
A set of three "extended asparagine" peptides was explored as a means to determine
whether PglB could tolerate a slightly longer residue in the place of the native amide side chain.
These peptides were generated by first synthesizing a peptide in which an allyl-protected
aspartate residue was substituted for the asparagine. After selective deprotection of the
carboxylic acid side chain with Pd(PPh3)4 in the presence of phenylsilane, the acid was coupled
with either methylamine, hydroxylamine, or t-butylcarbazate and PyAOP/HOAt (Figure 6-13).
The peptides were then globally deprotected and cleaved from. the resin using a standard
cleavage cocktail to yield the isosteres 12, 13, and 14, respectively. Previous work in the
Imperiali group indicated that these peptides were modest inhibitors of OT; for example, the
hydrazine isostere exhibited a Ki of 2.5 [tM.12 Upon testing these peptides with PglB, we
observed that the hydroxyasparagine (13) was in fact a poor substrate, with a Km3 of > 100 PM.
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However, both of the other extended asparagine peptides (12 and 14) exhibited neither substrate
nor inhibitor activity.
0 0'o. 0 o NH
0 H0 H0  H 0  a, b HO 0)LH 0
H" N PAL-PEGQ a N PAL-PEGQ0 000
o R = CH (1) NO
NH2 (14)
Figure 6-13: Synthetic strategy for extended asparagines 12-14. Reagents and conditions: (a)
Pd(PPh3)4, phenylsilane, CH 2C12 (3x); (b) NH2CH 3 (12), NH2OH (13), or NH 2NHCOOtBu (14),
PyAOP, HOAt, DMF.
Other isosteres: Fluoropropenylalanine (16), Histidine Analogs (19-23)
The final set of isosteric peptides involves the fluoropropenylalanine (16), histidine (21),
and histidine analogs (19, 20, 22, 23), all of which present variations in the stereoelectronic
profile of the side chain compared with asparagine. All of these peptides were produced through
the incorporation of the relevant amino acids into the peptide backbone as previously described.
The fluoropropenyl amino acid was provided by GUnter Haufe,3 2 while L-2-(1,2,3-
triazolyl)alanine and L-(4-methyl- 1,2,4-triazolium)alanine were both obtained from the Haines
group (Wellesley College). Histidine, thiazolylalanine, and 4-pyridinylalanine were also
installed in the place of asparagine to give 21, 22, and 23 respectively. Unfortunately, none of
these peptides displayed activity as either PglB substrates or inhibitors.
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b. Bisubstrate Inhibitors: Aryl Asparagines/Neoglycopeptides
Another approach to designing PglB inhibitors involves use of the bisubstrate inhibitor, a
compound that combines structural features of two separate enzyme substrates. These types of
inhibitors are widely utilized in the pharmaceutical industry in order to achieve increased
binding affinity of a small molecule for the target enzyme. Inspiration for applying this method
to the design of PglB inhibitors was derived from tunicamycin, which to date is the only
commercially available inhibitor of N-linked glycosylation. Tunicamycin, first isolated from the
soil bacterium Streptomyces lysosuperificus in 1971,33 is a potent inhibitor of the first
committed step in the N-linked glycosylation pathway in eukaryotes carried out by the GlcNAc-
1-P phosphoglycosyltransferase (Alg7 in S. cerevisiae). As depicted in Figure 6-14, the
structure of tunicamycin incorporates features of both the UDP-GlcNAc and Dol-PP-GlcNAc
substrates of this enzyme.
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Figure 6-14: The structure of tunicamycin, a natural product found to inhibit eukaryotic N-
linked glycosylation.
A panel of bisubstrate analogs was generated to test for PglB inhibition (Figure 6-15);
these peptides were synthesized through modification of a key aspartate within the peptide
scaffold in a similar approach to that taken for the extended asparagines illustrated in Figure 6-
13. As shown in Figure 6-15, two distinct classes of molecules were designed as bisubstrate
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analogs. In the first set (40-44), modified benzyl groups were coupled to the free aspartate to
generate aryl asparagines. These analogs were envisioned to be potential inhibitors of PglB
based on past analysis of the crystal structures of several carbohydrate-binding proteins, in
which aromatic and hydrophobic amino acid residues line the binding groove.3",36 Recent
studies have shown that key interactions between these hydrophobic side chains and the
pyranose rings of the glycan are often critical for substrate recognition. We theorized that PglB
may contain similar types of residues in the sugar-binding region, and the introduction of aryl
rings into the active site would result in favorable hydrophobic interactions and/or 7-stacking
that might lead to inhibition.
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Figure 6-15: Aryl asparagines (40-44) and neoglycoconjugates (45, 46) outlined in this study.
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In the second set of bisubstrate analogs, either N-acetylglucosamine (GlcNAc) or 2,4-
diacetamidobacillosamine (Bac) was appended to the asparagine backbone to afford the
neoglycoconjugates 45 and 46. These molecules were synthesized using chemoselective
ligation, in which the sugar aldehydes are coupled to the hydrazidoasparagine side chain (14) at
low pH. As in the case of the aryl asparagines, it was postulated that the carbohydrate moieties
appended to the inhibitor peptides would bind to regions of the enzyme active site that interact
with the glycosyl donor substrates. However, no inhibition of PglB was observed for any of
these peptides (40-46).
In addition to the asparagine isosteres and the bisubstrate analog peptides outlined in this
chapter, many other peptides were synthesized and tested against PglB in an effort to observe
inhibition; several of these peptides are depicted in Figure 6-16. These peptides include
modifications at the Asn residue as well as the required Asp or Ser/Thr sites of the peptide
scaffold. For example, phosphoserine (54, 55) was utilized to introduce an additional negative
charge at these positions, as was a Cys residue to serve as a potential nucleophile (49-51). In one
case, an N-methylserine residue was incorporated in the place of Ser/Thr (56) to prevent the
peptide from adopting the Asx turn. This peptide was not glycosylated by PglB, thus
highlighting the importance of this peptide conformation to glycosylation in C. jejuni.
In summary, a wide array of peptides has been synthesized and tested against PglB for
inhibition. Despite the variety of peptides described herein, none exhibited inhibitory activity
against PglB. These findings were surprising, particularly in the case of the asparagine isosteres,
as several similar peptides have previously been found to be inhibitors of OT (Table 6-1). All
peptides were additionally tested as possible substrates, and all except for one,
hydroxyasparagine (13), were not glycosylated under the assay conditions employed. These
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results indicate that PglB may display exquisite specificity for the glycan acceptor compared
with OT; in support of this hypothesis, PglB exhibits a Km = 1 [tM for the acceptor peptide
compared with that for OT (Km = 240 1M for the tripeptide Bz-NLT). While PgIB is unable to
tolerate even minor modifications to the asparagine amide, OT appears to bind a variety of
asparagine isosteres and other peptide analogs. Further biochemical characterization of PglB is
required to understand the source of this unique substrate specificity.
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Figure 6-16: Representative examples of additional peptides designed as inhibitors of PglB.
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PgIB peptides
R OT activity PgIB activity
NH2 Km0.24 mM Km = 1.0 sM
Y0
OH No activity No activity
0
011No activity No activity
0
NKKi > 100 iM No activity
0
H Km= 20-50 M Km > 100 RM
OH
0
H NH2 Ki = 2.5 stM No activity
0
No activity No activity
0
No activity No activity
0
NH2 K,= 40 sM No activity
NH3 K, 0.06 [M No activity
H OH K= 4.5 tM No activity
N NHAc
0
Table 6-1: Comparison of peptide-based inhibitors of OT (S. cerevisiae) and PglB (C. jejuni). In
the case of PglB, all potential inhibitors were assayed at concentrations ranging from 50-250
[tM.
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OT peptides
Screening PglB with Small Molecule Alkylating Agents
Based on the lack of enzyme inhibition observed by the peptide-based inhibitors
described in this chapter, PglB was screened against several small molecule alkylating agents.
Although these agents do not mimic the peptide substrate, they can often provide information
about key residues involved in substrate binding and/or catalysis by covalently modifying
specific residues and potentially disrupting enzyme function. Earlier studies in the Imperiali
group indicated that treatment of OT with the sulfhydryl modifying agent methyl
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methanethiolsulfonate (MMTS) resulted in complete inactivation of the enzyme. Further
analysis using a biotinylated analog of MMTS showed that alkylation occurred in the Wbplp
subunit, and that incubation of OT with the substrate dolichyl-pyrophosphate chitobiose prior to
introduction of MMTS was sufficient to prevent alkylation, suggesting that the Wbplp may be
involved in binding the glycan donor.
PglB was incubated with three different alkylating agents, the cysteine-labeling agents
MMTS, iodoacetamide (IAA), and N-ethylmaleimide (NEM), and the histidine-specific
diethylpyrocarbonate (DEPC) at an initial concentration of 5 mM. After 30 mins, the acceptor
peptide was introduced into the mixture to initiate glycosylation. Aliquots were removed from
the reaction over time, partitioned between the aqueous and organic phases, and analyzed by
scintillation counting. As indicated in Figure 6-17, the cysteine-labeling agents MMTS, IAA,
and NEM had no effect on the rate of glycosylation. Surprisingly, total inactivation of PglB was
achieved with DEPC.
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Figure 6-17: Activity of PglB in the presence of the Cys-alkylating agents NEM, MMTS, and
IAA, and the His-alkylator DEPC. PglB was incubated with 5 mM of each alkylating agent for
30 mins prior to the addition of the acceptor peptide to initiate glycosylation.
Further investigation of this result indicated that enzyme inactivation was dependent on
both time and DEPC concentration (Figure 6-18) and occurred regardless of whether PglB was
introduced as pure protein or as part of a crude membrane fraction. DEPC has been previously
shown to modify histidine over other amino acid residues in a specific manner.39 In addition, it
has been used to identify critical histidine residues in proteins where X-ray crystal structures
were not readily available, as in the case of spinach leaf ferredoxin-NADP* oxidoreductase44
and E. coli RNA polymerase. 4 1 In some cases, enzymatic activity of the DEPC-modified protein
can be restored after treatment with hydroxylamine, which acts to remove the carboxyethyl
group from the imidazole ring (Figure 6-19). However, efforts to restore the activity of PglB
after DEPC incubation were unsuccessful due to the lability of Und-PP-Bac-[ 3H]GalNAc;
degradation of this substrate was rapidly observed at even low hydroxylamine concentrations.
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Figure 6-18: Concentration-dependent inactivation of PglB by the histidine alkylation agent,
DEPC.
N On N\NH
NH2OH0
Figure 6-19: Alkylation of histidine residues by DEPC, which can
incubation with NH 2OH.
be reversed through
Functional Characterization of Histidine to Alanine Mutants of PglB
The inactivation of PglB by DEPC suggests that a histidine residue may play an
important role in substrate binding or catalysis. Interestingly, this finding is supported by the
observation that a single point mutation of PglB in which His479 is replaced with Ala results in
a complete loss of enzymatic activity relative to the wild type enzyme. In order to further
characterize the role of His479 in the activity of PglB, the remaining histidine residues in the
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PglB sequence were systematically mutated to alanine and these mutant enzymes were tested for
activity. As shown in Figure 6-20, PglB contains a total of five histidine residues, four of which
are found in the predicted N-terminal transmembrane domain of the enzyme. The fifth histidine
residue, His479, is located at the beginning of the large soluble C-terminal domain in close
proximity to the canonical WWDXGX motif.
MLKKEYLKNPYLVLFAMIVLAYVFSVFCRFYWVWWASEFNEYFFNNQLMIISNDGYAFAEGARDMIAGF
QPNDLSYYGSSLSTLTYWLYKITPFSFESIILYMSTFLSSLVVIPIILLANEYKRPLMGFVAALLASV
ANSYYNRTMSGYYDTDMLVIVLPMFILFFMVRMILKKDFFSLIALPLFIGIYLWWYPSSYTLNVALIGL
FLIYTLIFERKEKIFYIAVILSSLTLSNIAWFYQSAIIVILFALFALEQKRLNFMIIGILGSATLIFLI
LSGGVDPILYQLKFYIFRSDESANLTQGFMYFNVNQTIQEVENVDFSEFMRRISGSEIVFLFSLFGFVW
LLRKIKSMIMALPILVLGFLALKGGLRFTIYSVPVMALGFGFLLSEFKAILVKKYSQLTSNVCIVFATI
LTLAPVFIMIYNYKAPTVFSQNEASLLNQLKNIANREDYVV PVRYYSDVKTLVDGGKILGKD
NFFPSFSLSKDEQAAANMARLSVEYTEKSFYAPQNEILESDILQAMMKDYNQSNVDLFLASLSKPDFKI
DTPKTRDIYLYMPARMSLIFSTVASFSFINLDTGVLDKPFTFSTAYPLDVKNGEIYLSNGVVLSDDFRS
FKIGDNVVSVNSIVEINSIKQGEYKITPIDDKAQFYIFYLKDSAIPYAQFILMDKTMFNSAYVQMFFLG
NYDKNLFDLVINSRDAKVFKLKI
Figure 6-20: Protein sequence of PglB. The N-terminal transmembrane domain (as predicted by
TMHMM)43 is highlighted in bold and underlined, and the WWDXGX motif conserved in all
Stt3 homologs is shown in cyan. Histidine residues are colored in pink, and the DXXK motif
44identified by Kohda et al is in green.
Plasmids encoding the desired PglB mutants were prepared using standard site-directed
mutagenesis techniques, and these constructs were transformed into E. coli BL21 (DE3) RIL
cells and overexpressed. Each mutant was then prepared as a crude cell membrane fraction and
analyzed by Western blot using an anti-T7 antibody directed against the N-terminal T7 tag,
which showed that all mutants were expressed at rQughly the same level. These mutants were
then tested for glycosylation activity using the standard assay, as shown in Figure 6-21.
Interestingly, all of the PglB mutants exhibited normal level of activity except for His479Ala,
suggesting that perhaps His479 plays an important role in substrate binding or catalysis.
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Figure 6-21: Activity of PgIB alanine mutants.
In December 2009, a preliminary crystal structure of the soluble C-terminal domain of
PglB was published by Kohda et al (Figure 6-22).45 It is unclear whether this structure
represents a biologically relevant form of PglB, as the C-terminal domain is unable to catalyze
substrate turnover. In addition, the structure is missing several large sections of the soluble
domain, and the lysine residues of the protein were methylated following purification to aid
crystallization. Nonetheless, analysis of this structure reveals that His479 is situated in close
proximity to the conserved WWDXGX motif. Thus, it follows that DEPC modification of this
particular histidine residue could affect substrate binding or catalysis either directly, by
preventing this residue from participating in the reaction mechanism, or indirectly, through
structural perturbation of the critical WWDXGX motif thus altering its proper function.
Regardless, further work is required to determine whether this key histidine residue is involved
in the catalytic mechanism of PglB.
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Figure 6-22: Crystal structure of the C-terminal soluble domain of PglB (PDB code: 3AAG). 5
His479 is highlighted in yellow, illustrating its proximity to the WWDYGY motif (cyan).
In addition to the histidine mutants described above, initial work was carried out to
investigate the importance of a newly identified motif in oligosaccharyl transferase homologs,
DXXK. In a recent report, Kohda et al assert that this sequence is highly conserved among all
known OTases, and present genetic knockout experiments in the hyperthermophile Pyrococcus
44furiosus to highlight its importance in glycosylation. To this end, three PglB mutants were
prepared to further analyze the role of these residues, the two single mutants (D519A and
K522A), as well as the double mutant (D519A/K522A). The mutants were generated in the
same manner as previously outlined, and analysis of crude cell membrane fractions indicated
that the overall expression level of each protein was roughly comparable. However, functional
analysis of these mutants indicated that they were all catalytically competent (Figure 6-23).
Although these results were surprising, examination of the amino acid sequence of the PglB C-
terminal domain reveals that in fact three different DXXK motifs are present; thus, perhaps one
of the remaining two motifs could in fact be key sequence. Current work in the laboratory is
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underway to investigate these further investigate this motif in PglB to determine if in fact it is
important for oligosaccharyl transferase activity in vitro.
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Figure 6-23: (A) PglB activity assay, comparing the overall reaction rates of the DXXK
mutants; (B) Crystal structure of the C-terminal soluble domain of the P. furiosus OTase,
highlighting the proximity of the newly identified DXXK motif (yellow) to the WWDYG
sequence (cyan). Figure adapted from Kohda et al.44
Conclusions
In this chapter, the design, synthesis, and in vitro screening of a large panel of substrate-
based peptides was described in an effort to obtain an inhibitor of the bacterial oligosaccharyl
transferase PglB. However, despite trying a wide variety of reaction conditions, no inhibition of
the enzyme was ever observed. It is currently unclear why we were unable to see inhibition of
PglB, particularly in light of the fact that several similar peptides were capable of affecting
activity of the yeast OT. One explanation for this difference may be related to the affinity of
each enzyme for its substrate; in the case of OT, the Km = 240 ptM for its substrate peptide,
while PglB exhibited a Km = 1 [M which represents a remarkable 200-fold variation. This
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marked difference in Km implies that PglB binds its substrate with greater affinity, and may
suggest a concomitant increase in peptide specificity not observed for OT. Another hypothesis
involves a recent finding by the Szymanski laboratory, in which PglB was found to be involved
in the hydrolysis of the Und-PP-BacGalNAc 5Glc glycan donor to provide free
oligosaccharide.46 The levels of free oligosaccharide in the periplasm of C. jejuni have been
linked to changes in growth conditions and osmolarity of the surrounding environment, and are
proposed to play a protective role for the organism. Although further work is required to fully
understand how this free oligosaccharide is formed and whether PglB is directly involved,
perhaps our inability to observe inhibition of PglB is somehow related to in vitro formation of
the hydrolyzed glycan.
In addition, this chapter describes efforts to identify key amino acid residues within PglB
to gain insight into substrate binding and/or catalysis. To this end, PglB was incubated with a
small panel of enzyme alkylating agents and found to be completely inactivated by the histidine-
specific DEPC in a time and concentration dependent manner. In order to further investigate this
finding, a series of histidine mutants of PglB were generated; it was found that only mutation of
His479, located near the putative enzyme active site, had an effect on enzyme activity. Enzyme
mutants were also generated to explore a newly identified DXXK motif. Future work in this
area will entail further investigation of PglB using site-directed mutagenesis, and may provide
key insight into the elusive reaction mechanism of oligosaccharyl transferase.
246
Acknowledgements
I am grateful to Professor Eranthie Weerapana for early help with peptide design and synthesis
and the oligosaccharyl transferase assay. Special thanks to Professor K. Jebrell Glover for his
advice on handling and purification of PglB, and to Drs. Matthieu Sainlos and Langdon Martin
for their assistance with MALDI TOF MS analysis.
Experimental Methods
General information
Unless otherwise noted, all solvents and reagents were obtained commercially and used without
further purification. Fmoc-protected amino acids and coupling agents were purchased from
Novabiochem (Gibbstown, NJ) and GenScript (Piscataway, NJ). Solvents were obtained from
VWR (West Chester, PA) or Sigma Aldrich (St. Louis, MO). Fmoc-PAL-PEG-PS resin was
acquired from Applied Biosystems (Carlsbad, CA). Oligonucleotides were purchased from
Eurofin MWG Operon (Huntsville, AL) or Sigma Life Sciences (St. Louis, MO). Sequencing of
all bacterial plasmids was conducted by the MIT CCR Biopolymers Laboratory (Cambridge,
MA). Analytical TLC was performed on silica gel 60 F254 plates (EMD Chemicals) and
visualized with either UV or staining with ninhydrin, vanillin, or CAM. Flash column
chromatography was performed using forced flow of the indicated solvent on silica gel 60,
particle size 0.043-0.063 mm (EMD Chemicals). HPLC was carried out on a Waters Prep LC
4000 or Waters Delta 600 systems, each equipped with a Waters 2487 dual wavelength detector.
For analytical HPLC, a C18 YMC ODS-A 5 [tm (4.6 x 250 mm) column was used, and for
preparatory HPLC, a C18 YMC-Pack ODS-A 5 [tm (250 x 20 mm) column was employed. ESI-
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MS was conducted on a Mariner instrument (Applied Biosystems), and MALDI-TOF MS was
performed on the Voyager system (Applied Biosystems). NMR spectra were acquired on a
Bruker 400 MHz spectrometer equipped with a 5 mm variable temperature gXH probe.
Chemical shifts (6) are reported in parts per million (ppm) and referenced to internal standards,
where either the HOD signal at 4.80 ppm, CHCl3 signal at 7.28 ppm, or (CH 3)2SO was used for
'H analysis. Coupling constants (J) are reported in Hertz (Hz) and multiplicities are abbreviated
as singlet (s), broad singlet (br s), doublet (d), triplet (t), multiplet (in), doublet of doublets (dd),
and doublet of triplets (dt). Infrared spectrophotometry was carried out on a Perkin-Elmer
Model 2000 instrument with samples dried on NaCl plates (25 mm diameter x 4 mm width,
Sigma Aldrich).
Peptide Synthesis
All peptides were synthesized using standard Fmoc-based solid phase protocols on Fmoc-PAL-
PEG-PS resin (0.19 mmol/g). The resin was swelled first in CH 2Cl2 (5 mins) then DMF (5 mins)
prior to synthesis. Deprotection of the terminal Fmoc group was achieved by exposure of the
resin to an excess of 20% 4-methylpiperidine in DMF (3 x 5 mins). Each amino acid was
coupled to the resin by incubation with the amino acid (4 equiv), PyBOP (4 equiv), and DIPEA
(8 equiv) for 45 mins. Between each deprotection and coupling step, the resin was washed with
DMF (5 x 1 min) then CH 2C12 (5 x 1 min). The TNBS test was used to check the resin for
coupling efficiency, in which the formation of red color indicates the presence of a free amine. 47
All peptides were acetylated at the N-terminus by incubation with acetic anhydride (10 equiv)
and pyridine (10 equiv) in DMF for 30 mins. The side chain protecting groups were removed
and the peptides cleaved from the resin by exposure to a TFA:CH2Cl2:H20:TIS mixture
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(90:5:2.5:2.5) for 3 hrs while shaking vigorously, followed by filtration to remove the beads and
solvent evaporation under a stream of nitrogen. The resulting pellet was triturated with cold
Et20, and the peptides were purified by preparative C18 RP-HPLC using a 45 minute gradient of
5-95% mobile phase B, where the mobile phases are H20 / 0.1% TFA (A) and CH3CN / 0.1%
TFA (B). Purified peptides were characterized by analytical RP-HPLC for purity and either ESI-
MS or MALDI-TOF MS for identity. Peptides were stored as solutions of DMSO and quantified
by UV absorbance using the E280 of Nph (12,500 M-cm1 ).
Synthesis of L-Oxonorvaline
The methyl ketone amino acid was synthesized following previously reported procedures with
24,25
slight modifications.
OH
0
H 
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a. (L)-Boc-Homoserine-OtBu (25): To a stirring solution of Boc-Asp-OtBu (24, 800 mg, 2.76
mmol) in 10 mL dry THF under an atmosphere of argon at -15 'C, triethylamine (385.2 [tL, 2.76
mmol) and ethyl chloroformate (263.3 tL, 2.76 mmol) were added. After 30 mins, the
tetraammonium chloride was filtered from solution, and the filtrate was added dropwise to a
stirring solution of NaBH 4 (209.12 mg, 5.52 mmol) in H20 (10 mL) at 10 'C over the course of
10 mins. After stirring at room temperature for 4 hrs, the solution was acidified to pH 6.5 with 1
M HCl. The mixture was extracted with EtOAc (2 x 20 mL), and the combined EtOAc layers
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were then washed with 10% NaOH, H20, and brine (20 mL each). The EtOAc solution was
dried (Na2SO 4) and then concentrated under vacuum to yield the desired product as a light
yellow oil with no discernible impurities (- 750 mg, 92%). 'H-NMR (400 MHz, CDCl 3): 5 1.50
(18H, s, CH 3), 2.2 (2H, m, CH2CH 2OH), 3.72 (2H, m, CH2CH2OH), 4.43 (lH, m, a-CH), 5.41
(1H, d, NH). ESI-MS: calcd for [C1 3H2 5NO5 + H]* requires m/z = 275.2, found m/z = 275.3.
0
0 H
H
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b. (L)-Boc-#-Aspartyl-semialdehyde-OtBu (26): Anhydrous DMSO (541.8 1iL, 7.62 mmol) was
added to a stirring solution of oxalyl chloride (1.91 mL, 3.81 mmol) in dry CH2Cl 2 at -78 'C
under an atmosphere of argon. To this mixture, Boc-homoserine-OtBu (25, 350 mg, 1.27 mmol)
dissolved in dry CH 2C12 (4.5 mL) was added and allowed to stir for 30 mins, followed by the
addition of anhydrous DIPEA (2.21 mL, 12.7 mmol). After 5 mins, the reaction was removed
from the cold bath and allowed to warm to room temperature while stirring over the course of 2
hrs. The solution was then diluted with CH2Cl2 (30 mL) and extracted with brine (2 x 30 mL).
The organic layer was dried over Na2SO 4, concentrated under vacuum, and purified by silica gel
column chromatography (1:1 hexanes:EtOAc) to provide the pure product, 26 (295 mg, 85%).
'H-NMR (400 MHz, CDC13): 8 1.49 (18H, s, CH 3), 2.93 (2H, m, CHCH2C(O)H), 4.48 (1H, m,
a-CH), 5.40 (1H, d, NH) 9.71 (lH, s, C(O)H). ESI-MS: calcd for [C13H23NO5 + H]* requires
m/z = 273.2, found m/z = 273.2.
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c. (L)-Boc-Oxonorvaline-OtBu (27): Diazomethane was generated from Diazald (3.26 g, 15.22
mmol) in a mixture of ether (12 mL), KOH (3.6 g), EtOH (4 mL), and H20 (3 mL) at 65 'C,
using a ClearSeal distillation setup and following standard procedures. Caution was taken
during the distillation due to the extreme volatility of diazomethane. The freshly distilled
diazomethane was slowly dripped into a stirring solution of Boc--aspartyl-semialdehyde-OtBu
(26, 300 mg, 1.10 mmol) in dry CH2Cl 2 (2 mL) at -78 'C as it was formed. The solution was
allowed to stir overnight, after which the characteristic yellow color of diazomethane
disappeared. The reaction was then quenched with 0.1 M HCl (10 mL) and extracted with
CH 2C12 (3 x 10 mL). The organic layers were combined, dried over Na2SO 4, and purified by
silica gel chromatography (1.5:1 hexanes:EtOAc) to afford the desired product (287 mg, 91%).
'H-NMR (400 MHz, CDCl 3): 6 1.46 (18H, s, CH 3), 2.11 (3H, C(O)CH 3), 2.89 (1H, dd, J= 4.1,
J= 12.8, CHCH2C(O)CH 3), 3.10 (1H, dd, J= 4.1, J= 12.8, CHCH 2C(O)CH 3), 4.35 (1H, m, C-
CH), 5.42 (1H, d, J = 6.7, NH). ESI-MS: calcd for [C14H2 5NO5 + H]* requires m/z = 287.2,
found m/z = 287.3.
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d. (L)-Oxonorvaline-OH hydrochloride (28): Boc-oxonorvaline-OtBu (27, 250 mg, 0.87 mmol)
was added to a stirring solution of CH2Cl2:TFA (2:1, 6 mL) and incubated for 16 hrs at room
temperature to yield a deep red mixture. The reaction was then concentrated under vacuum, and
the remaining red oil was washed with Et2O (2 x 10 mL) and lyophilized from H20 to afford an
orange solid as a TFA salt. The salt was dissolved in MeOH (6 mL) and incubated with Dowex
resin (Cr~ form, 0.5 g). The suspension was stirred at room temperature for 24 hrs, and the resin
was filtered and washed with MeOH (3 x 10 mL). The combined organic fractions were
concentrated under vacuum and the resulting orange solid was recrystallized from
MeOH:EtOAc (1:1) to achieve the desired product 28 (110 mg, 76%). 'H-NMR (400 MHz,
D20): 8 2.06 (s, 3H, CH 2C(O)CH 3), 3.18 (2H, dd, J= 3.9, J=12.8, CH2C(O)CH 3), 4.16 (1H, t, J
= 3.9, ac-CH). ESI-MS: calcd for [C5HioNO 3 + H]* requires m/z = 132.1, found m/z = 132.1.
0
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e. (L)-Fmoc-Oxonorvaline-OH (29): A solution of oxonorvaline-OH (28, 100 mg, 0.978 mmol)
and NaHCO3 (458.7 mg, 5.46 mmol) in H20 was prepared in a round bottom flask. 9-
Fluorenylmethyl N-succinimidyl carbonate (Fmoc-OSu, 398.0 mg, 1.18 mmol) dissolved in
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dioxane (8 mL) was then added to the stirring solution in a dropwise fashion. The pH of the
cloudy suspension was adjusted to 8.5 by the addition of additional NaHCO3 (~50 mg) and after
3 hrs, TLC analysis (1:4 MeOH:CH 2Cl2, ninhydrin stain) indicated complete conversion of the
starting material. The reaction mixture was then extracted with Et20 (3 x 10 mL) and the
aqueous layer acidified to pH 2.5 by the slow addition of 1 M HCl, causing a thick white
precipitate to form. The precipitate was dissolved in EtOAc (10 mL), and the aqueous layer was
extracted with additional EtOAc (2 x 10 mL). The EtOAc layers were combined, dried over
Na2 SO 4, and purified by flash silica chromatography (5% MeOH/CH 2Cl2) to yield the desired
Fmoc-protected amino acid 29 (74%). 'H-NMR (400 MHz, (CD 3)2SO): 8 2.07 (3H, s,
CH 2 C(O)CH 3), 4.32 (lH, m, CH-Fmoc), 4.40 (1H, m, CH 2-Fmoc), 4.46 (1H, m, CH 2-Fmoc),
4.63 (1H, m, c-CH), 7.39 (2H, m, Ar), 7.43 (2H, m, Ar), 7.61 (1H, d, J= 6.1, NH), 7.69 (2H, d,
J= 7.0, Ar), 7.86 (2H, m, Ar) (Appendix 1). ESI-MS: calcd for [C2 0H19NO + H]* requires m/z
= 353.1, found m/z = 353.3.
Synthesis ofAminoserine
The aminoserine amino acid was prepared using previously published protocols with slight
modification.
\ /
NH
I 0 o'
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a. (L)-Fmoc-Cycloserine (31): L-Cycloserine (100 mg, 0.978 mmol) was protected with Fmoc in
a similar procedure to that described above for Fmoc-oxonorvaline-OH (29) to yield the desired
Fmoc-cycloserine (31) in good yield. 'H-NMR (400 MHz, CDCl 3): 6 4.12 (1H, tapp, J = 7.1,
CH 2ON), 4.25 (1H, t, CH-Fmoc), 4.45 (2H, d, J= 4.2, CH 2-Fmoc), 4.69 (lH, m, CH 2ON), 4.83
(1H, tapp, J= 7.8, c-CH), 5.45 (1H, br s, NH), 7.30 (2H, t, J = 7.1, Ar), 7.42 (2H, t, J= 7.1, Ar),
7.60 (2H, d, J = 7.0, Ar), 7.81 (2H, d, J = 7.7, Ar), 8.05 (1H, m, NH). ESI-MS: calcd for
[C18H 16N20 4 + H]* requires m/z = 324.3, found m/z = 324.4.
NH3 CI
0
0
o KN OHH
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b. (L)-Fmoc-Aminoserine Hydrochloride (32): To a stirring solution of 31 (136 mg, 0.42 mmol)
in THF (2 mL) at 60 'C, 2 M HCl (2 mL) was added in a slow, dropwise manner. The reaction
was monitored by TLC, and after 96 hrs was neutralized by the addition of NaHCO 3 and
concentrated under vacuum to provide the crude product (32), which was purified by
preparative HPLC in high yield (87%). 1H-NMR (400 MHz, (CD 3)2SO): 6 4.22 (6H, m, CH-
Fmoc, CH 2-Fmoc, a-CH, CH 2ON), 7.27 (2H, t, J= 7.1, Ar), 7.36 (2H, t, J= 7.1, Ar), 7.63 (2H,
d, J = 7.0, Ar), 7.84 (2H, d, J = 7.6, Ar). ESI-MS: calcd for [C1 8H 1 8N20 5 + H]* requires m/z =
342.4, found m/z = 324.5.
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c. (L)-Fmoc-Aminoserine(Boc)-OH (33): Fmoc-Aminoserine HCl (32, 100 mg, 0.31 mmol)
dissolved in DMF (5 mL) was treated with DIPEA (108.0 ptL, 0.62 mmol) and di-tert-butyl
dicarbonate (Boc 20, 74.2 mg, 0.34 mmol) while stirring. The reaction was incubated for 3 hrs,
and the pH was monitored over the course of the reaction, adding DIPEA to ensure a pH of 8.5.
Once the reaction was complete, the reaction was diluted with Et 20 (10 mL) and washed with
0.1 M HCl (2 x 10 mL), H20 (2 x 10 mL), and 2% NaHCO3 (3 x 10 mL). The combined
aqueous layers were then acidified to pH 2 with 1 M HCl, and the precipitated material was
dissolved in ether, dried (NaSO4), and concentrated under vacuum. The crude product was
recrystallized from acetone/hexanes to give the final product, 33. 'H-NMR (400 MHz,
(CD 3)2SO): 5 1.42 (9H, s, CH 3), 3.91 (1H, dd, J= 6.5, CH 2ON), 4.01 (1H, m, CH 2ON), 4.21
(4H, m, CH-Fmoc, CH2-Fmoc, and c-CH), 7.23 (2H, t, J= 7.3, Ar), 7.39 (2H, t, J= 7.3, Ar),
7.57 (1H, d, J= 6.0, NH), 7.67 (2H, d, J= 7.2, Ar), 7.86 (2H, d, J= 7.6, Ar), 10.03 (1H, br s,
COOH). ESI-MS: calcd for calcd for [C23H26N2 0 7 + H]f requires m/z = 442.5, found m/z
442.5.
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Synthesis of(L)-Fmoc-thioasparagine(xanthen-9-yl)-OH
The synthesis of the desired thioasparagine amino acid, Fmoc-thioasparagine-(xanthen-9-yl)-
48
OH, (37), was achieved using previously published procedures with slight modification.
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0 NH OCH 3
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a. (L)-Fmoc-asparagine 4-methoxybenzyl ester (34): A solution of (L)-Fmoc-Asn-OH (1.5 g, 4.2
mmol, 18), 4-methoxybenzyl chloride (688.9 uL, 5.08 mmol), sodium iodide (919.4 mg, 6.13
mmol), and DIPEA (1.47 mL, 8.46 mmol) in dimethylacetamide (DMA, 30 mL) was prepared
in a round bottom flask and stirred under nitrogen at room temperature for 18 hrs. After dilution
with CHC13 (200 mL) and extraction with H20 (2 x 200 mL), the organic layer was dried
(MgSO 4) and filtered before removal of the solvent by evaporation. The solid was recrystallized
from CHCl3-pentane to give the desired product as a pale yellow solid (1.49 g, 71%). 'H NMR
(400 MHz, CDCl 3): 8 2.70 (1H, dd, J= 4.6, J= 12.3, CHCH2C(O)NH 2), 3.05 (lH, dd, J= 4.6, J
= 12.3, CHCH 2C(O)NH2), 3.75 (3H, s, CH3 OPh), 4.22 (1H, in), 4.35 (1H, in), 4.44 (1H, in),
4.63 (1H, m, c-CH), 5.18 (2H, s, CH 30PhCH2), 5.46 (1H, br s, C(O)NH 2), 5.63 (1H, br s,
C(O)NH 2), 6.10 (lH, d, J = 6.4, Fmoc-NH), 6.87 (2H, d, J= 7.2, Ar), 7.32 (4H, m, Ar), 7.43
(2H, t, J = 7.5, Ar), 7.62 (2H, d, J = 7.0, Ar), 7.82 (2H, d, J = 7.3, Ar). ESI-MS: calcd for
[C2 7H26N206 + H]* requires m/z = 475.2, found m/z = 475.2.
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b. (L)-Fmoc-thioasparagine 4-methoxybenzyl ester (35): A mixture of Fmoc-Asn-OPMB (34,
1.2 g, 2.5 mmol) and phosphorus pentasulfide (632 mg, 2.78 mmol) in dry THF (25 mL) was
assembled in a round bottom flask under an atmosphere of nitrogen and placed in a sonication
bath for 3 hours, maintaining the bath < 40 'C. The mixture was filtered to remove precipitate,
which was washed with hot CHCl3 (3 x 15 mL). The CHC13 washes were combined with the
THF filtrate and dried under vacuum. The crude product was purified by flash column
chromatography (CH 2Cl2:pentane:EtOAc; 3:3:2) to give the desired product (35) as a white
solid (749 mg, 61%). 'H NMR (400 MHz, CDCl 3): 8 3.27 (2H, m, CHCH 2C(S)NH 2), 3.80 (3H,
s, CH 3OPh), 4.22 (1H, m, CH-Fmoc), 4.43 (2H, d, J = 6.5, CH 2-Fmoc), 4.71 (1H, m, a-CH),
5.15 (2H, s, CH20Ph-CH2), 6.10 (1H, d, J= 5.8, NH-Fmoc), 6.87 (2H, d, J= 8.5, Ar), 7.32 (4H,
m, Ar), 7.42 (2H, t, J= 7.5), 7.61 (2H, J= 7.1, Ar), 7.76 (2H, d, J= 7.6, Ar). ESI-MS: calcd for
[C27H2 6N20 5 S + H]+ requires m/z = 491.2, found m/z = 491.2.
S
0 NH2
0 ' N OH
H
0
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c. (L)-Fmoc-thioasparagine-OH (36): Fmoc-ThioAsn-OPMB (35, 100 mg, 0.2 mmol) was
treated with a solution of TFA (1 mL) containing 1% of both thioanisole and ethanedithiol
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(EDT) for 30 mins at room temperature. The reaction was stopped upon addition of a Et 20-
pentane mixture (1:1, 10 mL), wherein a white precipitate was formed. The mixture was
allowed to stand for 2 hr at 0 'C, after which it was transferred to a 15 mL Falcon tube and
centrifuged at 3000 rpm for 5 mins. After removal of the supernatant by decantation, the
precipitate was washed with Et 20 (2 x 5 mL) to remove impurities, affording the desired
compound 36 as a white solid (47 mg, 63%). 1H NMR (400 MHz, CDCl 3): 6 2.85 (1H, dd, J =
4.6, J= 12.9, CHCH2C(S)NH 2), 2.98 (1H, dd, J= 4.6, J= 12.9, CHCH 2C(S)NH 2), 4.36 (3H, m,
CH- and CH 2-Fmoc), 4.67 (1H, m, a-CH), 7.33 (2H, t, J= 6.8, Ar), 7.42 (2H, t, J = 7.1, Ar),
7.64 (1H, d, J= 7.9, Ar), 7.70 (2H, d, J= 7.0, Ar), 7.90 (2H, d, J= 7.3, Ar), 9.22 (1H, br s,
NH 2), 9.56 (1H, br s, NH 2). ESI-MS: calcd for [C19Hi 8N20 4S + H]f requires m/z = 371.1, found
m/z = 371.1.
S 0
N
OH
O NH
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d. (L)-Fmoc-thioasparagine-(xanthen-9-yl)-OH (37): A solution of Fmoc-thioasparagine-OH
(36, 70 mg, 0.19 mmol) and 9-hydroxyxanthene (75.1 mg, 0.38 mmol) in glacial acetic acid (2.5
mL) was prepared in a round bottom flask and heated to 85 'C under an atmosphere of nitrogen
for 2 hrs. Following the removal of the solvent by rotary evaporation, the orange-colored
residue was triturated with Et20 (3 x 3 mL) to provide the product as a white precipitate. The
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product was recrystallized from CHCl3 to give the final compound (48 mg, 46%). 'H NMR (400
MHz, (CD 3)2 SO): 6 2.75 (IH, m, CHCH 2C(S)NH 2), 3.31 (1H, m, CHCH 2C(S)NH 2), 3.71 (1H,
m, CH-Fmoc), 4.27 (2H, m, CH 2-Fmoc), 4.45 (IH, m, CH-Xan), 4.69 (H, m, a-CH), 7.08 (2H,
m, Ar), 7.27 (2H, m, Ar), 7.33 (2H, t, J= 6.1, Ar), 7.43 (2H, t, J= 6.9 Hz), 7.50 (2H, t, J= 7.7,
Ar), 7.69 (2H, m, Ar), 7.72 (1H, m, NH), 7.90 (2H, m, Ar), 8.02 (1H, d, J= 7.1, NH), 8.22 (2H,
dd, J= 3.1, J= 7.6, Ar), 11.28 (1H, br s, CO2H). FT-IR: vmax (cm-) = 3310, 1730, 1650, 1515,
1250, 1170, 1030, 735. ESI-MS: calcd for [C3 2H2 6N20 5 S + H]* requires m/z = 551.2, found n/z
= 551.2.
Synthesis of Thiosasparagine peptide, Ac-Asp-Phe-ThioAsn- Val-Ser-Nph-NH2 (17)
The Ac-Asp-Phe-Asn-Val-Ser-Nph-NH2 peptide was synthesized on PAL-PEG resin following
standard solid-phase protocols. After deprotection and cleavage from the resin, the peptide was
purified by RP-HPLC, lyophilized, and characterized by MALDI TOF MS. The peptide (0.38
[tmol) was then dissolved in DMSO and added to a solution of Lawesson's reagent (0.5 mg, 1.24
tmol) in THF:DMSO (1:1, 250 [tL). The mixture was exposed to sonication at 25 'C in an H20
bath for 6 hrs, after which the reaction was purified by HPLC to provide the desired product
(17) in a very poor yield (- 8%). ESI-MS: calcd for [C35H4 5N9 012S + H]* requires m/z = 815.2,
found m/z = 815.3.
Synthesis of Methyl Sulfoxide Peptide, Ac-Asp-Phe-(MeS(O)Ala)-Ala-Thr-Nph-NH2 (18)
The Ac-Asp-Phe-(S-methylcysteine)-Ala-Thr-Nph-NH2 peptide (39) was synthesized on PAL-
PEG resin following standard solid-phase protocols. After deprotection and cleavage from the
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resin, the peptide was purified by RP-HPLC, lyophilized, and characterized by MALDI-TOF
MS. The peptide (3.0 mg, 3.7 tmol) was then dissolved in MeOH:H 20 (1:1, 100 [iL) and cooled
to 0 0C, after which the oxidizing agent NaIO 4 (15.0 [mol) in H20 (100 tL) was added
dropwise. The solution was stirred for 1 hr, during which the formation of a white precipitate
was observed. The suspension was warmed to room temperature and stirred for an additional 24
hrs. The reaction was then filtered, and the filtrate purified by HPLC to give the desired peptide
(18) as a mixture of diastereomers. ESI-MS: calcd for [C35H4 6N 8 0 13S + H]* requires m/z =
815.9, found m/z = 815.7.
Synthesis of Extended Asparagines (12-14) and Aryl Asparagines (40-44)
The Ac-Asp-Phe-Asp(OAl)-Ala-Thr-Nph-NH 2 peptide was synthesized on PAL-PEG resin (150
mg) using standard solid-phase protocols. Removal of the allyl group was carried out by
incubation with Pd(PPh 3)4 (20 mg) and phenylsilane (20 [tL) in DMF (10 mL) for 30 mins while
agitating with bubbling N2. The solution was drained by vacuum, and the beads were washed (1
min) with DMF (5 x1O mL) and CH 2C12 (3 x 10 mL); the procedure was repeated twice to give
the free acid moiety. The beads were then taken up in DMF (10 mL), and PyAOP (62.5 mg,
0.18 mmol), 2,4,6-collidine (79.3 [tL, 0.6 mmol), and the appropriate amine (0.06 mmol) were
added in order. The suspension was mixed for 1 hr, the solution drained, and the beads washed
with DMF/CH 2Cl2 as previously described. The coupling was repeated twice. The peptide was
cleaved from the resin following the standard procedure then purified by RP-HPLC to yield the
desired peptides, which were characterized by ESI.
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Synthesis of Neoglyconjugates (45 and 46)
The Ac-Asp-Phe-Asp(Hz)-Ala-Thr-Nph-NH2 peptide (14) was synthesized on PAL-PEG resin
following standard solid-phase protocols. After deprotection and cleavage from the resin, the
peptide was purified by RP-HPLC, lyophilized, and characterized by MALDI-TOF MS. The
peptide (530 nmol) was then dissolved in DMSO (100 [L), and either GlcNAc (100 tL of 1 M
solution dissolved in 1 M NaOAc, pH 5.6) or Bac was added. The pH was adjusted to pH 4.5 by
the dropwise addition of glacial HOAc while stirring, and the reaction was allowed to stir at
room temperature for 3 days while monitoring progress by HPLC. The glycopeptide was
purified using by RP-HPLC gradient using a long gradient (5 min 5% B, 1 min transition to
20% B, 50 min transition to 60% B, 10 min transition to 95% B, 5 min 95% B, where B =
CH3CN + 0.1% TFA), and analyzed by ESI-MS.
Synthesis of Undeceprenylphosphate
Undecaprenylphosphate was prepared following previously published protocols. 49,50
Undecaprenol in hexanes (7 imol) was placed in a round bottom flask and dried under vacuum
for 3 hrs, after which tetrazole (0.027 mmol), anhydrous bis-(2-cyanoethyl)-NN-
diisopropylphosphoramidite (0.011 mmol), and freshly distilled THF (1.3 mL) were added. The
reaction was stirred under argon for 2 hrs, then cooled to -78 'C for 10 mins. H20 2 (30%, 44
tL) was then added to a final concentration of 1%, and the mixture was allowed to stir for 15
mins before warming to room temperature over the course of 15 mins. The reaction was diluted
with EtOAc (5 mL), quickly washed with 1% Na2 SO 3 (5 mL) and saturated NaCl (5 mL), dried
over Na2SO 4 , then concentrated under vacuum. After solubilization in NaOMe/MeOH (1%, 5
mL) to remove the cyanoethyl protecting groups, the reaction was stirred for 48 hrs at room
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temperature and followed by TLC. Undecaprenylphosphate was purified by DE-52 anion
exchange chromatography, eluting with a stepwise gradient of NH40Ac in MeOH (15 mM, 25
mM, 37.5 mM, 50 mM, 100 mM) to yield roughly 2.0 mg (-40%) of the desired product. 'H
and 3 1P- NMR data matched previously reported values.
Synthesis of Und-PP-Bac-[3H]GalNAc
The Und-PP-Bac-[ 3H]GalNAc disaccharide donor was prepared as described previously. 5'
Undecaprenol (10 [tg, 13 nmol) was added to a 1.5 mL eppendorf tube and dried under a stream
of nitrogen. After solubilization in DMSO (3 iL) followed by Triton X-100 (14.3%, 7 [L), 1
mM MgCl2 , 10 mM ATP, I M TrisOAc, pH 8.5, 50 [IL S. mutans kinase CEF, 20 [tL PglA, and
20 [tL PglC CEF were combined in a final volume of 200 [IL. A mixture of 2 mM UDP-Bac and
UDP-[3H]GalNAc (150 mCi/mmol, 5,250,000 DPM total) was prepared and added to the
undecaprenol mixture to initiate the reaction. The reaction was incubated at 25 'C for 2 hrs,
after which it was quenched by the addition of CHCl3:MeOH (2:1, 1.3 mL). The organic layer
was extracted with pure solvent upper phase (PSUP, 3 x 300 [tL), then dried and stored at -20
'C until use. The overall reaction yield was determined by scintillation analysis of a small
quantity of the reaction product, and was regularly found to be between 60-75%.
Cloning of PgJB Mutants
Site-directed mutagenesis was performed by the polymerase chain reaction using a PglB
pET24a(+) plasmid as the template, Pfu Turbo polymerase (Stratagene), and the
oligonucleotides described in the Appendix (Table 1). The resulting PCR products were then
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incubated with DpnI restriction endonuclease to remove the template and transformed into XL 1
Blue competent cells. The final gene products encoded proteins with an N-terminal T7-tag and a
C-terminal His 6-tag and contained the desired mutations.
Overexpression of PglB
The pET24a(+) plasmid containing PglB was transformed into E. coli BL21-CodonPlus(DE3)
RIL competent cells (Stratagene) using both kanamycin (50 [tg/mL) and chloramphenicol (30
Rg/mL) for selection. For overexpression, 1 L of Luria-Bertani media supplemented with
kanamycin and chloramphenicol was inoculated at 37 'C while shaking until an optical density
(600 nm) of 0.6-0.8 was achieved. The cultures were then cooled to 16 C and protein
expression was induced by the addition of IPTG (1 mM). After 16 hrs, the cells were harvested
by centrifugation (5000 x g) and the resultant cell pellets were stored at -80 C until needed.
Preparation of PglB Cell Envelope Fraction
All steps were performed at 4 C. A frozen cell pellet of E. coli expressing PglB was
resuspended in 50 mM HEPES, pH 8.0 / 1 mM EDTA buffer (30 mL) supplemented with
Protease Inhibitor Cocktail III (Calbiochem, 30 RL). The cells were lysed by sonication, and the
mixture was centrifuged at 6000 x g for 30 mins to remove the cellular debris. The supernatant
was gently decanted and subjected to a second round of centrifugation (37,000 x g) for 1 hr to
collect the membrane fraction. The pellet was washed with 50 mM HEPES, pH 8.0 / 1 mM
EDTA buffer, centrifuged (140,000 x g) for 1 hr, then homogenized in 50 mM HEPES, pH 8.0 /
263
100 mM NaCl buffer (3 mL). The crude cell membrane fraction was aliquoted and stored at -80
'C for future use.
PglB Activity Assay
To a tube of radiolabeled Und-PP-Bac-[ 3H]GalNAc, DMSO (10 pL), 2x PglB Assay Buffer
containing 100 mM HEPES, pH 7.5 / 280 mM sucrose / 2.4% v/v Triton X-100 (100 [tL), 1 M
MnCl2 (2 [IL), H20 (53 jL), and 25 uL PglB freshly thawed cell envelope fraction were
combined. The assay was initiated by the addition of 10 [tL of a 2 mM stock of the peptide of
interest in DMSO. Aliquots of the reaction mixture (25 [L) were removed every 2 mins and
quenched by addition of 3:2:1 CHCl3:MeOH: 4mM MgCl2 (1.2 mL). The aqueous layer was
then removed and the organic layer extracted with 600 uL theoretical upper phase (TUP) with
salt (2 x 600 [tL). The aqueous layers were combined, mixed with 5 mL of scintillation fluid
(Ecolite, MP Biomedicals) and subjected to scintillation counting.
PgJB Inhibition Assay
To test peptides as potential PglB inhibitors, the procedure outlined above was followed with
slight modification; 10 [IL of a DMSO stock of the peptide of interest was added to the Und-PP-
Bac-[3H]GalNAc substrate in the place of 10 [IL DMSO. Upon addition of the remaining
components, the entire mixture was allowed to incubate at room temperature for 20 minutes
prior to reaction initiation with the acceptor peptide, Ac-Asp-Gln-Asn-Ala-Thr-Nph-NH2 (10 uL
of a 2 mM stock).
264
Screening Pg/B with Alkylating Agents
To a tube of radiolabeled Und-PP-Bac-[3H]GalNAc, DMSO (10 pL), 2x PglB Assay Buffer
containing 100 mM HEPES, pH 7.5 / 280 mM sucrose / 2.4% v/v Triton X-100 (100 [tL), 1 M
MnCl2 (2 tL), H20 (53 pL), and 25 uL PglB freshly thawed cell envelope fraction were
combined. The appropriate alkylating agent was added to the reaction mixture to give a final
concentration of 10 mM, and the reaction was incubated for 30 mins at room temperature. The
mixture was then assayed for activity by adding the acceptor peptide Ac-Asp-Gln-Asn-Ala-Thr-
Nph-NH 2 (10 uL of a 2 mM stock) and following the protocol outlined above for enzyme
inactivation.
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Table 1: Constructs and Oligonucleotides
Target Gene Primer ID Primer (5' to 3')
M. jannaschii stt3
M. voltae stt3
A. fulgidus stt3
M. maripaludis stt3
H. marismortui stt3
wbpA
wbpB
wbpE
wbpD
pgB-H70A
pgB-H217A
pglB-H350A
pgB-H423A
pglB-D519A
pglB-K522A
FOO CGATGGATCCATGTATATAAAGGTGAAACTTATG
ROO CGATCTCGAGTTTTAGATAATCAGTTCCATAATCTAC
F002
R002
F003
R003
CGATGGATCCATGACTGAAAACAACGAAAAAGTC
CGATCTCGAGTTTTGAGTAATTACCGTAATCCACG
CGATGGATCCATGGACAGAAAGGTATTGATGCTGGC
CGATCTCGAGGCTACCCACAACCTCAAAAATC
F004 CGATGGATCCATGGGTGAATTTTTAAATAAAGTCTC
R004 CGATCTCGAGATTGAGATAGTCAGTTCCATAATC
F005 CGATGGATCCATGAGTCAATCACGGGGCTATC
R005 CGATAAGCTTTGCGCCCGCTTCAGCTGCGTC
F013 CGATGGATCCATGATAGATGTTAACACAGTG
R013 CGATCTCGAGAGCCTTGATGATGTGTGC
F014
R014
F016
R016
F015
R015
CGATGGATCCATGAAAAATTTCGCTCTCATC
CGATCTCGAGACGCGCAAGCGCCGCG
CGATGGATCCATGATTGAATTCATCGACC
CGATCTCGAGATTCGTCAACGCAGCACAG
CGATGGATCCATGAGTTATTATCAGCACC
CGATCTCGAGCACGTCCACCTTGCTCAG
F021.2 CACTTATTTTTGCTAGAAAAGAAAAGATTTTTTATATAGCTG
R021.2 CAGCTATATAAAAAATCTTTTCTTTTCTAGCAAAAATAAGTG
F022.2 GTATGGCTTTTGAGAAAAGCTAAAAGTATGATTATGGCTTTACC
R022.2 GGTAAAGCCATAATCATACTTTTAGCTTTTCTCAAAAGCCATAC
F023.2 GGCTCCAGTATTTATCGCTATTTACAACTATAAAGCGCC
R023.2 GGCGCTTTATAGTTGTAAATAGCGATAAATACTGGAGCC
F025.2 CTTTTATGCTCCGCAAAATGCTATTTTAAAATCAGACATTTTACAAGC
R025.2 GCTTGTAAAATGTCTGATTTTAAAATAGCATTTTGCGGAGCATAAAAG
F026.2 CTTTTATGCTCCGCAAAATGATATTTTAGCATCAGACATTTTACAAGC
R026.2 GCTTGTAAAATGTCTGATGCTAAAATATCATTTTGCGGAGCATAAAAG
F027 GTAGATGGTGGAAAGGCTTTAGGTAAGGATAATTTTTTCCC
R027 GGGAAAAAATTATCCTTACCTAAAGCCTTTCCACCATCTAC
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Figure 1: Alignment of archaeal OTases with PglB (C. jejuni) and Stt3 (S. cerevisiae)
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(1) ---- MSQSRGYLDDNPELESALEWAER---------------WYHVPVLLVLLGFMLWNR
(1) ------ MSD---EQTKYSPSIAELARD---------------WYHIPVLSVLLGFMLWNR
(1) --- MGSRSK---TDNKSDQSLLDILTD---------------WYHLPVLLLIVGAMFAIR
(1) ---- MSQSRGYLDDNPELESALEWAER---------------WYHVPVLLVLLGFMLWNR
(1) ------------ MNLSSISRLN--------------------ILLGIIVFCFVILGLWIR
(1) ------- MDNKNLAIL--------------------------IAPFIIAILLVLAVFAVR
(1) MYIKVKLMSNALEKINNFFKEKSW------------------IKVFLIILMLMFVSFQLR
(1) ------- MGEFLNKVSDFFKKNEK------------------IKIILILLFIGMMSFQIR
(1) ------- MTENNEKVKNSDSANNQSSKNSKFNFNFEDKKVKCAKTILIIIFLAFLSFQMR
(1) ------ MVKTKVKKVEKGK-EGEEK---------------RSTYVLLKKVLIPILVFGFA
(1) ------ MVKTKVKEEKEEKSEKSEG---------------KSLYPLLKRILIPLAVIGFG
(1) ------------------------------------------ MKIDKRLMVIVAIATLFR
(1) --------------------- MDFN---------------KIFRPKIALPMITAVALILR
(1) ------------------------------------------ MDRKVLMLAVILFALAVR
(1) ------------------------------------------ MTRLRGTLSVCIDAFPAW
(1) ------- MGSDRSCVLS-------------------------VFQTILKLVIFVAIFGAA
(1) ---------------------------------------- MLKKEYLKNPYLVLFAMIVL
(1) ---- MQSVKGLRRDLRKMS-----------------------FIDLPLIVGLSLVSILIR
(42) VRSWENFIV-DGEVLFS-------------G HYRSTQY-------------VVNNWP
(37) LRSYDAFIR-EGTVFFS-------------G YLRQVEY-------------TVRNWP
(40) MQTYSNFIR-DGEVFFS-------------G 1HFREVMY-------------ITEHWP
(43) IRDYGRHIAADGTVLYR-------------G PYYHYRTTNY-------------VLENYP
(29) LLPSDFLLESIQPIVSS-----------------PWYTVRQVEQ-------------IIHHFP
(28) AETINLGGITNSSQKALYQ-DDSGMPYFTEI SYYNYRLTENYLKNGQ------LGDTVV
(43) AQTADMKFAQDNEFLKDMFSDEHGRMYLLA PYYYLRLSENLYNNGHC--GDTIKVVDG
(36) AQTADMAFT-DNSYLQDMFSDDNGRMYLTA PYYYLRMTENYVNNDYSNVGETTVGIDG
(54) AQTADMGFT-TNEQYLDVFSDDNGRMYLT PYYYLRMSENYLENGHT--GDTLKNIDG
(39) IYAFYLRHLTAGKYFP--------------D TFYHFEIYK--------------LVLKEG
(40) IYAYYLRHLTAGKYFP---------------D TFYHFEIYK--------------LVLKEG
(19) MIPFRLKYLVG-------------------S PYFHLAYIE--------------EALKAG
(25) LIPIRFRYLLG-------------------PY'HLAYIE--------------EALKAG
(19) FQNFGEIFDSGIYYTG- --------------- SYYHMRLVEV-------------MVKES
(19) TRPLALAFVVYALSFGMR-------------MLEYPAWQNPEY-------------MLDGEY
(34) SLSANWPLAVN---------------------EFPWYLFYNALLIA------------QVHGNW
(21) AVYFSVFCRFYWVWWAS------------EFNEYFFNNQLMIIS-------------NDGYAF
(29) ISSRLFAVIKFESIIHE--------------FIPWFNYRATKYLVN-------------NSFYK
(77) ATMPFDPWTYFPYGTSTGQFGTLLDQIVATVALIIGLGSPSE-QTVAMTLLFAPAVLGTL
(72) ATMPFDPWTEFPFGRTAGQFGTIYDQLVATAALVVGLGSPSS-DLVAKSLLVAPAVFGAL
(75) SPIPFDAWTGFPYGKWVGQFGTLYDQVIATVALILGVGSPTQ-ALIGETLLIAPAVAGAL
(79) FNMPFDPWTSFDTGTRVGQFGTILDQLVATAALIVGLGSPSE-ETVILTTLFSGPVLAAL
(64) NYSWFDPFLSYPNGKIVDWGPVFPLFSSLIALILNASIQG---DIIRAISWVPVILGMV
(81) AVLPAFYIVRRATGNTWGAIVAGVIAGAAPAYFSHTYGGFFDTDMFNVLLPLMIVVFLTE
(101) KETPYDLYQYAPPGHPLPWE-PPVICLATLAIYYIWHSIDLT-VTIMNAAFWVPAVLGML
(95) ENIPYDTIQYAPPGREAGLV-S-ALSIATVLVYSVWNSIDST-VTIMNAAFWVPAIMSIF
(111) QQVPWDSYKYGPTGARATFN --- LLSVVTVWVYQVWHAMDST-VTLMNAAFWVPAILSMF
(73) LPRYYPMSDAPFGSLIG--- ELPGLYLLPAAFYKVVSLFG--YNELQAFLLWPPFVGFL
(74) -LPKYYPMAEAPFGSLIG --- EPLGLYILPAIFYKVVSVFG--YNEFQAFLMWPPFVGFL
(47) EWFNFFTYAGGPWGLQVRLF-HPLGLWATPAYIYKLFSFLG--ISLYTAFRVTPVIFGVL
(53) KWLNVFTIANGPWGFQMRTF-HPLGLWATPAYVYKLLKIFG--LSLYNAFRITPVIFGIL
(52) FRPDYDYYINYPFGLKITWP------PPLFDYILAFPGMLFGF-HSSEIFAVFLPVILGVL
(55) LLATHIDAYHWIAGAEGFEFG--AGHPMSELVRLAAAFTG-TTPAAVGFWLPPVMASL
(66) YAVPPDVLGWFPWGYFIELGNTIGLPFLVALASLPFYGTYGA-NAVYTVAIFSDILLAGL
(59) AEGARDMIAGFHQPNDLSYY------- GSSLSTLTYWLYKITP-FSFESIILYMSTFLSSL
(66) FLNWFDDRTWYPLGRVTGGTLYPGLMTTSAFIWHALRNWLGLPIDIRNVCVLFAPLFSGV
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VAVPTYLVGRRLGGRLGGVTAVTVMAFSTGGLLQRSRVGFSHHVAELALFQILGVLGVMV
TVIPTYLIGKRLGGRLGGLFGAVILMLLPGTFLQRGLVGFADHNIVEPFFMGFAVLAIMI
AVIPVFFIIKSLSGRIAGIFGAVVLMLLSGTFLNRTLVGVADHNAIEPLMLGIAVFGLVV
CAIPLYFIGKRLGGRFGGIIAVVVLALTAGQFLTRSVAGYYGHHVTBVLFTLIALLVGMK
LIPLCYMFGKIIWDVKAGWFAAILICVVGGETLFRSFFGDVDHHIM$VVVTSSFFISYFI
AVLPAPYIVRRATGNTWGAIVAGVIAGAAPAYFSHTYGGFFDTDMFNVLLPLMIVVFLTE
LGIPIYFVVRRVTNSNIGGIAGAIALISAPGLLYKTCAGFADTPIFSVLPILFIVWFILE
LGIPVFFIVRRNTASNIGGLVGALLLISSPSLLYKTSAGFSDTPIFEILPLLFIVWMIME
LITPIFFTVRRITSSDIGGAVAAILASLSPSIFVKTVAGFSTPILEILPLLFIVWFIIE
GVIAVYLLGRKVLNEWT-GLWGAVVLTVSTANFSRTFSGNARGDGPFMALFIFASVAMLY
GVIAVYLLGRKVLNEWA-GLWAAVILSVSTANFSRTFSGNARGDGPFMTLFLFSLVAMLY
TVVFFYLSLKLYNRDV-AFIVGLFLGVNYGHIFRSMANYYRGDNYMLFWYSVALLGIAL
TIAVFYWALLKLYDEKR-AFFASLFLAVSFGHVFRSMAGYYRGDNYMLFWYSISLLGIAY
SVVLICLTALQIVNNQTFALISAFIYAAAPVAVWKTVLGQADHHALVIFLFLLSAYLLLK
VAVGVFGWAAALGGVEAGVCAG-VLASLAPGFLARTLLGYCDTDLVTLLFPLLMGLGPAF
GVIASYLSIESITNSRLAGYMAAAIIAVSPALTYKNLLGGLPKTSWGAVFILFAIFLLNQ
VVIPIILLAN-EYKRPLMGFVAALLASVANSYYNRTMSGYYDTDMLVIVLPMFILFFMVR
TAWATYEFTKEIKDASAGLLAAGFIAIVPG-YISRSVAGSYDNEAIAITLLMVTFMFWIK
AVSVAARDKPIYEQFIER------------------------------------------
ALTVADREKPVWELVAAR------------------------------------------
AFQKAEATMPVWEVVYEEVFD---------------------------------------
MVAVAQREKPIYEFVRTR------------------------------------------
LLSYFN-------------------------------------- -----------
SVYAS-----------------------------------------------------
SIHSQEKTALFKKDLKNPISLFVIAALIIELIIGAYLNIASGESVVIASILFYTVSLAFI
AIHE------------------------------------------------------
AIHYS-------------------------------------- -------
YLKES----------------- ------- ----------------- ---
YLKEN-----------------------------------------------------
GLKTR-------------------------------------------------------
AFSTR-------------------------------------------------------
---------------------------- -----------------------------
WMARFMFTPLQVAR--- -------------------------------------------
GLKKK-------------------------------------------------------
MILKK------------------- -------- ------------------
AQKTG------------------------- ----------------- -----
-----------DIDALRDTISWSMLAGVAIAMYL PPGVLLLGILGVFFLLRLCLEYV
----------- DLDALREPLKWSVLAGVATAIYMWS PGILLVGIFGLFLVLKMASDYV
---------NHDIDSIEEPLKWGLIGGVLTGLYLW PPGVFIVGIVGIFTILKISSDVV
----------- EFDLLREPVLWGAAFGVTLVVAIL PPAVFLFGVFAAFLFVQLSLEFI
-------------ANNNNRTKWKAPLSTKSWSHHYFGNSKIQNLVIVLSIICGILYYLAI
--------------KPLFKGLYAGIASLFLGLFALS SGYTYMVLLTFGTLILFIPISYI
LAGLIIAGIKKLKGNELEFELFALLAVILTAVSPK GAWWYGFDVITAFLVIYIIALAL
------------ QENSKKSGIFGGIAAILIGLYPM SGWWYAFDITAGFLVLYTAYETL
------------ KEKNYKSLIYGLLATLMLALYPF SAWWYGYYIVIAFLVIYAIYKGI
------------NKT--RKIIYGTLFVLLTVISLG GSPFGLMVLLGFASLQTIILFI
------------ DIK--KKSLWGAVFVLLASISLG IGSPFGLMVLIGFASFQTIALFI
------------ SKY---RYLFYLLPGIATGFASA QAYYPIFVFVLAGGLLLGVTAYL
------------ ERLGHKSLAFYAVPALASGLAAA QAYYPIFVFLLASAVFLGVGDFL
------------------ DGVWKILAGLPMLFMAL GSPIYGALLAFSALVH-----F
----------- RLLARRTGTSDVVPDAVAVMMTSRGEADDDWHGGALSPRWLALLAGSGL
------------------NIWYGIPAGIVLFLAEISIGGYTYIDLSLLVAAFLLILLNRN
------------------ DFFSLIALPLFIGIYLWWYPSSYTLNVALIGLFLIYTLIFHR
------------------ SIMHATCAALFYFYMVSAGGYVFITNLIPLHVFLLILMGRY
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HDS-----------------------------------SPEHTAIAGAITMVTAAVVSAS
RGR-----------------------------------SPEHTAFVGAISMTVTGLLMFI
NER-----------------------------------TPEPTAFAVVVTMSVVAVMSLI
RGH-----------------------------------SPDHIAIPSVVAMVATAVLLLP
MTMP----------------------------------TCTLIAIIIALFTFFLPVLITE
MDK-----------------------------KDGKDLSNKKQWLKNNPATLPLVVFIIL
LKS----QVKIKEFINIG--------NLKNIVYLSIFYIFGSFVLLVAIYGMGIAISPITS
-------- TKSKN-------------LKNVITTSLITLVGGAILVSLSTGLSGFINWILS
SYNSIAKYTKSKNNNHKDKIESEKLEMLNILKISGLFIIGGAVLITALYGVSTTMNALQA
FGK--------------------------------LEELKKFVKEFYPAYLAILAFGYAL
FGK--------------------------------IKELKKFVKEFYPAYLAILAIGYGL
KS---------------------------------PKLFLDSILIVLSTGLGVLIANILG
LGR--------------------------------DRYILDGILLTVSTAIGALIANYLG
DRK--------------------------------------ALRLVAASYLIPAISFVLY
VGSWG-----------------------------AEWHSLFPYLIRYDVVLLFGCICVFG
DE------------------------------------------ITANLYTIMVVVTSFL
KEK-----------------------------------------IFYIAVILSSLTLSN-
SSK-----------------------------------LYSAYTTWYAIGTVASMQIPFV
RINVLEITATAQSLLQPGLALAVGFGCVFMAWLARFMEQREYGQYVYPATVFGILAFGAV
PIEEPGFGVTDFGFLQPLFSLGVALGAVFLAALARWWESNDVDERYYPAVVGGTMLVGIV
AIDRVQFDTTSLSLLQPVAAIGVAGSAIALSWLARIWERKNIDISLYPVAVTGLATVGIA
FIQTTELTVTDYSVFHLAFALGVAAGAVVMAGVARLWERRDIARRAYPAGVVGVGLIVGA
KSDYSRIFVMNGIIFGLFIILFALSGIQVSGWSLGQYSIIHLFIPAGIIAESGILYILSR
SIIILALTVGSSMFESITTVLGSATSLQSATAGTAYPNVYVSVGELQIPQVIDVANQSGG
PLGYNQILSTYTQTTGWPNVYTTVAELAKPSSWSEIFTNAIGSDTIAIVGILGILLSFLS
PIGF-TVINEATKITGWPNVYMTVSELAIPT-VTDIIENSVGNIWLLIAGISGILLSFVS
PLNY-LGLDEVSSQTGWPNVLTTVSELDTAS-LDEIISSSLGSIHLFAIGLIGIFLSLFR
TFPGIVKIGGFIRFAFEVFLGLIFLLVIMLY-GGRYLNYSDKKHRFLVVTIIVLLGFGGA
TIPGIAKIGGFIKFAFEVFLGLVLLVTIMLY-GGKFLNYSDKKHRFAVVAVIVLLGFAGA
DVKGYGMLG-YTDWMGKKVAETFGLEFGFIK-DAYLLIHVKYLLPLSLV-FLGFLIITKK
ARVGYGMLG-YDRWLSKTVAEKLSLELTTVR-DAYLLFHLKYLVPLALAGLLALLALSKF
PPVGISFFG----------LAAFLFVGSVVKGYEDRFRNATIYYIALSLATVLIIYFIPLP
RPGMRRALLVGGLAYALPMLVGAWGLLFALALGWGLHRADARFMAFVRGRALPVAGWCAV
TSLAPNNIGFMSGLAHGFSLLLISAVLYLDLYLSRTLPKEIVDSRNLIVIAVLIFILTLG
-------------------- IAWFYQSAIIVILFALFALEQKRLNFMIIGILGSATLIFL
GFLPIRSNDHMAALGVFGLIQIVAFGDFVKGQISTAKFKVIMMVSLFLILVLGVVGLSAL
LMAVLTP--------DLWSFFTNNVMRIIGLTTSETANTVGEASPLRNAGVLFDR------
LFSLVLP--------SVFDSIARNFLRTVGFSAGAATRTISEAQPFLAANVLQSNGQTAVG
VLSLLQI--------GLIDLITGNLLRIVGFSASATARTVGEAQPFVSQGSLRRFGVSIPG
VIAVALP--------SVFDFLISQVERVAGFGATDTRATIGEAQAPDSPVSFFFAN-----
FIVAKNRFFYTGILLMIFFVFSALLILINSEISNSFTNMVTRFFALNGTSVTIQEMQSSN
LFSLLYA--------VAALFMLGYVLRKKPVNKDKKDETEEKTETIEDKKPRNRRYTPKTK
LRYE-----------KVKLDIKYSILLAIWLAVTLYAATKGIRFAALATPPLAIGLGIFVG
FKHD-----------KQKIDIKYALYLTLWLIATVYAATKGIRFVALMTPALAIGIGIFAG
KVLTPVKQISN-GLAEKLDIKYALLLIIWFAVTFLAASKGVRFVALMVPPLSIGVGIFVG
YAYVG----------PKLFRLMGG----AYQSTQVYETVQELAKTTIGDVKAYYGVESGNG
YAYVG----------PKLFRLMGG----AYQSTQVYQTVQELAKTTLSDIKLYYGVEGNNG
LNPK-----------IKVGVLVGGSILAFIVMLVKFPALKDLSTGFGTFREVPISETLPPT
IRDKRL---------RTLTVLVFG-ALAVYLLFARFEGLKDLSTGFGIFNEWPISETRPST
HFEFVKG-------------GINYIFGANIYLPTISEARSLQIFEIISASGYIYFIFALIS
AVLLFDP------DVFRMFRLNSIAGYVKRSGDPSPGAGGDDPLVYPSVAQSIIEVQDLS
LSG-----------------LSILRPTSAPIPSRYYAIINPFYQVTVPIDKTVAEYIPQP
ILSGG-----------VDPILYQLKFYIFRSDESANLTQGFMYFNVNQTIQEVENVDFSE
TMYGLIAPWTG---RFYSLWDTNYAKIHIPIIASVSEHQPVSWPAFFFDTHFLIWLFPAG
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M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
H. marismortui
H. volcanii
H. walsbyi
N. pharaonis
M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
H. marismortui
H. volcanii
H. walsbyi
N. pharaonis
M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
(348) ----- HGFAVIVAGIGGLLLLGKQFLSDDAP-----------------------------
(343) RIMSEYGFTFFTGALAAVWLVAKPLVKGGNSRKIGYAVGSLALIGVLFLIPALPAGIGSA
(351) RIAVEYGLTFFTGLAAAFILHAKPLFKKGTQRAYAYLGVGISIIGLLFLAGFIPDALETV
(350) ----- YGLGIYTALAGFGLLLYRVFSTKRPQ-----------------------------
(319) IFTFLKVFNITAILSCFGFLILCFQFYRTKN-----------------------------
(339) KAEEVMHHEDVFKPGRYELTSKEKYNNLFLY-----------------------------
(448) QLERFLKMKSDIAIFGIGIP-AGIFGLLILS-----------------------------
(361) QIENIIKR-YEKKVEYILYPVIGILSVITLI-----------------------------
(398) FIEQFIKNNLDKKYEYVAYPTIAIIVLYALF-----------------------------
(324) LIFFLSIPGLLILLTKYLYDLFKKAKSDNET-----------------------------
(325) LVFFLSIPGFLIILGLYLNALLKKSESSNEY-----------------------------
(297) LDDLWRAYNIAIFLAALYILRLR--KIRSGD-----------------------------
(308) FHDLWSAFAVGLFLAPLFFLRFRPGKVRVQD-----------------------------
(275) VLFFRNRFVLSMFFLSFGFVWLLRKHKSMIM-----------------------------
(322) LSEVLSYFHPWLWVALAGLGGFVPLLLARPA-----------------------------
(310) ITAMIQDFGIALFLSVIGMYYLIRRGNLVGL-----------------------------
(276) FMRRISGSEIVFLFSLFGFVWLLRKHKSMIM-----------------------------
(317) VFLLFLDLKDEHVFVIAYSVLCSYFAGVMVR-----------------------------
(395)
(396)
(404)
(398)
(379)
(392)
(498)
(411)
(457)
(371)
(372)
(347)
(359)
(323)
(375)
(353)
(325)
(374)
(421)
(456)
(464)
(424)
(410)
(423)
(528)
(441)
(488)
(402)
(403)
(376)
(390)
(354)
(406)
(384)
(356)
(405)
--------------------------- AEEMLVVVWAVFILLATFTQRRFAYYLVAPIAV
LGVEPSLVSLTIVTALIVGAVMQADYESERLFVLVWAAIITSAAFTQVRFNYYLAVVVAV
TGLDEQVAALLVVSAIIGGATFLASYDADKLFIIVWAAFITGMAFTQVRFNYYLAIVVAV
--------------------------- AEYLLIAVFSAFMLAFTLTQVRFDYYFVIAVGA
--------------------------- PLNLAVIIWASVYIVISLLVVRFQYYSGEIFVI
------------------------------ VLTLLWILGIAIMLTQGTRFIEQFAVPVAL
------------------------------ KYS----AKISQILLPTTYVPIIAYGFLIV
------------------------------ KYS----GELFNILVPTTYVPIAVYLSIIA
------------------------------ TIYRADSADLVRMLLPSNYVPIAEGIMLAS
------------------------------ LFALVFYTMSLYLLYLAVRFLFLASYAVAL
------------------------------ MLSLVFYIMSLYLLSLAVRFLFLASYAIAL
------------------------------ AILLGYVITSLWMLRYWTFLFLASYAIAL
------------------------------ FMLLGLVLPSLYMIKTWTRFLFIGSMGVAL
------------------------------ VPSALLSAYLVSLVLERLEYPVFEKADEEE
----------------------------- AFFLLPLGVLSFLSVKLGGRMVMFGAPVLAL
------------------------------- WLLVLGVASIFGTSEQPYLFNYTAYMVAT
-------------------------------- ALPILVLGFLALKGGLRFTIYSVPVMAL
------------------------------- LMLTLTPVICVSAAVALSKIFDIYLDFKT
LSGMVVGRFIRWFDFSAD-----DGIEYYQVMTILTVLLVIVVPLFAFGTTP---------
MNAYLLREALGIDFVGLANVERFDDISYGQVAAVVIAVLLILTPVLIIPIQLGNGGVSQT
FNGYLFGQLLGYLDLKRSLTSLKNDIDGYQVLAIGAAILLILGPGLAVPISLGNTTTSPA
GNAYLVGWVYQYVDLDNVR-QDFTNIQPYQILIVIAILFVIAGVPLVTGATLA-------
LAGVFLSALYDKIQVRHHKIQKNDKNKFFWKIIFINNKGILCIGFLITMITILSIPVAME
LSGLFVGIMVKYIDLKTENYSYVALIAAILVLLAVVSPLYADHLASS-------------
LALLAIYKISDIISTLNDKKETIIKVSTLLLCIGVVIPPLSAVVPFS-------------
LLVLAVYKIIDIISE---KEQAVKKVFGILLAFMLVFPSMAAAVPFY-------------
LAVLIIYKVAELIAESN-KKLVMNKIFMILLAIGLITPTIATIVPFY-------------
FFGIFIGFSMDVIEKMKENIGIKAALGIVLSLMILVIPFVHAPVLARSARALK-------
FSGIFAGFTMEVIEKMKENVGIKAALGIAIAVMILMVPITHGPVIARNAKALK-------
LSGIG---VYELTRRIKENKIRITSLGVVILLS---SAFSLGEVYS---------------
MAGIGLLELYEILPRFEGRKGLAVALGLLLFVPAVDTAIGFEKVAA--------------
KSRRRKRKDRKVKQKNAEVEWKDHAVVAAFLVILAIPCIVVAVVPFD-------------
GFALPMVWGVQRVLRHDLRTGWVRLALSAVLLVIVATPFVDLLPAMT-------------
LGGLGVYYISDNLLKGVKNGNGNKILVGFILALVGISLVADAGLATLASNEPP-------
GFGFLLSEFKAILVKKYSQLTSNVCIVFATILTLAPVFIHIYNYKAP-------------
SDRKYAIKPAALLAKLIVSGSFIFYLYLFVFHSTWVTRTAYSSPSVVLP-----------
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marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarensis
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarens is
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarensis
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
(454)
(516)
(524)
(457)
(1)
(453)
(554)
(467)
(517)
(432)
(433)
(406)
(420)
(384)
(437)
(413)
(384)
(434)
(501)
(576)
(584)
(509)
(503)
(500)
(601)
(511)
(564)
(485)
(486)
(446)
(466)
(431)
(484)
(466)
(431)
(483)
(559)
(633)
(643)
(566)
(550)
(524)
(624)
(534)
(587)
(508)
(509)
(469)
(489)
(460)
(507)
(496)
(452)
(511)
-VEAGSTGPGPSIQ DESLQ
AMQASQTGPG-TVT DGSLT
WEAAQNNGPG-AVT DDSLE
-TADDASQPG-EME TDSLD
VGLNETPKDS-INDE IQSLK
-QAVGSTNDD-----MYNTLT
--VAPTFNNG----- KEGLD
-- TAPTMNNG----- DSLS
-- SVPTYNDG----- EGSLE
-- NTEIEVTG----- EQALK
--VSEIETTG----- EQVLK
-- VKPFMNEN----- EKALI
-- VEPFMNEH----- ERALT
------ LTED----- EALE
MEGNTPAEGAYGSGGDAT-LEHYGTYERQEDFDZQEGQ
MQNNTPANGEFG--GESNRMEYYGTYEYTDDFDYPDGA
MQGNTPEEGNLGGAGNADEMELYGTYEFTDDFEYPAGT
LSEETPEPGAYG-TGDDPRLDYYGTYEPTDDFEYEAGE
LSQQNNTDVP------------DYYSIYKESFSYPQNI
IKANTSQD------------------------------
IKANTPNN------------------------------
IKSETPEN------------------------------
INTQTPNN------------------------------
LRSNTSKY------------------------------
LNENTSKY------------------------------
IRENSNEN------------------------------
LGENSNEN------------------------------
MRTSLEEQNYLN--------------------PYEKPE
-- QGPIINKR-----HAEALRHIRTATPED------------------------------
AITNAATSFLTTNYSIVSAANIlRTHSPQN------------------------------
--- TVFSQNE------ASLLNQLKNIANRE------------------------------
-- SQTPDGKLALIDDREAYYILRMNSDED------------------------------
YGVL
YGYM
YGVQ
YGVL
STVI
TVLA
SVIT
SVVT
SVVT
ATAT
ATAT
DIVL
DIVL
YSVM
SMVW
AFVL
DYVV
SKVA
IWIT--TRAERVPNANP-FQQGTETVAPFLVAQNETQANNILDST--DED
WIT--VLGERIPNANP-FQGGATEAANYLLAEDEQQAESLVTSMGDDGE
iWIT--TQSNNIPNANP-FQQGATSAANFLLSPNETQSHTVLNEQ--STE
4YIT--TRGERIPVANP-FQHHATESADFLLADDEDEALDLLDEN--HGD
*WIL--VLAHKIPATSP-FODNIVPVAKFLLADSNIQAEMIASQL-----
iLFT--AVADRQVVFDG---GSQNNMRAYWIGNALTSTDEAKSAG-----
IIYT--YEARRMVTFDG---GSQNSPRAYWVGRAFATSNENLSIG-----
IIYT--WATRKMVTFDG---GSQNTPRAYWVGHAFSTSDENLSVG-----
IITY--WKTDRMVTFDG---SSQNTPRAYWVGRAFSTSNESLANG-----
(WIESSLLGNRRASADGGHARDRDHILALFLARDGNISEVDFESW-----
(WIESSLLGHRRASADGGHARDRDHILALFLARDGNVSEVDFESW-----
IFVT--YYARRSPVAQG---SPNSGVAGYYLGLVDNGWAQSLG-------
rWVT--YYARRAPVAEL---APNTGVALYYLGKRDENWAMGLG-------
2WIL--YVSKKAVVCNN-FQAGAVDAAKFFTAKSEDEAIKIAKKR-----
fSAH--HFAHRRTIADG---ASHGGPSLYVPAAVFSTANPRFAWQ-----
UlE-VLTNRSVIDENNTLNGTQIRLMAEMFLNNETFAANVLENDFHLYP
fPVR-YYSDVKTLVDGGKHLGKDNFFPSFSLSKDEQAAANMARLS-----
EQIG-GMADRTTLVDNNTWNNTHIAIVGKAMASPEEKSYEILKEH-----
DAKTRYIAVDWKMAETNGNLNGKFFAPATFAD---GVEPGDYYSRMYIQSQDGAR-----
GDQTRYVMVDWQMASTD----AFKSAPTVFYD-ESNISRSDFYNPMFRLQEQGEQTTVAA
GNQTRYVMVDWQMATPG----SKFGAPTVFYNAEPNVSRSDFLRTVYQFNQEGR---FSG
GEGVQYVMVDYQLGYAG---TQKYGAPTAFES-EHDISDGDVGIQVIN-PETGEF-----
-- HGKYIITTNEYLFNDFPMIQKWIPAQPDEDPYYFVFYNRASKTSSILTPMLG------
-- ILRMLANSGEDASNT----LDLYTNNTEKTVEILNAILPMDRTEANSALTGT------
-- IIRMLATSGDEAFKKGSVLMNFTHNNVSKTVKILNEILPVDRSKAYDILTKK------
-- ILRMLATSGDSAYDDDSILIKKTG-SIKDTVDILNKILPLTRTEAKASLVNN------
-- IFRMLASSGDKAYTTDSVLIKKTG-SIKNTVDVLNEILPLTKSDAQKALKNSS-----
-- ELNYFIIYLNDWAKFN--AISYLGGAITRKEYNGDENGRGRVTTILLTQAAG------
-- ELNYFIIYLNDWAKFN--AISYLGGAITRREYNGDETGRGQVTTILPLQGSG------
--- VDYVIVSLYDILKFE--AIVDTAKLSRKWENISRADYG---VDFLKLTEST------
--- VDYVIVSYYDFLKFG--TIVDTAMMCSRCN--VSENYG---LVVLPMVSSA------
-- GVRYVVTADEITMKDAN------------------------NTKFPAIMRIAG-----
-- LIRYTAERGG-------------------------------IPGSVFEGMGG------
YGSPNYTIPVYIVAYDAVTFVYAGSQAQWYVGYPPSFPGAFFGYTTSLGDIGKAMG----
---VEYTEKSFYAPQND-------------------ILKSDILQAMMKDYNQSN------
-- DVDYVLVIFGGLIGFG----------------------GDDINKFLWMIRIS------
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marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarensis
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarensis
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
marismortui
volcanii
walsbyi
pharaonis
hungatei
stadtmanae
jannaschii
maripaludis
voltae
horikoshii
abyssi
furiosus
kodakarensis
fulgidus
vulgaris
solfataricus
jejuni
cerevisiae
(614)
(690)
(698)
(621)
(602)
(574)
(674)
(584)
(637)
(563)
(564)
(517)
(537)
(512)
(557)
(555)
(506)
(565)
(666)
(745)
(751)
(671)
(654)
(622)
(726)
(635)
(689)
(613)
(614)
(563)
(581)
(541)
(578)
(611)
(538)
(595)
(726)
(799)
(809)
(723)
(710)
(677)
(781)
(690)
(744)
(666)
(668)
(612)
(633)
(592)
(633)
(666)
(593)
(650)
QITFQQQAYYETMTARLYRFHGSAAEPQPIVVDWENKQTGQGAQYRGAPTNEQEPEGQRQ
ASSLKDQRYYESLMVRLYAYHGSAREASPIVVDWEER-----TSADGSTTFRVTPSDGQ-
TTSVRTDRFYNSTMTRLYYYHGSARQPSPIVVDWENRRV--QTNDGGDITVAANPRGNQS
VYGAHTQRGYDSMRVQLYQHHGSAQEPASFTLQLGEY--------DEASGIATIPEGAQP
----MKPAFFNTTLVKLHANDGSYVHANGSVVIQYQSTIVSGKEVPLLQKMYPIDQTQTI
----- YGLSQQEANSVLDLTHPAKVKPVNLILSSDMLSKAAWWSYFGSWDFKNQNSTHYS
----- YGLSDKKAKLVLNATHPEHPNPDYLITYNRMTDIAPVWSMFGFWNFSLPPNTPND
----- YDLTDAEAEEVLDLTHPKVTNPDYLITYNRMTSIASVWSMFGNWNFSLPASTENS
----- YKFTDTEVSEILDATHPKVTNPDYLITYNRMTSIASVWSYFGNWDFNLPAGTSRS
------ NVYVNPYARIVIKVIQQNKTRRIAVNIG-QLECSPILSVAFPGNIKIKGSGRCS
------ GIYVNPYAGISVRVVQSNTTSKVTVNVRGRAECSPIYTLLIPGNKKIPGNGRCS
------ GSILRFDSQYSTLIVKEG---NIRVILSGKVVY-PREAIIES-NGRIKNLKYPA
------ GALVFRNSGY-TVVARPGEKWDVKISVSGHVFG-PREVYVEYGDKIIKPNITPS
----- YNVDLMTEGEILNFFNHTVLYRLHMENAENLTHFRLVKEFGDVKIFEVVGS----
----- AQAQELVHRLGIEKMTFADAPRQYLVVSYDMLRLGFWITNFGTWDFLSREGKGYA
----- AMTTIAGYPLDEYVNLTEINNTITQIINTYATTNPTIAQTLASQVSQAEPFAWTP
----- VDLFLASLSKPDFKIDTPKTRDIYLYMPARMSLIFSTVASFSFINLDTGVLDKPF
----- EGIWPEEIKERDFYTAEGEYRVDARASETMRNSLLYKMSYKDFPQLFNGGQATDR
GQIVRQFESMEQARQYVEEDATAQIG-----------------------------GFGDN
-- AVRTFDNMSAAEEYVANDPTSQIG-----------------------------GIGTF
-- TVRTFNSMREAEAFVANDTTSQLG-----------------------------GGAY
DDLIQEHASPEEAREAAQAPNVIHGG-----------------------------VLGQ-
QFLSQPWSNTEIISLMYTS-----------------------------------------
YYPSQSNIENINGREFTLGMDNGVIG------------------------------VSSP
KREKGAFFKGTAYYLGNG-----------------------------------------T
DREMGYYQQLGGSAQDING-----------------------------------TTVVYI
EREAGSFQGLQTYATNIND-----------------------------------TLIVRS
DGSPFPYVVYLTPSLGVLAYYKVATSNFVKLAFGIPTSSYSEFAEKLFSNFIPVYQYGSV
DGSPFPYVLYLAPNFGLITYYKVATSNFIKLAFNIPISKYSGFTEKLYSNFVPVYGGNV
RSGVYVYVN---------------------------------------------LDYGYA
ESGAYLYIN---------------------------------------------LNYNYA
------------------------------------------------------------
ISSIPQQLSYSLDTGEVQVQG----------------------------------NTTGV
KAYNSLIVQMFIESLYQIG-----------------------------------------
TFSTAYPLDVKNGEIYLSN--------------------------------------GVV
-------S -EE L---------------------------------------------
PSERVSAMEHYRLVGSS-------------------------------------------
PEERVSALEHYRLVKSSNSSALRSG -----------------------------------
PTHRVEALDQYRLVHVNNQSAR--------------------------------------
PGERTEALEHFRLVHAGG------------------------------------------
PITDTPALKNYRLIYESNG-----------------------------------------
TNETNGSTMTFAYVDQSK------------------------------------------
ILANVNVYTYSYVTLINS------------------------------------------
PLQETDSYRVINILEITD------------------------------------------
LIQQTAEYNIYTLIEVRN------------------------------------------
IVYEFRPFAIYKIEDFINGTWREVGKLSPGKHTLRLYISAFGRDIKNATLYVYALNGTKI
IVYEFRPFAIYRIEELINGTWKAVNSLTPGKHELKLYISAFGRDIRNATLYVYAIG--NK
ILANEKAWETNLLRLFTQ------------------------------------------
ILMNGEAFNTNLARLFIK------------------------------------------
------------------------------------------------------------
LASTIDVFDEGQLERRDY ------------------------------------------
YGQPIAPFTTQIVPTSSG------------------------------------------
LSDDFRSFKIGDNVVSVN------------------------------------------
--------- ----- ----- ----- 
--- -------------------------
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H. marismortui
H. volcanii
H. walsbyi
N. pharaonis
M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
H. marismortui
H. volcanii
H. walsbyi
N. pharaonis
M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
H. marismortui
H. volcanii
H. walsbyi
N. pharaonis
M. hungatei
M. stadtmanae
M. jannaschii
M. maripaludis
M. voltae
P. horikoshii
P. abyssi
P. furiosus
T. kodakarensis
A. fulgidus
D. vulgaris
S. solfataricus
C. jejuni
S. cerevisiae
(757)
(828)
(838)
(753)
(729)
(707)
(800)
(715)
(769)
(726)
(728)
(627)
(648)
(592)
(659)
(685)
(615)
(650)
(774)
(853)
(861)
(771)
(748)
(725)
(818)
(733)
(787)
(786)
(786)
(645)
(666)
(592)
(677)
(703)
(633)
(650)
(877)
(968)
(976)
(878)
(804)
(786)
(869)
(784)
(842)
(906)
(906)
(695)
(720)
(592)
(711)
(729)
(663)
(683)
-------------ETEAFPNNPRYQSS---AWAKIFERVPGATIEGTG-PANATVRAAVQ
----- SYQRSLISEGNTYGLQPQALVPNNPAWVKTFERVPGATVDGSGAPANTTVTARVQ
----- SILRTTYRGAQAAGINPRTTVPPQPStVKTFERVPGATIEGSNAPTNSTVTAQVE
-----------PVQPSMFELLMTQQVGAGDQWVKTFERVDGATIEGTG-PAESEIQAAVE
-------------------- TQTFPGDVTLNNIKIFERVKGYTIPG--------------
-------------------------- LNKSLNMSTLEDKQMRSKELSDGTGN--------
-------------------------- TNISTAIVQKINGQAKIIGT--------------
-------------------------- SEIKSANAVIDSNNQTSMQS--------------
-------------------------- ETLTGAMMAVTNDGQMQTQQ--------------
IKRIKVGEIKYMNHLEEYPIIVNVTLPTAQKYRFILAQKGPVGVLTGPVRVNGKITNPAY
TEKIKIGEIEYMNHLNEKPIIVNVTLPKAEKYRLVLVQKGPVGVLTGPPKLNGEIANPIR
-------------------------- RTGENYELVYSDGGFVKFVR--------------
-------------------------- PDGP-YELVYSDGGIIKILR--------------
------------------------------------------------------------
---------------- -----------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
MRNPATNKTFVYRQRTQTDQNGNFEMTVPYSTTGYDDWGTDEGYTNVSVRAETQYQFTAI
MRDLTTGTNFTYTQQAQTDADGEFTMTLPYSTTGYDEYGPDNGYTNVSVRAAGGYAFTGP
LTIPNKNSTFTYTQQAQTTDTGAFSMTVPYSTTEYDEYGPDNGYTDISVHANDSYTISSA
IDDG-TGEAFTYTQFAETDADGNFEMTVPYATTGYDEYGVEEGYTNTDVRANTTYQFIEM
---------------------------- TGTIEVPIVTNQGRHFTYRQQSENGTFTLP--
-------------------------
TLLKPHKLIVVENNQLTEKIVNNNSNMSIMAIHQN
-------------------------
FKIHKLYIKTPLG----VKELVLNKDGQLSEFIRI
------------------------- PNFHKLILKVNGN----VYEQETNENGDYSEIVRL
-------------------------LNMHKVKLMVNENGKSKMYNSLADPDGQLSLLIKV
IMREGESGRLELKVGVDKEYTADLYLRATFIYLVRKGGKSNEDYDASFEPHMDTFFITKL
IAREGEKGTLSLKVGVDKDYTADLYLRATFIYLVRKEGKSNDDYNAAFEPHMDTFFITKL
-------------------------
FVHPNVVFR---GNKFILTGNGTG--LGLYGYLDN
------------------------- LKHPNVVVERRGGETLLQFENATGTRLGIWGFLDN
------------------------------------------------------------
-------------------------- IVRQGGSGNAIADYAARQRNIESRRNIHFLFNKV
---------------------------------- YTITGSPLPRVQLMYFQPAYIALFPV
------------------------------ SIVEINSIKQGEYKITPIDDKAQFYIFYLK
--------------------------- VRQQMITPLDVPPLDYFDEVFTSENWMVRIYQL
GANNGNRTGFTGATE------VTEGQVIGEDDDAATVELEPVTIQQ---GNGTSGES---
TSVTGNSTIVSYQAEN---VAVDEGLVNGAEDGTVQVTLERNEQELDLPGDSSSEDSSSE
PSFNESGYVVSYQAN----VSVPEGLVNGDESGAIDVELDRNAQELSIGGSSSDSDSGSD
EEG------MIAEAD------VSEAQVIGEDDSPVAVEMEP-FEESDLTDPAPDGDVTAP
---------------------- YATTNSPYDVKTTGPYRIIETNQTIDVDESQIEKYYT--
DGS---------------YFTVLFDSHLEESLFTKLYLKSGLNVTRFNMTHSEPGISVWDV
EA------DG------RGYAWLATRNLEDSIYAKLHFLDGYGLKHIKLVKATIDPTDFGI
EK----LSDG----TYQVYAWVSSKNLEDSIYTKLHFLDGYGLEKISLEKESVDPTSYGI
DKNSIIGTDGSNNPVYSSSSWMATANLEDSVYSKLHFFDGEGLDTIKLEKESLDPTANGV
KEGIKLRPGE--------NEIVVNAEMPKNAISSYKEKLEKEHGDKLIIRGIRVEPVFIV
KGGIKLHKGD--------NVVTAELNMPNGVISSYKEKLEKEYGDKLIIRGIRVEPVFIA
GTLVFKKWYS--------VKNMQEFELPNNLNGSVVVRYVYTQKIVLDRGIVRVKN----
GTKVFEKWYN--------VEGLKEFELPAEVNG-TVIRYAYAEGEKILDRGVFRRD----
------------------------------------------------------------
TG----------------ELKVLDDRLYNTVMVQLLLCSFDDTRFAPYFKLIYDNVYARV
GNG-------------------GAGGLYYTVYIMVMVYQFTQPGTVLKPTVMVNS-----
DSAIP-----------YAQFILMDKTMFNSAYVQMFFLGNYDKNLFDLVINSRDAKVFKL
KK---------------------DDAQGRTLRDVGELTRSSTKTRRSIKRPELGLRV---
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(925) -------------------------- RTPMTEDAAEAGA---------------------
volcanii (1025)
walsbyi (1032)
pharaonis (925)
hungatei (841)
stadtmanae (832)
jannaschii (917)
maripaludis (836)
voltae (902)
horikoshii (958)
abyssi (958)
furiosus (744)
kodakarensis (767)
fulgidus (592)
vulgaris (755)
solfataricus (765)
jejuni (712)
cerevisiae (719)
marismortul (938)
volcanil (1055)
waisbyl (1092)
pharaonis (958)
hungatei (841)
stadtmanae (859)
jannaschii (934)
maripaludis (853)
voltae (918)
horikoshii (977)
abyssi (977)
furiosus (744)
kodakarensis (767)
fulgidus (592)
vulgaris (759)
solfataricus (765)
jejuni (714)
cerevisiae (719)
DGTSD------GSQTNESAST-----STSASVDASAVSAAA-------------------
PSESDTATNNGASETSESSSTDSGSDSTDSSSDADSDSTAGDEGGSNSGSDSDSQSSLDS
PE------------------------EDAADEEMVAGSVDGDETADGETGDDETAEE---
------------------------------------------------------------
SEYAN--------------------TTANSTTNSSTNGTNVQTNTST-------------
QP-----------------------GFKVYSVDYGTDYLN--------------------
QP-----------------------GFKVYSVDYGTDYLN--------------------
QP-----------------------GFKVFSVDYG-NYSK--------------------
EK-----------------------EYTMIEVSASAPHHSSE------------------
EK-----------------------EYVMAEVRASAPHHGSE------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
YEVR --------------------------------------------------------
-- - - - - - - - -----------  ---- 
------ - - - - - -
KI ----------------------------------------------------------
------------------------------------------------------------
PISSPMSKRAG
------ - -
-----------
------ - -
------ - -
-- ------
-- -- ----
-----------
-----------
----------
-----------
-----------
-----------
Haloarcula marismortui (AAV45464)
Haloferax volcanii
Haloquadratum walsbyi (YP_658398)
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Desulfovibrio vulgaris (ADP86315)
Solfolobus solfataricus (NP_342526)
Campylobacterjejuni (CAL35243)
Saccharomyces cerevisiae (CAA96722)
Figure 1: Sequence alignment of archaeal OTases with PglB (C. jejuni) and Stt3 (S. cerevisiae).
Homologs were obtained using BLAST, and the alignment was performed with ClustalW.
Conserved residues are highlighted in black and similar residues are indicated in gray. The
GenBank accession number of each homolog is listed.
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